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ABSTRACT
The recognition of hookworm infection as a leading cause of global morbidity has 
led to the establishment of a major initiative to develop a vaccine against human 
hookworms. Lead candidate hookworm antigens have been selected on the basis of 
either their association with the dog hookworm attenuated larval vaccine or because 
they are homologues of the major vaccine candidates from the related species of 
veterinary importance, Haemonchus contortus. Some of these hookworm antigens 
have been established as modestly protective in recombinant form, but have not been 
tested as native proteins. Higher levels of protection against homologous challenge 
have been achieved using the corresponding native H. contortus antigen in sheep 
trials. The feasibility of obtaining native protein from H. contortus and the 
convergence of vaccine targets in hookworms and H. contortus render the latter a 
useful model to aid vaccine development against the fonuer.
Homologues of the major larval hookworm vaccine candidate antigens thought to 
play a role in the transition to parasitism {Ancylostoma secreted proteins, an astacin- 
like metalloprotease and a transthyretin-like protein) have been sought in H. 
contortus with a view to assessing their efficacy as protective antigens against this 
infection in sheep. H. contortus larval excretory/secretory proteins were collected 
and fractionated by affinity chromatography into lentil lectin-binding and non­
binding fractions. The former was purportedly enriched for an Ancylostoma secreted 
protein-1 homologue and the latter shown to contain metalloprotease activity. A 
sheep protection trial demonstrated the lectin-bound fraction had a modest protective 
effect indicated by a trend towards lower faecal egg count, a significant 16% 
reduction in worm burden and a reduction in the length of female woiTns. 
Vaccination with the non-binding fraction showed a trend towai'ds reduced faecal 
egg count and worm burden and sera from vaccinated sheep inhibited larval 
establishment in an in vitro abomasal challenge model.
The full length sequence of the H. contortus larval ASP-1 homologue was 
established, and the transcript shown to be expressed by ex sheathed larvae and adult
J
woiTTis. However, expression of the recombinant protein was not possible thus 
definitive establishment of the protein within the lectin-binding ES fraction not 
confirmed. Novel homologues of the hookworm transthyretin-like protein and 
astacin-like metalloprotease were identified in H. contortus, cloned and 
characterised. The former was expressed in all life stages and immunolocalised to 
the lining of the uterus wall and on the surface of the eggs in utero as well as in the 
sub-cuticular muscle. Degenerate PCR followed by rapid amplification of the cDNA 
ends identified full length sequence of the latter, a novel astacin-like metalloprotease, 
the protein product of which was immunolocalised to foci within the exsheathed 
larvae immediately sub-cuticular to the lateral alae, possibly labelling the 
hypodermal chords.
This work has established the modest protective effects of fractionated larval ES thus 
indicating the proteins therein to be of protective potential. Homologues of the lead 
hookworm larval vaccine candidates in H. contortus have been identified and these 
may have potential as larval vaccine candidates against homologous challenge.
XXI
Chapter 1
General Introduction
1.1 Introduction
The soil transmitted nematode helminths (STH) Ascaris lumbricoides, Trichuris 
trichiura and the hookworms Necator americanus and Ancylostoma duodenale, 
are estimated to infect more than one third of the World’s population. In 1999 a 
report commissioned by the World Health Organisation (WHO) estimated that in 
combination with Schistosomiasis, soil transmitted nematode infections account 
for forty percent of all tropical disease burden excluding malaria (WHO World 
Health Report, 1999), Hookwoim accounts for a large proportion of this disease 
burden, infecting an estimated 700 million. The numbers infected, combined 
with the iron deficiency and protein malnutrition associated with hookworm 
disease, earned it a reputation as “the great infection of mankind” (Stoll, 1962).
Disease caused by hookworm manifests itself as an intestinal helminthiasis 
caused by either W americanus or A. duodenale, though zoonotic infections with 
A. ceylanicujTiy A. caninum and A. braziliense are also reported (Prociv and 
Croes, 1996). Morbidity caused by hookworm infection is attributed to the 
voracious blood-feeding nature of the intestine dwelling adults; intestinal blood 
loss from the host can lead to iron deficiency and protein malnutrition.
Unlike, for example. Schistosomiasis, infection with hookwoim is not 
necessarily associated with dramatic clinical symptoms and mortality. Perhaps 
due to this, hookwoim disease has been somewhat overlooked as a major public 
health problem in comparison to its more dramatic cousin. It is now recognised 
that, in teims of morbidity, hookworm outranks all other major tropical diseases 
with the exception of malaria, leishmaniasis and filariasis (WHO, 2002). For this 
reason, and many more, a major initiative has been set up to develop a vaccine 
against the human hookworms: the Human Hookworm Vaccine Initiative 
(HHYI) (Hotez et al, 2003).
The nematode order Strongylida contains parasites which infect all classes of 
vertebrates and is divided into supeifamilies which include the Strongyloidea and 
Trichostrongyloidea. The hookworms fall into the former and the latter include 
Haemonchus contortus, an economically important parasite of sheep and goats.
Both H. contortus and the hookworm species have well-developed buccal 
capsules and fourth stage lai'vae and adults ai*e blood feeders. As well as 
similarities in morphology and the pathology of infection, H. contortus and the 
hookworms share a number of other characteristics; studies have demonstrated a 
number of proteins and enzymes common to both species. Research over the last 
two decades on vaccine development against H. contortus has discovered several 
highly protective protein complexes that line the worm gut (Knox, 2000). 
Contained within these protective fractions are pro teases common to both H. 
contortus and the hookwoim species (Hotez et ah, 2003). Studies focusing on 
antigens excreted or secreted by adult //. contortus have also identified protective 
fractions that contain proteins with homologues in the hookwoim species 
(Schallig et al, 1997). The similarities between the protective antigens of H. 
contortus and the hookworm antigens and the wealth of knowledge gained from 
sheep vaccine studies in the veterinary field combine to suggest that H, contortus 
could be used as a model for vaccine candidate selection and evaluation for 
hookwoim.
Support for the feasibility of vaccination against hookworm comes from the 
collective knowledge that protective immunity can be stimulated by antigens 
secreted by living larvae; dogs can be highly protected by vaccinating with 
radiation attenuated A. caninum infective larvae (Miller, 1971), and the evidence 
from the veterinary field that protection against H. contortus can be elicited using 
antigens of the adult paiasite gut and antigens secreted by the adult parasite.
1.2 Parasite Biology
1.2.1 Classification and morphology
1.2.1.1 Hookworm classification
The hookwonns belong to the Supeifamily Strongyloidea and the family 
Ancylostomidae. This family is characterised by the large buccal capsule, 
usually aimed with teeth, lancets, cutting plates or a dorsal cone, indicative of the 
blood feeding nature of the adult worms. The site of predilection is the mucosa 
of the small intestine, where the adults attach and feed on tissue fluids and blood. 
The most important species in terms of potential infection to man are N. 
americanus, the only member of this genus thought to infect humans, and A. 
duodenale, the only member of this genus known to cause significant morbidity. 
Infection with A ceylanicum causes insignificant pathology and is rarely found 
other than when it has constituted a small proportion of woims in a mixed 
infection (Miller, 1979). Other species can cause zoonotic infection; including A. 
braziliense, the cat hookworm and A. caninum the dog hookwoim.
1.2.1.2 Haemonchus species classification
Within the Strongylida and Supeifamily Trichostrongyloidea is the family 
Trichostrongylidae to which the Haemonchus genera belong. Trichostrongylids 
parasitise all the major classes of vertebrates and are noimally small worms with 
a simple buccal capsule that feed on the mucosa or blood in the host gut. 
Haemonchus species have a single tooth within the buccal capsule, which is used 
to pierce the mucosal lining of the abomasum (the “true stomach”) and allows 
blood to be sucked from the wound. There are four species of Haemonchus 
found in domestic ruminants; H. contortus, the ovine and caprine species; H. 
longistipes, from camels; H. similis, a bovine species; and H. placei, a bovine 
species (Jacquiet et al., 1997). The species of greatest importance in terms of 
economic and welfare cost, and the particular focus in this body of work, is H. 
contortus. Female worms are approximately 3 cm long and of a pale cream 
appearance; males are slightly smaller. When blood feeding, the white ovaries of 
the female wind around the blood filled intestine giving the worm its 
characteristic barber’s pole appearance.
1.2.2 Hookworm life cycle
The life cycle of the hookworm species is of a direct nature in that it only 
involves one host species (Looss, 1901) (Figure lA): man in the case of N. 
americanus and A. duodenale", the dog in the case of A. caninum", the dog or cat 
in the case of A. braziliense", and certain carnivorous species in the case of A. 
ceylanicum.
Eggs laid by the adult female are passed in the faeces and onto the soil. To 
develop, eggs require a moist and waiTn (at least 17°C; 23-30°C is optimal) 
environment and ai'e sensitive to both frost and direct sunlight. The aerobic 
nature of the hatching larvae’s metabolism also necessitates a damp but not 
waterlogged soil (Schmidt and Roberts, 1996). First stage larvae (LI) hatch from 
eggs within 24-48 hours under conditions as those described above and feed on 
suiTounding faecal matter. The shedding of the LI cuticle and moult to the 
second stage larvae (L2) occurs within two to three days. L2 continue to feed 
and undergo a second moult (the second stage cuticle is often retained as a loose 
fitting sheath) to the infective third larval stage (L3) within three to five days. L3 
do not feed and are sustained by stored food ingested as earlier larval stages, 
Under optimal conditions the time taken from eggs hatching to L3 can be as little 
as five days. Infective L3 can survive on the ground for several weeks under 
optimal conditions, though freezing or desiccation kills them quickly. At 
temperatures of 35°C and above, larvae die. However, when the ambient 
temperature is greater than this, larvae are able to survive by migration to areas 
of shade or below the soil (Brooker et al, 2005). L3 live in the layer of moisture 
suiTOunding soil particles and under damp conditions (for example morning dew) 
a short vertical migration to the top of the soil in is undertaken where many 
worms may gather, swaying to and fro to maximise exposure to passing potential 
hosts (Schmidt and Roberts, 1996).
Upon contact with the host, L3 larvae penetrate the skin epidermis directly. 
Larvae are capable of penetrating any part of the skin, though those parts that are 
most often in contact with the ground are most susceptible. In the case of N.
americanus skin penetration must occur for the parasite to successfully infect 
whereas, A. duodenale can penetrate the oral mucosa as well as the skin (Brooker 
et al, 2005). During skin penetration the sheath is normally shed, although the 
biochemical basis of this is poorly understood (Hawdon and Schad, 1990). 
Following successful skin penetration, feeding and development are resumed 
[this can be achieved in vitro by stimulating L3 with host serum (Hawdon and 
Schad, 1990)]. This resumption in development is concomitant with the 
expression of proteins likely required for infection (Zhan et al, 2002; Hawdon et 
al, 1996; Hotez et al, 2003).
L3 enter the vasculature and are earned through the circulation to the heart and 
then lungs. Once in the lungs, L3 emerge from the capillaries and migrate up the 
alveoli, are earned up the trachea to the glottis from where they are swallowed 
and pass through the stomach to the site of predilection, the small intestine. 
Here, L3 attach to the gut mucosa and moult to the fourth larval stage (L4) which 
has a fully developed buccal capsule and blood feeds. Following a final molt to 
the adult, worms become sexually mature and mate and females begin egg 
laying. Female woims are capable of laying thousands of eggs daily. The whole 
process from infection to gravidity takes at least five weeks and once established, 
adult A. duodenale can live in the human intestine for up to three years; N. 
americanus for three to ten years (Hoagland and Schad, 1978).
There is evidence for the vertical transmission of A. duodenale, although the 
exact mechanism has not been established. This would not prove suiprising as 
the resumption of development of A. caninum L3 following a period of 
dormancy in muscle tissues, and transmission of L3s across the mammary glands 
to newborn pups, is a well documented phenomenon (Schad et al, 1982). A. 
duodenale infection has been observed in children likely to be too young to have 
picked it up by environmental transmission. In these cases, the only hookworm 
species is A. duodenale despite there being a local prevalence of N. americanus 
(Schad, 1991).
1.2.3 Haemonchus life cycle
Like the hookworm species, Haemonchus contortus is dioecious and undergoes a 
direct lifecycle (Figure IB). The adult females are prolific egg layers and eggs 
are passed in the faeces onto pasture. Eggs hatch to LI within a couple of days 
and feed on microbes within the faecal pat. LI undergo a moult to L2 which in 
turn moults to the infective L3. Like some of the hookworms, the L2 cuticle is 
retained by the infective L3 as a loose fitting protective sheath; this acts as a 
protective barrier against moisture fluctuations on pasture (Ellenby, 1968). L3s 
are non-feeding and have to survive on energy stored in the early larval stages. 
The sheathed L3 are fairly resistant to desiccation and can survive for up to three 
months on pasture under conditions of reasonable humidity (Urquhart et ai, 
1987). The L3 migrate from the faeces and onto the herbage where they are 
ingested by their ruminant host (sheep or goats). Once in the rumen, the L3 
exsheath. Exsheathment is thought to occur in response to a combination of 
temperature rise to 39°C, optimal pH of between 6.5 and 7.5 (Rogers and 
Sommer ville, 1957) and exposure to CO2 and H2CO3 in the rumen (Rogers and 
Sommerville, 1968). L3 release a zinc metalloprotease that acts to digest a 
refractory ring approximately 20 pm from the anterior end allowing release of a 
cuticular cap and escape of the L3 from within the sheath (Gamble et al, 1989;
1989). Following exsheathment, L3 pass through to the abomasum where they 
become closely associated with the mucosa and buiTow into the gastric glands. 
Here the L3 moult to L4 within about two days and gain the buccal lancet that 
allows the onset of blood feeding. Following a final moult to the adults, worms 
exit the gastric gland and move freely upon the mucosal surface. Upon 
achievement of sexual maturity, females begin egg laying approximately 17-20 
days post infection, and can each lay between 5000-10,000 eggs per day.
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Figure 1: The lifecycle of human Hookworm and H. contortus. A - 
Lifecycle of N. americanus in the human host. B - Lifecycle of H. 
contortus.
1.3 Epidem iology
1.3.1 Epidemiology of Hookworm
Despite a dearth in actual organised surveillance programmes, a recent and 
extensive study of the literature (de Silva et al, 2003) estimated the numbers 
infected by hookwonn globally, at 740 million. Human hookworm infection is 
found throughout South America, Africa, the Middle East, Central, East and 
South East Asia, China, Indonesia and the Pacific islands (de Silva et al, 2003). 
Areas of highest prevalence are sub-Saharan Africa, Southern China and East 
Asia and Papua New Guinea; high transmission levels are found within areas of 
rural poverty throughout the tropics including China, Central and South America 
(Hotez et a t, 2003) and the Indian subcontinent (Yadla et al, 2003). 
Throughout all these areas, there is a conspicuous relationship between levels of 
hookworm frequency and socioeconomic status; the poorest economies have the 
highest worm prevalence (de Silva et al, 2003).
N, americanus is the predominant species globally. Areas where A. duodenale 
occur include Egypt, Northern Argentina and Paraguay (Brooker et al, 2005), A 
duodenale infection is also found in the more northerly latitudes of South and 
West China and India where N, americanus cannot survive the harsher 
conditions. There is evidence of hypobiosis in A. duodenale (Scahd, 1991) and 
this ability of A. duodenale L3 to undergo airested development within the 
human host may allow survival during cold periods where development on the 
ground is not viable (Schad et a l, 1973).
Hookwonn infection can occur in children as young as six months (Brooker et 
al, 1999). Typically hookworm epidemiology was considered similar to other 
major STH, A. lubricoides and T. trichiura; children become infected at a young 
age with a peak of infection intensity between five and ten years old followed by 
a decline in intensity in adults, giving a convex age-intensity profile (Bundy,
1990) (though prevalence remains constant in adults). This, however, is now 
recognised as not the case with hookworm. Recent data from studies earned out 
in China (Bethony et al, 2002; Gandhi et al, 2001) shows both hookworm 
prevalence and infection intensity to increase with age with the highest levels
shown in middle age with a peak prevalence and infection intensity occurring in 
those aged greater than fifty in the former study; a concern in countries such as 
China where they are the most rapidly expanding age group (Hotez et ai, 2002). 
Data from a similar cross sectional study in Brazil demonstrated an analogous 
monotonie profile (Hotez et al, 2003). Interestingly, this does not seem to be the 
case in Mali: a study looking at age-intensity profiles earned out by Behnke and 
colleagues (2000) found a convex pattern, with intensity decreasing in adulthood. 
A possible explanation for the variation in age-intensity profiles may be higher 
levels of exposure to hookworm among adults and the elderly in Asia (Brooker et 
al., 2004), though age-intensity profiles will also reflect larval establishment and 
adult mortality.
An analysis of the literature earned out by Brooker et al (2004) looked at the 
prevalence of infection with STH in males and females of a school age. They 
found no differences between male and females with regard to prevalence of A. 
lubricoides and T. trichiura. However, males showed a significantly higher 
prevalence of hookworm infection than females, a finding likely to reflect a 
difference in exposure. When considered in conjunction with prevalence in 
adults, occupational exposure is thought to be important (Brooker et al, 2004). 
This is consistent with Behnke et a l (2000) findings that in Mali, where there 
was a significantly higher incidence and intensity of hookworm infections 
amongst males. Human faecal matter is often incoi'porated into building 
materials to strengthen housing, and it is predominantly men who undertake this 
work.
A further compounding variable in hookwonn epidemiology is that of worm 
burden heterogeneity within the population. Reviewed by Anderson and May in 
1991, it is a well established trend that a minority of the infected population 
harbour very heavy worm burdens, whereas the majority of an infected 
population have few worms [sometimes 10% of the human population cam es 
70% of the worms (Anderson and May, 1985)]. A study in Mali found that, 
when age and sex were controlled for, it was apparent that a subset of the 
population appeared relatively woim free, whilst another subset seemed 
predisposed to heavy infections, and became quickly re-infected following
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treatment (Behnke et al, 2000). This is in line with findings from work carried 
out in Papua New Guinea that found a significant predisposition to hookworm re­
infection following drug treatment, that did not vary with age or sex (Quinnell et 
al, 1993). This predisposition to re-infection remained detectable up to eight 
years following drug treatment (Quinnell et a l, 2001). However, should 
individuals have received repeated chemotherapy treatments during this time, 
predisposition to re-infection was not detectable. This led Quinnell et a l (2001) 
to suggest that differences in host susceptibility are involved, but variation over 
the long term in exposure to infection or susceptibility limits the detection of 
predisposition. Interestingly they also report a correlation between male 
hookworm weight and individual host following measurement of hookworms 
upon expulsion after two doses of chemotherapy at a two year interval (Quinnell 
et al, 2001). This would suggest that individual hosts are predisposed to 
infection with light or heavy worms, perhaps indicating a host genetic aspect to 
susceptibility.
Early studies in the southern states of the USA indicated a far higher prevalence 
of hookwoim in individuals of European versus African origin further suggesting 
a genetic basis (see Quinnell, 2003 and references therein). Familial clustering 
of predisposition may also be indicative of a genetic factor though this could be 
explained by exposure levels. Quantitative measurements of heritability give the 
most convincing case for a genetic component to hookworm susceptibility, A 
quantitative genetic analysis of 289 infected individuals earned out in Zimbabwe 
by Williams-Blangero et a l (1997) demonstrated that, after controlling for 
confounding variables, 37% of the variation in hookworm eggs per gram in the 
study population could be attributable to genetic heritability factors. 
Unpublished work earned out in Brazil by Bethony and co-workers (described in 
Brooker et al, 2004) looked at the role genetic factors played in regulating 
infection and humoral immune responses to hookworm infection using “multi­
household extended pedigrees”. They found that 49% and 26% of the variation 
in faecal egg output was accounted for by additive genetic factors when modelled 
with or without household effects, respectively. Further to this, they found that 
45% of the variation in the specific humoral response (Immunoglobulin isotypes 
G l, G4 and E) directed to L3 and adult woim antigens could be explained by
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additive genetic factors. These studies all indicate the importance of the 
underlying genetics of susceptibility.
1.3.2 Epidemiology of H. contortus
Due to optimal larval development of H. contortus occuning at higher 
temperatures, the species is most prevalent in tropical and sub tropical regions, 
although it can still be a problem in temperate areas such as Northern Europe and 
Canada. The epidemiology of infection within the tropics and subtropics is quite 
distinct to that in temperate zones. Larval development is highly dependent on 
high humidity, thus disease outbreak often follows periods of high rainfall 
(Urquhart et al, 1987). The very high fecundity of H. contortus (a faecal egg 
count of between 5000 and 20,000 is not uncommon, even in moderate 
infections) allows large pasture contamination to build up quickly leading to the 
appearance of acute disease. In certain areas of the subtropics, such as the 
Middle East, South America and Australia, H. contortus can undergo hypobiosis 
as aiTested L4 larvae, within the host. The cues for this are unknown, though an 
environmental trigger has been suggested (Blitz and Gibbs, 1972). Hypobiosis 
occurs at the beginning of the dry season and allows survival within the host, 
when environmental conditions on the pasture would cause desiccation of the L3 
and break the infective cycle. Often both adult worms and hypobiotic larvae 
coexist and although the existence of hypobiotic larvae may not be absolutely 
crucial to woim survival during the dry summer season, it is thought to play a 
major role (Gatongi et al, 1998). Resumption of development begins prior to 
the rainy season and allows completion of the cycle to gravid adult (Urquart et 
al, 1987). Interestingly, hypobiosis does not occur in all areas of the tropics; this 
has been explained by more frequent rainfall negating any need to survive 
prolonged dry spells.
In temperate zones, such as the UK, the infective cycle is normally described as a 
single annual cycle. Infected larvae that have developed on pasture from eggs in 
the spring are ingested in the early summer and many undergo hypobiosis as 
early L4 and remain arrested until the following spring (Urquart et al, 1987). 
Although either immune mechanisms or environmental stimuli may contribute to
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stimulation of hypobiosis, it has been suggested that in temperate areas, over 
winter hypobiosis may be an obligatory survival mechanism that occurs 
regardless of external stimuli (Capitini et al, 1990) and is likely regulated by the 
woims themselves (Blitz and Gibbs, 1972). Developmental resumption occurs 
the following spring and in non pregnant animals it may not occur en masse but 
over a couple of months (Blitz and Gibbs, 1972). In pregnant ewes, development 
is often associated with lambing, though not necessarily in a peri-parturient 
synchronous fashion as rapidly as is seen in the development of Teladorsagia 
circumcincta (Connan, 1967). During this period of hypobiotic larval 
maturation, acute disease may be seen in ewes post lambing and grazing lambs.
Clinical haemonchosis is sometimes seen in grazing lambs in late summer, 
however the epidemiology behind this is not well understood; it has been 
suggested that infection may be with those ingested larvae that did not undergo 
developmental aiTest in the late spring, and have become gravid adults (Urquart 
et al, 1987).
1.3.3 Pathology and impact of Hookworm
In areas of very high transmission of either N. americanus or A. duodenale, the 
first sign of pathology associated with hookworm may be ground itch: a 
cutaneous condition of the feet caused by high numbers of L3 penetrating the 
epideiTnis characterised by a pruritic macuio-papular eruption. Should this occur 
by zoonotic infection with A. braziliense, the cat hookworm, L3s penetrate the 
skin epidermis but are unable to develop any further in their lifecycle. This can 
result in a larva migrans and creeping eruption causing an intensely itchy pruritis 
characterised by a serpiginus tract that may fall foul of a secondary bacterial 
infection, noiTnally occumng on the lower limbs or feet (Blackwell and Vega- 
Lopez, 2001). In contrast, there is evidence that zoonotic infection by A. 
caninum can result in the dog hookwoiTn completing its lifecycle in a human 
host, and this has been associated with human eosinophilic enteritis (Prociv and 
Croese, 1996),
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Following host entry and pulmonary migration, human hookworm L3s exit the 
lungs, as previously described, and this may be accompanied by production of 
eosinophilic infiltrates that can cause a mild, dry cough. Other upper respiratory 
tract complications may include laryngitis, pharyngitis and pain when speaking 
or swallowing (Miller, 1979). Upon entry to the gastrointestinal tract, !
development to adults is commonly accompanied by epigastric and abdominal 
pain (Anyaeze, 2003). In experimentally infected volunteers, abdominal pain, ?
nausea and flatulence just prior to the appearance of eggs in stool samples were 
found, the pain sufficiently acute in one circumstance to wan’ant chemotherapy ;
administration prior to the proposed trial endpoint (Maxwell et ai, 1987). Jj
Severe abdominal pain has been described as commonplace in twenty to fifty ;
percent of chronic infections (Miller, 1979).
As prolific and voracious blood feeders, the most common and important clinical 
sign of hookworm infection is intestinal blood loss; volumes of blood loss have 
been estimated at 0.04 ml per worm per day for N, americanus and 0.20 ml per 
worm per day for A. duodenale resulting in 25 worms causing the loss of 1 ml 
blood per day in the former species and only 5 worms causing 1 ml blood loss 
per day in the latter (Martinez-Toixes et al, 1967; Crompton, 2000). As long ago 
as 1947, the eminent parasitologist Norman Stoll estimated that the volume of 
blood lost to hookworms in a single day was equivalent to the complete 
exsanguination of one and a half million people (Stoll, 1947). More recently it 
has been suggested that this may even be an underestimate (Schad, 1991). A 
consequence of this blood loss is either the cause, or exacerbation, of anaemia.
In acute canine hookworm infection (with A. caninum) massive blood loss can 
cause an immediate, acute and often fatal anaemia; however, though reported, 
this type of acute haemorrhagic anaemia is very uncommon in human hookworm 
infection (Miller, 1979). The cardinal symptom of human hookworm infection is 
iron-deficiency anaemia (IDA).
Chronic IDA develops gradually following primary infection and is usually 
associated with a continuous exposure to hookworm infection. Development of 
IDA is also dependent upon a number of sequelae including the level of infection 
and species of hookworm, iron-reserve status of the host, dietary iron intake and
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its absorption and on other sources of iron loss from the body (Miller, 1979).
Thus, a malnourished population with little dietary iron intake is likely to be al 
an increased risk of IDA associated with hookworm infection. Groups at highest 
risk include those whose iron status is impaired; adolescent girls, women of a 
child bearing age and pregnant women are particularly vulnerable (Crompton,
2000).
A negative association between hookworm eggs counts and serum ferritin levels 
(a measure of IDA) has been reported by several authors (Gilgen and Mascie- •
Taylor, 2001; Pritchard et a l, 1991; Crompton and Whitehead, 1993). ;î
Compelling evidence that intensity of hookworm infection is associated with i
blood loss and IDA was demonstrated in a study of school children carried out in ;j
Zanzibar. A positive relationship was found between faecal egg count (a !
measure of intensity) and blood loss (as measured by faecal haeme) and this was ;j
negatively correlated with serum ferritin concentration. Thus, the prevalence of ;
IDA increased with hookwonn infection intensity and blood loss (Stoltzfus et al,
1996). Interestingly, a recent study on the affect of daily low dose iron 
supplementation and quarterly anthelmintic treatment on anaemia in young 
children with light helminth infections found that, in toddlers, iron 
supplementation did not improve mild to moderate anaemia, however 
anthelminthic treatment did (Stoltzfus et al, 2004). This suggests that in these 
young children, the affect of iron supplementation on anaemia was constrained 
by intestinal worm infection (albeit light) of which hookworms made a 
significant proportion.
Due to the difficulties faced in speciating hookwoiTn eggs, there is a dearth of 
evidence relating the iron status of infected individuals to the specific hookworm 
species. By culturing eggs collected from individuals’ faeces and speciating the 
L3, Albonico et a l (1998) surveyed hookworm species prevalence and infection 
intensity and related it to individuals iron status and community burden of IDA.
Infection with A. duodenale was clearly associated with a heavier burden of IDA, 
adding epidemiological weight to the concept that a difference in blood loss 
translates to a greater extent of IDA.
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Thus IDA associated with hookwonn infection is governed by a variety of 
complicating cofactors, including the iron status of the individual, the dietary 
iron intake, the level of infection and the hookworm species responsible for 
infection. The general consensus is that hookworm chemotherapy can improve 
IDA, and this can be further progressed by dietary iron supplementation, 
particularly important in very poor quality diets,
IDA has an adverse effect on the growth and development of children, and there 
is a general consensus (though it remains a topic of some debate and beyond the 
scope of this review) that IDA is closely associated with impaired academic 
performance at school. The relationship of infection with IDA infers hookworm 
will contribute to this effect (Crompton and Nesheim, 2002). Sakti et al, (1999) 
demonstrated an association between hookworm infection and lower scores in 
tests aimed to measure cognitive abilities, however infection intensity was not 
measured and there was no link found between levels of anaemia and cognitive 
ability. It would certainly seem that improving severe anaemia by iron 
supplementation and anthelminthic treatment is associated with a positive effect 
on motor and language development in pre-school children (Stoltzfus et al, 
2004). IDA is associated with a fatigue and listlessness that is thought to affect 
physical labour, productivity and work capacity (Guyatt, 2000). Due to the 
nature of much of the work undertaken in countries where hookworm is endemic 
(often land based physical labour), it can be assumed that IDA associated with 
hookwonn infection may be responsible for some loss of productivity. In her 
extensive review, Guyatt (2000) also points out that a link between adverse 
growth and development of children (both cognitive and physical) associated 
with helminth infection and a loss of productivity in adulthood, although not 
proven, is certainly suggested. Crompton and Nesheim (2002) cite the 
productivity losses due to IDA in South Asia to have a value of five billion U.S. 
dollars annually.
Chan et a l (1994) used a method of estimating potential global morbidity based 
on the observed infection prevalence. The global numbers infected by 
hookworm were estimated at 1297 million; 96 million of whom were estimated 
to suffer from a developmental morbidity, 61 million a more severe clinical
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morbidity. An update of the picture was delivered by de Silva et al in 2003 who 
found a marked decline in total global numbers infected to approximately 740 
million. The decline is most dramatic in some Asian and Latin American 
countries and reasons suggested for this decline are an increase in national 
control activities combined with economic development and a shift away from a 
largely agricultural and rural economy to a more suburban one (de Silva et al,
2003). On the other hand, no change in hookworm prevalence combined with an 
increase in population at risk has lead to an actual increase in the numbers 
infected from sub-Saharan Africa (de Silva et a l, 2003).
Recently, the measurement of choice to quantify the burden of disease, injuries 
and other risk factors, and allow comparisons between these different factors, has 
been the disability-adjusted life years (DALYs). This measure is based on both 
the economic and ethical principles that can guide healthcare, treatment and 
financial policy and is particularly designed as a quantifier of burden of non-fatal 
disease (Muixay and Acharya, 1997). DALYs provide a summary of population 
health by combining the years of life lost from premature death and the years of 
life lived with a disability. According to a WHO World Health Report in 2002, 
hookworm causes the loss of 1.8 million DALYs worldwide, more than 
Schistosomiasis, Chagas disease. Trypanosomiasis and Onchocerciasis. (WHO. 
Reducing Risks, Promoting Healthy Life, 2002).
1.3.4 Pathology and economic burden of H. contortus
Like the pathogenic human hookworm species described, the pathology of H, 
contortus is almost entirely attributable to the blood feeding nature of the adult 
worms and manifests as anaemia. In acute H. contortus infection, a pronounced 
anaemia presents about two weeks post infection characterised by a prominent 
fall in haematocrit levels. Over the following weeks haematocrit stabilises at a 
low level, and this is associated with a visible pallor of the mucous membranes 
of the eye that can be used as a measure of clinical anaemia (Van Wyk et al, 
1997- cited in Vatta et a l, 2001). This drop in haematocrit is coupled with a 
compensatory expansion of erythropoiesis. However, this expansion in red blood 
cells cannot be kept up indefinitely and when compounded by a continual blood.
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iron and protein loss and an increasing inappetance, the bone maiTow becomes 
exhausted, haematocrit further falls and death may occur (Urquart et ai, 1987). 
A feature of haemonchosis and other gastro-intestinal (GI) nematode infections is 
a loss of protein into the GI tract causing hypoalbuminaemia (Holmes, 1987). A 
clinical consequence of this is a reduction in the colloid osmotic pressure within 
the blood capillaries which forces fluid out of the capillaries into the interstitial 
spaces causing oedema. This often occurs in the submandibular area leading to a 
condition known as bottle jaw. Loss of protein leads to reduced nitrogen 
retention and is characteristic of GI nematode infection. This is associated with a 
decrease in growth rates and protein deposition in muscle and wool. In the case 
of H. contortus, nearly all the loss of nitrogen into the GI tract is attributable to 
blood loss (Holmes, 1987). In very heavy infestations, up to 30,000 worms, a 
very acute severe haemoixhagic gastritis can occur. Though rare, this can kill 
apparently healthy sheep very suddenly (Urquart et al., 1987).
In tropical areas, when infection with blood feeding adults takes place all year 
round, chronic haemonchosis can occur. Less clinically obvious than acute 
disease, it is nonetheless economically important. During the dry season, when 
the nutrient value of the pasture is inferior, but fresh reinfection is unlikely, a 
small burden of blood feeding adults can cause clinical signs associated with 
weight loss and inappetance rather than anaemia (Urquart et al., 1987).
There is very little infoixnation regarding the global economic losses caused by 
parasitic nematodes of livestock. Within the UK, production losses due to G I 
parasites cost the sheep farming industry approximately £60 million annually (F. 
Jackson, personal communication) and the total annual expenditure on 
endoparasticides is approximately £44 million (source: http://www.noah.co.uk/). 
On a global scale. Coles (2002) estimated the amount of money spent on 
antiparasitic drugs in 1999 to be in the region of 3.5 billion $US and of that, 
approximately 379 million $US are spent on the sheep industry. Despite a dearth 
of exact figures for the economic impact of H. contortus, there is no question that 
it runs into hundreds of millions of $US.
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1.4 The im m unology associated with gastro-intestinal
helminth infection
Whilst much work has been earned out to characterise the immune response 
associated with GI nematodes and their persistence or expulsion in rodent 
models, it is always a contentious issue as to whether one can extrapolate these 
results to humans (or ruminants). As such, the cell mediated, humoral and 
cytokine responses associated with generalised GI helminth infection will be 
discussed first, followed by a focus on the immune responses associated with 
hookwonn and H. contortus infection specifically. The majority of the murine 
work has focused on four nematode infection models, Nippostrongylus 
brasiliensis, Heligomosoides polygyrus, Trichinella spiralis and Trichuris muris. 
The former three species reside in the small intestine and the latter, T, muris 
inhabits the proximal colon; primary or secondary infection with these species 
often results in expulsion of worms in immune animals, thus this is commonly 
used as a measure of immunity (Artis and Grencis, 2001).
1.4.1 I  cell mediated immunity
An essential function of T cells in the immune response to nematodes was 
confirmed by the requirement of a thymus for mice to expel T. muris (Koyama et 
al., 1995). Convincing evidence for a pivotal role of CD4"^  T helper cells in 
resistance to nematode infection comes from adoptive transfer experiments 
(Grencis et al., 1985) and in vivo depletion experiments using murine models 
(Katona et al., 1988). Furtheixnore, CD4^ cells from an immune mouse were 
demonstrated to confer immunity to infection in severe combined 
immunodeficient (SCID) mice that would not normally be able to mount any 
immune response (Else and Grencis, 1996).
The highly influential work by Mosmann et al. (1986) describing two individual 
subsets of CD4^ T helper (Th) cells defined by the distinct cytokine profiles 
secreted by, and associated with, them has been central to understanding the T 
cell responses to nematode infection. T helper 1 (Thl) cells are associated with 
cell mediated inflammatory reactions and produce type 1 cytokines: interferon 
gamma (IFN-y), lymphotoxin and interleukin (IL) 2 and are associated with
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Immunoglobuliin (Ig) G2a and cell mediated responses. T helper 2 (Th2) cells 
are associated with antibody production and allergic responses and produce type 
2 cytokines: IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13 and drive production of IgE, 
IgGl, mastocytosis and eosinophilia (Mosmann and Sad, 1996). Both subtypes 
can produce tumour necrosis factor alpha (TNF-a), IL-3 and granulocyte- 
macrophage colony stimulating factor (GM-CSF). There is considerable 
evidence for a cross-regulation of Thl and Th2 cells; cytokines produced by one 
subtype can inhibit proliferation or cytokine production by the other cell type. 
IFN-y will inhibit Th2 cell proliferation and ÏL-10 can inhibit cytokine synthesis 
by Thl cells and this cross regulation can lead to the skewing of either a Thl or 
Th2 type response to a pathogen. When first stimulated by an antigen presenting 
cell, the undifferentiated naive Th cell produces principally IL-2 (Mosmann and 
Sad, 1996). Following this, the T helper cell goes through an inteiTnediate stage 
(ThO) where a mixed profile of cytokines is produced prior to differentiating into 
the polarised Thl or Th2 phenotype cells (Janeway et al, 1999). A critical factor 
in influencing T helper cell polarisation is the cytokine environment at the 
moment of antigen presentation (IL-12 promotes Thl and IL-4, Th2), and the 
type of antigen presenting cell/pathway involved (Else and Finkelman, 1998). It 
would appear that antigen presented by macrophages favour a Thl response, and 
B cell antigen presentation favours a Th2 response (Gajewski et al, 1991). The 
costimulatory ligands and receptors involved is also likely to play a role, 
however this is really beyond the scope of this thesis (see Else and Finkelman, 
1998 for a comprehensive review). This Thl/Th2 paradigm, based on the type 1 
or type 2 response profiles is now regarded as oversimplified, but it does prove 
useful as a basis for looking at the response to GI nematodes (Hayes et al, 2004). 
Utilising the aforementioned murine infection models, a wealth of experimental 
evidence indicates a Th2 and associated type 2 immune response as resistant to 
nematode infection, and a Thl, type 1 response as susceptible (see reviews by 
Hayes et al, 2004; Artis and Grencis, 2001; Else and Finkelman, 1998). The 
roles some of the key cytokines play in infection in murine models are 
summarised in Table 1.1 and Figure 1.2
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Table 1.1: A summary of the role of some of the key cytokines indicated 
in promotion of resistance or chronicity in murine rodent models.
Model
System
Summary of key cytokines involved and 
infection outcome
Key References
T. muris IL-4, IL-5, IL-9, IL-13 and eosinophilia 
associated with resistance. IL-12, IL-18 
and IFN-y associated with promotion of 
chronicity. Th2 type of response necessary 
for resolving infection.
Else and Grencis, 
1991; Else et al., 
1992; Else et al., 
1994; Bancroft et 
al., 2000; Helmby 
et al, 2001
N. brasiliensis IL-12 and IFN-y associated with 
enhancement of adult worm survival. IL-4 
not required for resistance but may play a 
role. IL-13 required for worm expulsion, 
even if a Th2 type response exists. Thl 
response promotes chronicity, aspects of a 
Th2 response are protective
Finkelman et ai, 
1991; Finkelman 
et al., 1994; 
McKenzie et al., 
1998
T. spiralis IL-18 downregulates Th2 responses and 
promotes chronic infection. Th2 type of 
response required for worm expulsion
Flelmby and 
Grencis, 2002;
H. polygyrus IL-4 required for resistance. IL-9 indicated 
in resistance, by maintaining mastocytosis
Urban et al.,
1991; Faulkner et 
al, 1997 ; Hayes 
et al, 2004.
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Figure 1.2: A simplified schematic overview of the major cytokines 
involved in the Th1/Th2 response to nematode infection in the mouse. 
The Th1 polarisation is associated with susceptibility and the Th2 
polarisation with resistance (adapted and redrawn from Else and 
Finkelman, 1998).
Aside from the rodent models, the role of the Thl and Th2 response in parasite- 
host interactions remains ill-defined. One recent study focused on the cytokines 
expressed by cells in abomasal lymph nodes or mucosa from calves following 
vaccination with a host protective fraction and challenge with Ostertagia 
ostertagi L3. Although vaccination itself had no effect on cytokine profiles, cells 
from the lymph nodes showed a significant decrease in Thl type cytokines and 
an increase in Th2 type cytokines following challenge infection suggesting that 
polarisation to a Th2 profile following GI nematode infection occurs in 
ruminants. Intriguingly, this polarisation was not observed at the mucosal level 
(Claerebout et a l ,  2005). Experiments looking at the cytokine profile in
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abomasal tissue of immune and non immune sheep challenged with H, contortus 
found an increase in EL-4 associated with rapid expulsion of worms and an 
increase in EL-5 and EL-13 in animals that expelled woims after they had reached 
the tissue (Meeusen et al, 2005). The authors suggest that this might imply IL-4 
to play a role in the mast cell and globular leukocyte-associated rapid expulsion, 
whilst EL-5 and EL-13 are important in delayed worm rejection. In humans, there 
is evidence that susceptibility to STH infection is associated with a weak Th2 
response, with a negative cori'elation between IL-5 and IL-13 levels and STH 
infection (Jackson et al, 2004).
1.4.2 Effector m echanism s
The exact bases of the effector mechanisms that underlie a protective Th2 
response are still not well understood. As already discussed, the hallmarks of the 
type 2 response associated with GI helminth infection are eosinophilia, intestinal 
mastocytosis, goblet cell hyperplasia, IgE and IgGl. A direct roll for all or some 
of these cells and/or antibodies has been difficult to establish.
1.4.2.1 Eosinophils
Cells of the polymorphonuclear leukocyte family, eosinophils are produced in 
the bone maiTow from where they migrate via the blood to the tissues or site of 
predilection. Eosinophilia (the upregulated production of eosinophils in the bone 
maiTOw and increase in numbers in the blood and tissues) is characteristic of 
allergic reactions, inflammation and helminth parasitoses (Jones, 1993). 
Demonstration of eosinophilia inhibition in vivo using antibody to EL-5 
confirmed this cytokine’s role as a key growth and differentiation factor 
(Coffman et al, 1989). In 1979, Butterworth et a l showed that eosinophils 
could cause direct damage and kill schistosomula of Schistosoma mansonl More 
recently, it was shown that, in the presence of specific antibody, eosinophils 
could kill H. contortus L3 in vitro (Rainbiid et al, 1998). Despite the 
demonstration of an in vitro affect, direct in vivo evidence of a protective role for 
eosinophils is limited to correlative evidence of an association between 
eosinophils and dead parasites (Meeusen and Balic, 2000), and work citing an 
association between sheep bred for resistance to GI nematodes and an increased
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level of eosinophilia compai'ed to non responders or those selected for high 
faecal egg count (Dawkins et al., 1989; Buddie et at., 1992).
Antibody inhibition of IL-5, leading to eosinophilia depletion, had no effect on 
immunity against N. brasiliensis (Coffman et al, 1989). Similar depletion 
experiments found no effect on immunity to T. spiralis (Herndon and Kayes, 
1992), H. polygyrus (Urban et al, 1991) or T. muris (Else and Finkelman, 1998). 
These experiments would suggest that eosinophils are perhaps not important 
effector cells against GI nematodes. In contrast there is some evidence that in 
unnatural or non-pennissive helminth infections, often characterised by an 
increased non specific or innate inflammatory response, eosinophils may play a 
protective role (Meeusen and Balic, 2000).
Upon lai’val challenge of sheep several weeks after they had cleared a previous 
infection, H. contortus larvae found within the tissues of the abomasum 24 hours 
post challenge are suiTounded by eosinophils (Meeusen and Balic, 2000). 
Though not reflected by an increase in circulating eosinophil numbers, 
eosinophils seemed to be specifically recruited to the site of larval gastric 
penetration, and larval damage could be detected microscopically. Thus the role 
of eosinophils as effector cells in GI nematode infection is unclear; it seems 
likely that they are more important in some infections than others. A recent 
development is the demonstration that ruminant GI nematode species produce a 
potent chemotactic factor for eosinophils and that this activity is not seen in the 
related, but free living, species Caenorhabditis elegans. This suggests that these 
ovine nematodes may actively encourage eosinophil recruitment (Wildblood et 
al, 2005); local eosinophil-mediated tissue damage might actually prove 
beneficial to the parasite.
1.4.2.2 Mast cells, globule leucocytes and mucous
Prominent intestinal mastocytosis is a characteristic of Gl nematode infections. 
Mast cells contain basophilic granules with histamine as a constituent, have on 
their cell surface high affinity IgE receptors and are a major component of 
hypersensitivity reactions (Huntley, 1992). Historically, mucosal mast cell 
hyperplasia has been shown a feature of rodent infections with N. brasiliensis
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(Miller and Jarrett, 1971), T. spiralis (Ruitenberg and Elgersma, 1976) and in 
ruminants with T. circumcincta (MuiTay et at., 1968) and H. contortus 
(O’Sullivan and Donald, 1973). During maturation, and after stimulation with 
antigen, mast cells migrate to the epithelia (for example, the GI epithelium) and 
can degranulate, becoming globule leucocytes. In animals subjected to a 
continuous parasite burden, mast cell secretion is likely to be under a continuous 
stimulation, thus globule leucocytes will be common (Huntley et al, 1984). 
Antigen cross-linking of bound IgE on mast cells leads to degranulation and 
release of a number of inflammatory mediators including histamine, leukotriene 
and serine proteases (mast cell protease) and cytokines (Janeway et al, 1999), 
Indeed, IgE has been shown to promote mast cell pro tease release and enhance 
paiasite expulsion clearance, although is not essential for intestinal mastocytosis 
(Gurich et al, 2004). As the level of mast cell protease coirelates with numbers 
of tissue mast cells and globule leucocytes, it can be used as a serological 
measure of mast cell hypeiplasia (Huntley, 1992).
Although associated with the hypersensitivity reactions that may play a part in 
immunity to nematodes, evidence for a role of mast cells in parasite protection 
remains unclear, and seems to depend on the species involved. In ruminant 
infection experiments, mast cell protease concentrations in local tissue were 
significantly raised in sheep immune to challenge infections with H. contortus or 
T. circumcincta compared to the naïve challenge controls (Huntley et al, 1987) 
suggesting a role for mast cells in immunity of ruminants to GI helminths. 
Additional experiments demonstrated infected then treated animals to have a 
higher mast cell protease level, but lower worm burden than naive controls upon 
challenge with a mixed T, circumcincta and Trichostrongylus vitrinus infection 
(Huntley et al, 1995).
Despite evidence of mast cell proteinase secretions detectable in the gut of rats 
during expulsion of N, brasiliensis and T. spiralis, indicating a role for 
functionally active mucosal mast cells in woim rejection (Woodbury et al, 
1984), some studies have questioned the importance of mast cells during 
immunity to the foimer infection. Mice treated with anti EL-3 and IL-4 antibody 
showed an 85% decrease in mastocytosis but expelled N, brasiliensis as noimal
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(Madden et al, 1991). Likewise, stem cell factor receptor (c-kit) knockout mice, 
deficient in mast cells, expelled this infection normally (Crowle and Reed 1981). 
However, evidence for a role of mast cells in immunity to T. spiralis is more 
persuasive. Alizadeh et al, (1984) showed that prolongation of T. spiralis 
infection in mice occuiTed in strains that had a delayed appearance of mucosal 
mast cells and levels of mast cell protease were found to be higher, and mast cell 
response quicker in fast responder mice (those able to clear infection quickly) 
than in inteimediate and low responder strains (Tuohy et al, 1990). 
Furthermore, mice with antibody neutralised stem cell factor (or c-kit) showed a 
complete abrogation of mast cell response and a significant delay in worm 
expulsion; this delay, and the mast cell response, could be reversed by restoration 
of stem cell factor (Donaldson et al, 1996).
The mechanism behind mast cell hyperplasia-associated worm expulsion is still 
not well understood. Worm infection is associated with an increase in mast cell 
activity which is accompanied by an increased permeability of the Gl duct wall; 
this has been hypothesised to create a leaky membrane that might allow 
circulating or locally produced antibody or other mediators access to the 
parasites and cause expulsion, termed the leak-lesion hypothesis (Munay et al, 
1971). Recently, using the T. spiralis infection model, it has been demonstrated 
that, under control by CD4^ T helper cells, mast cells are directly responsible for 
the increase in permeability of the gut epithelial cells. It seems likely that this 
permeability is a result of degradation of the tight junction protein occludin, most 
probably by a protease, possibly by the mast cell protease itself (McDermott et 
al, 2003). Interestingly, N. brasiliensis expulsion from rats is also associated 
with intestinal permeability, and detectable levels of mast cell protease in the 
intestine (King and Miller, 1984), despite mast cells not being required for 
expulsion, thus indicating an as yet unresolved cell type or effector mechanism in 
this system.
Another role that mast cells may play is to allow the accumulation of substances 
toxic to invading worms in the intestinal or gastric mucous (Miller, 1996). As 
well as playing a physical role in nematode immunity, by providing a thick, 
sticky barrier, mucous can contain histamine, leukotriene and antibody and show
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a distinct anti-nematode property (Douch et al, 1983; Miller, 1987). Mucous 
from the small intestine of immune sheep cause T. colubriformis larvae to clump 
\n vitro, and can prevent larval establishment in vivo (Harrison et al, 1999). The 
recently elucidated mechanism responsible for this phenomenon is likely to be 
worm specific IgGl and IgA in the mucous (Hanison et al, 2003).
1.4.2.3 Role of antibody
Of the different antibody isotypes, those associated with immunity to GI 
nematode infection aie IgA, IgGl and IgE with evidence suggesting that 
antibody secreted at the mucosal surfaces may play an important role (Else and 
Finkelman, 1998). Adaptive transfer of purified IgGl from immune serum can 
confer resistance to naïve mice infected with H. polygyrus (Pritchard et al, 1983) 
suggesting a role for this isotype. A comparison of antibody levels in guinea 
pigs genetically determined as high responders and low responders found the 
high responders to generate a significantly higher anti T. colubrifomris IgGl 
upon homologous challenge. Serum from high responders did not transfer 
passive immunity to low responders (Manjili et al, 1999) suggesting that, albeit 
important in immunity, IgGl in this system is not sufficient an effector on its 
own to confer immunity.
The adoptive transfer of immunity against A. caninum from vaccinated pups to 
susceptible pups was demonstrated using both lymphoid cells and serum (Miller, 
1967). Immunity against both H. contortus and T. circumcincta in sheep can be 
confeiTed by passive transfer of lymphocytes from immune animals and the 
authors suggest, although other cell types may play a role, this may be due to the 
IgA producing cells transferred (Smith et al, 1984; Smith et al, 1986). Mucosal 
IgA in the abomasum appears a feature of H. contortus infection (Smith, 1977). 
IgA is also thought to be important in the immune response to T. circumcincta', 
IgA has been shown to regulate the growth of worms in vivo (Stear et al, 1995) 
and IgA levels negatively coirelated with worm size (Smith et a l, 1985). Levels 
of specific IgA directed against antigens of the L4 have been demonstrated 
statistically to account for over 90% of the variation in worm length (Stear et al, 
1999).
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IgE is a prominent antibody isotype and is classically related with GI nematode 
infection. However, despite the almost universal increase in IgE associated with 
nematode infection, evidence of a protective role is limited. IgE was found to 
enhance T. spiralis clearance in mice and to regulate the mast cell response 
(Gurish et al, 2004). Mice, though a non-peraiissive laboratory model host for 
hookworms, do allow tissue migration of the L3 stage and heavy infections can 
be fatal. After several doses, mice become resistant to larval challenge; this 
immunity coincides with significantly increased levels of IgGl and IgE (Hotez et 
al, 1999) suggesting a role for IgE in host protection. Rats transfused with IgE 
from immune animals rapidly expel N. brasiliensis infection (Ahmad et al,
1991); however, despite this, earlier evidence would suggest that in rats unable to 
mount an antibody response woim expulsion is not necessarily affected 
(Jacobson et al, 1977). Although adoptive transfer from immune animals may 
be unsuccessful, significant immunity against T. spiralis can be transferred to 
normally non-immune mice by infusing with serum from vaccinated animals 
(Robinson et al, 1995). In contrast, experiments using SCID mice infected with 
T. muris have questioned a role for antibody: the adoptive transfer of CD4^ T 
helper cells reconstituted immunity to worms in the total absence of antibody 
(Else and Grencis, 1996).
During infection with T, circumcincta there appeal’s to be a marked contrast 
between the levels and specificity of worm-specific IgE levels of primary and 
secondary infected sheep. In primary infections, gastric lymph had low levels of 
anti L3 and early adult specific IgE; however, a few days post challenge of 
previously infected sheep, a pronounced IgE response was detected against L3, 
but not adult, antigens. IgE levels in the serum were significantly lower than in 
the local lymph supporting the importance of this antibody in the mucosa 
(Huntley et al, 1998). Also reported were high levels of non-specific IgE. More 
recently a T. circumcincta allergen that reacts with IgE and is localised to the 
surface of the L3 has been discovered; in grazing lambs, levels of specific IgE to 
this allergen are significantly higher in animals with low faecal egg counts 
compared to those with high faecal egg counts (Huntley et al, 2001). These 
studies provide evidence of a protective function of specific IgE in this infection. 
Moreover, high numbers of IgE-bearing cells (lymphocytes and monocytes) are
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present in the blood of lambs selected for resistance to T. circumcincta compared 
to susceptible animals (Pettit et al, 2005).
Of significance is the fact that much of the IgE generated during worm infection 
is not specific, raising questions about the benefit of this response to the host or 
parasite; some authors postulate that non specific IgE may benefit the parasite by 
blocking the effects of specific IgE through a saturation of IgE Fc receptors 
(Pritchard, 1993) whilst others have suggested it may be of benefit to the host, 
reducing a hypersensitivity reaction to parasite allergens (Hagan, 1993).
1,4.3 Immune response to hookworm
Because of a lack of suitable animal models for human hookworm infection, 
much of the information on the immune response to hookwoim infection comes 
from immunoepidemiological studies in human populations; however, 
uncontrollable variables are inherent problems within this sort of study (Loukas 
and Prociv, 2001). The most noticeable trait of hookwonn immunology is that 
the response is highly heterogeneous. In terms of antibody isotypes, levels and 
specificity differ within the population (Brooker et al, 2004; Pritchard et al,
1992), Another feature is the long-lived infection and lack of intestinal 
inflammation compared to other intestinal nematodes, and lack of clear evidence 
for the development of a protective immunity (Loukas and Prociv, 2001).
Within a N, americanus infected population in Papua New Guinea a strong 
response of all Ig isotypes (IgG, IgM, IgA, IgD, and IgE) was found against 
larval and adult woian antigens (Pritchard et a l 1992); however, despite the 
vigorous humoral response there is little evidence that these antibodies actually 
play a protective role. As discussed, non-specific IgE is upregulated in response 
to helminth infections, but there is a strong specific IgE response directed against 
N. americanus, and in fact this IgE is more specific than any other class of Ig 
(Pritchard and Walsh, 1995). A study conducted over two years of the 
N. americanus endemically infected population in Papua New Guinea looked at 
the levels of circulating total IgE and the fecundity and weight of recovered adult 
parasites (post chemotherapy) whilst controlling for the confounding variables of
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host age and worm burden. A highly significant negative coiTelation between 
total IgE levels and worm weight and fecundity was found both in the first 
experiment and in the second, two years later (Pritchard et al, 1995). Curiously, 
worm-specific IgE levels were only weakly (not significantly) negatively 
coiTelated with female worm weight, and were not correlated with male worm 
weight. The authors suggest that the coiTelations are unlikely to reflect a direct 
effector role for non-specific IgE, but that this is indicative of a Th2-dependent 
immune response that acts to reduce parasite weight and fecundity. Quinnel et 
al, (1995) report that from the same sample population there was a negative 
coiTelation, as age progressed, between anti-adult excretory/secretory antigens 
IgE and IgM, and parasite burden; a result indicative of these isotypes playing a 
role in host immunity. Further evidence for an antibody mediated role in 
immunity comes from cross sectional epidemiological studies in China and 
Brazil that found patients exhibiting high titres of circulating IgE specific to 
Ancylostoma secreted protein 1 of L3, harboured a less intense woim burden 
(Bethony, unpublished results reported in Hotez et a l, 2003).
There is a strong peripheral eosinophil response associated with N. americanus 
infection (Maxwell et al, 1987) but although eosinophils adhere to L3 in the 
presence of complement and antibody in vitro, there is no evidence that this is 
harmful to the worms (Desakom et al, 1987). Indeed, IL-5 knockout mice with 
no eosinophilia showed no increase in tissue numbers of A. caninum (Loukas and 
Prociv, 2001), though the mouse is a non permissive host. Little is known about 
the mast cell response in human hookworm infections, though in the A. 
ceylanicum! hamster model, animals become quickly resistant to challenge and 
this is characterised by a mucosal mast cell hyperplasia (Brooker et al, 2004).
Recently, two separate studies carried out in Papua New Guinea and Brazil 
looked at the cytokine response in N. americanus infected populations. In the 
former study, looking at the cytokines release by lymphocytes, the authors found 
an expected upregulation of Th2 cytokines IL-4 and IL-5 in response to 
hookworm antigen. However, they also report detectable IFN-y released with a 
negative relationship between IFN-y levels and worm burden (Quinnell et al,
2004). This relationship could be explained as evidence of a protective effect or
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of immunomodulation by the woims; the increase of IFN-y levels found 5 weeks 
after chemotherapy and woim expulsion might indicate the latter. However, pre­
treatment EL-5 levels were shown to be negatively con'elated with the intensity of 
reinfection, providing clear evidence for a protective role of EL-5 and indicating 
that this response is directed against incoming larvae and that it may involve 
eosinophils. Interestingly, hookworms release products that cleave eotaxin, an 
eosinophil chemokine (Gulley et al, 2000). A study carried out in school 
children in Brazil found antigen specific IFN-y expression levels higher in egg 
negative endemic control patients than in hookworm patients but found IL-IO 
levels higher in patently infected patients (Geiger et al., 2004). These results 
would suggest that both Thl and Th2 aims of the immune response play a role in 
protection against hookwoims.
Despite the ability of dogs to develop immunity to A. caninum (Miller, 1965), 
there is still limited evidence to suggest that humans develop immunity to 
hookworms. Indeed there is evidence that chronic human infection with 
hookworm actually leads to a hyporesponsiveness of cellular immune response, 
to both hookworm and non-hookwoim antigens (Loukas et ai, 2005). The 
observed higher EL-10 production by stimulated peripheral blood mononuclear 
cells from N. americanus infected children compared to non-infected controls 
suggests a T regulatory cell response that might dampen a proinflammatory 
response, possibly as a mechanism to regulate pathology due to inflammation 
(Geiger et al, 2004). Loukas et al, (2005) reported that, in the presence of IL-2 
and EL-12, excretory/ secretory (ES) products from N. americanus can stimulate 
EFN-y production by natural killer (NK) cells; as such, hookwoims may be cross 
regulating a potentially host protective Th2 immune response, therefore, 
allowing long term survival of N. americanus (Loukas et al, 2005).
From an epidemiological point of view, the monotonie age-intensity profile of 
hookworm infection would not at first appear consistent with a development of 
immunity in adults (Quinnell et al, 2004). However, mathematical models 
suggest that because of the confounding variable of constant exposure (or 
increasing exposure) to infection with age, a partial immunity would not 
necessarily buck the monotonie trend (Woolhouse, 1992); therefore, this linear
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pattern may actually be consistent with a degree of immunity developing 
(Quinnell et al, 2004).
In summary, the protective immune response to human hookwoim is 
complicated and remains unclear but is likely to involve a combination of several 
effector cell types and mediators and is likely regulated to a degree by the 
secretion of immunomodulatory hookworm proteins.
1.4.4 Immune response to H. contortus
Following repeated infection, sheep can become resistant to H. contortus 
infection. Experimentally-infected hyperimmune sheep can rapidly expel 
infective larvae; invading L3 become briefly associated with the abomasal 
mucosa but, rather than enter the gastric glands, are expelled by means of an 
immune exclusion mechanism (Miller et al, 1983). These sheep show little 
increase in lymphocyte recruitment to the mucosal tissue (GoiTell et al, 1988) 
and the mechanisms behind immunity to infection are still not well understood. 
Both primary and secondary infection with H. contortus is accompanied by an 
increase in serum antibody (Smith, 1977; Schallig et al, 1994; Schallig et al, 
1995); however, a direct relationship between these antibody levels and the 
immune status of the sheep has been questioned (Schallig, 2000). If antibody 
does play a role in immunity, it may be that the local mucosal response is more 
important than the systemic. Interestingly, following a secondary challenge 
infection, circulating antibody levels rose slightly, but not until after a fall in 
faecal egg count associated with immunity. In contrast, local mucosal IgA levels 
rose rapidly following the secondary challenge, suggesting this to be a mediator 
of immunity (Charley-Poulain et al, 1984). By cannulating the gastric lymph 
duct. Gill et a l  (1992a) measured the number of cells containing the various 
antibody isotypes before and during H. contortus infection. Post infection, an 
increase in Ig containing cells was found, with a particularly marked increase in 
IgGl and IgA positive cells, the latter being the most frequently observed with a 
peak 2-4 weeks post infection. Strain and Stear (2001) have suggested that IgA 
is a particularly important isotype with regard to control of fecundity and worm 
size in T. circumcincta. Although, despite IgA levels being inversely associated
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with worm burden and faecal egg count in H. contortus infection, IgA levels 
were not found to differ between resistant and non-resistant breeds (Amarante et 
ai, 2005). As with other helminth infections, elevated serum IgE levels are a 
feature of FI. contortus infection; a negative coiTelation of total IgE with worm 
burden was found but, in a situation analogous to that in hookworm infection 
(Pritchard et al., 1995), specific IgE did not coiTelate with protection (Kooyman 
e ta l, 1997).
An investigation of the cytokine profiles associated with infection in resistant 
and non resistant breeds found infected sheep of both breeds to have lower IFN-y 
and higher IL-5 levels than their non infected counteiparts. Resistant sheep had 
higher IL-5 levels, increased levels of cultured cell derived IgE and IgGl and a 
higher density of local mast cells and eosinophils than non resistant sheep, 
implying a Th2 type response in genetically resistant sheep, and supporting the 
notion of a Thl/Th2 dichotomy in sheep (Gill et al., 2000). Elevated levels of 
EL-5 might suggest a role for eosinophils, concurring with the discovery that 
eosinophils can kill L3 in vitro in the presence of antibody and complement and 
that this killing is enhanced by IL-5 (Rainbird et al, 1998).
Smith et al. (1984) demonstrated transfer of immunity to naïve sheep by efferent 
gastric lymph from immune animals though this was only evident when the 
lymph was taken 3 and 5 days post challenge. The cell type responsible for this 
is likely to be CD4^ helper cells. The importance of this cell type in resistance 
against H. contortus was confirmed by the ability of anti-CD4^ T cell monoclonal 
antibody to abrogate resistance in vivo to normally resistant animals (Gill et al,
1993).
A recent study has provided evidence that there may be two distinct types of 
immunity elicited against invading H. contortus larvae. In two separate 
experiments, hyperimmune sheep were challenged and killed 3 and 5 days post­
challenge to allow investigation of larval-mucosal association and of cell types 
present (Balic et al, 2002). In the first study sheep had no larvae present at either 
time point and no lymphocyte or eosinophil recruitment was found. In the 
second experiment (of identical design) larvae were present within the abomasal
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tissue and there was an increase in activated CD4^ T cells, and an increase in 
7Ô-T cells, (but not CD8  ^T cells) and B cells. Higher levels of eosinophils were 
also observed, as was a close association between this cell type and the larvae. 
Balic and colleagues suggest that immune sheep show two distinct responses to 
invading L3, either a delayed or rapid expulsion, and that different responses are 
associated with the different expulsion kinetics. The reason for the different 
outcome in the two experiments is hard to explain, but does indicate the 
heterogeneity of response to infection.
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1.5 Control Strategies
Currently, control of hookworm disease relies heavily on anthelmintic drugs, 
predominantly benzimidazoles. Control programmes are aimed at reducing the 
worm burden, thus the transmission potential in an attempt to alleviate the 
morbidity associated with infection, rather than infection per se. (WHO, 
Prevention and control of intestinal pai*asitic infections, 1987). Albendazole is 
the treatment of choice for hookworm infection, and a single dose is sufficient to 
treat hookworm infection with a cure rate of 57-95% and an egg reduction rate of 
between 92 and 100% (Albonico et al, 1999). Thus, clearly, regular 
anthelmintic treatment would result in lowering worm burdens and help prevent 
disease, but to whom should treatment be directed? The bias in woim burden 
distribution in the population might suggest that treatment should be aimed at the 
people cari’ying the heaviest infections, but identifying this group may prove 
difficult. It has been suggested that, in terms of practicality, cost effectiveness 
and ease of administration, a programme of school-based treatment is simplest 
and most effective at treating disease associated with STH (Savioli et al., 2002). 
On this basis, the WHO put forward a resolution to see 75% of children receive 
regular anthelmintic treatment by 2010. However, the epidemiology of 
hookworm is distinct from that of the other STH, in that infection increases with 
age, leading some researchers to suggest that a school based treatment 
programme may have a more limited benefit than treatment of disease in adults 
attributable to hookworm (Chan et al, 1997).
Despite this, regular chemotherapy can clearly reduce morbidity. In Nepal a 
regular deworming programme, providing 2 albendazole treatments a year to 
95% of school children, has reduced anaemia by 77% since 2001 (WHO, 2005). 
Antenatal treatment with anthelmintics in Nepal was also found to significantly 
reduce maternal anaemia and improve infant survival (Christian et al, 2004). 
These results confinn work undertaken in Tanzania that found serum fern tin and 
haemoglobin levels were significantly improved in children by treatment against 
hookworm (Bhargava et al, 2003) and work in Zanzibar that demonstrated a 
regime of three doses per year of anthelmintic in school children to significantly
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improve iron status and decrease the chances of IDA occuning (Stoltzfus et ai, 
1998).
The importance of regular dewonning treatment is highlighted by the incidence 
of reinfection following treatment; a study in Tanzania reported a return to pre­
treatment levels of hookwonn infection just 4-12 months following treatment 
(Albonico et ai, 1995). Quinnell et al, (1993) found that in Papua New Guinea, 
levels of hookworm prevalence had returned to those pre-treatment 2 years 
beforehand and a geometric mean of worm burden had returned to 58% of the 
pre-treatment level.
A woiTy of large scale nematode control programmes based on chemotherapy is 
the emergence of drug resistant worm populations (Albonico et al, 1999). This 
is already a massive problem with nematodes of veterinary importance (including 
H. contortus, discussed below), and there are reports of drug failure likely due to 
resistance in hookworms (Albonico et al, 2003; de Clerq et al, 1997). A 
problem with detecting drug resistance in hookwoims is the variability in cure 
rates of chemotherapy, the difficulty in determining drug efficacy, and the lack of 
a standardised technique (Geerts and Gryseels, 2000). Recently, workers have 
looked to the veterinary research field to adapt established anthelmintic 
resistance assays for use with hookworms, and this may allow future drug 
resistance screening (Albonico et al, 2005; Kotze et al, 2005).
Improvement of diet, and iron supplementation may also contribute to reducing 
morbidity. Work looking at the effect of iron supplementation with or without 
helminth chemotherapy in adult females (with a high prevalence of hookwoim, 
as well as concomitant STH infections) demonstrated iron supplementation alone 
to significantly increase haemoglobin values; though, when administered in 
combination with anthelmintic, haemoglobin values further improved (Gilgen 
and Mascie-Taylor, 2001).
That improved sanitation is an important factor in any human helminth control 
programme is well recognised (Albonico et a l, 1999); however, the impact this 
has is often slow to develop, may not make a measurable impact for decades and
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the reduction may be greater on other STH than it is on hookworm incidence 
(Esrey et al, 1991). These authors report only a 4% decline in hookworm 
infection prevalence as a result of latrine use. Use of footwear is also likely to 
have an effect upon infection prevalence; a Tanzanian study linked compulsory 
shoe Wearing by school children to a lower hookworm incidence compared to 
children not attending school (Killewo et al, 1991). Whilst an improvement in 
the sanitary conditions is undoubtedly of long term benefit, cuiTently the only 
strategy available for effective short to medium-teim disease control is 
chemotherapy (Brooker et al, 2004).
Like human hookworm, control of GI nematodes in sheep is almost exclusively 
based on use of anthelmintics, there being 3 main broad spectrum drugs 
available: the benzimidazoles, the macrocyclic lactones and levamisole. Control 
is highly effective and results in an almost complete cure of the existing 
nematode infection. However, drug resistance is a major, and ever increasing, 
problem, with resistance to all classes of drug available, and a high prevalence of 
multi-drug resistant worms (reviewed recently by Kaplan, 2004). Reports 
indicating the seriousness of the situation in South America (Echevairia et al, 
1996; Eddi et al, 1996; Maciel et al, 1996; Nari et al., 1996), Australia (Love et 
al, 2003) and South Africa (Van Wyk et al, 1999) suggest that H. contortus 
strains now resistant to all three types of anthelmintic in use actually threaten the 
viability of sheep farming in these regions.
In the UK, although not on the scale in tropical areas, anthelmintic resistance in 
H. contortus is prevalent (Jackson and Coop, 2000). Multi drug resistance is a 
big problem in T. circumcincta (the more prevalent sheep GI species in the UK) 
and recently triple resistant isolates have been identified (Bartley et al, 2004). 
The problems highlighted have resulted in a concerted effort to seek alternative 
control strategies and research into vaccine development against the GI 
nematodes of ruminants, particularly H. contortus.
As well as the programme of chemotherapy for school children, in 2005 the 
WHO recommendations for STH control also stated that research into alternative 
control such as vaccines is considered essential. The combination of knowledge
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gained from the veterinary field and the HHVI is the subject of the following 
section.
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1.6 Rationale of Vaccination
It would certainly seem, from the immune responses associated with hookworm 
infection in man, that acquisition of solid natural immunity does not follow 
infection. How therefore, can one expect vaccination to be a feasible strategy? 
Early studies focusing on stimulating immunity in dogs to A. caninum found that 
administration of live L3, either orally or subcutaneously, repeatedly in small 
doses elicited an artificial immunity (McCoy, 1931). The immunity was not 
sterile, rather it was reflected by a much reduced woim burden compared with 
non immune controls. Control of disease was antibody mediated (Otto, 1940) 
and was primarily directed at antigens secreted by L3 (Sheldon and Groover, 
1942). This knowledge led to research in the veterinary field to design a vaccine 
against A. caninum for use in dogs. Irradiated L3 were shown to elicit good 
levels of protection, providing the damaged L3 remained viable (Miller, 1965) 
and able to secrete the antigens required to induce immunity (Hotez et al, 2003). 
This established the basis for a commercial vaccine using attenuated L3 which 
was marketed in the USA in the 1970s. Ultimately the vaccine was a 
commercial failure due to the high costs involved in production, the short shelf 
life and an inability of clinicians and pet owners to appreciate the value of a 
vaccine that, whilst not resulting in sterile immunity, was still of benefit in 
lowering environmental contamination and in preventing disease (Miller, 1978). 
However, the vaccine did demonstrate proof of concept, and confirmed that the 
larval stages contain or release protective antigens (iiradiated larvae do not 
develop into adults). The immunity stimulated by the murine vaccination with 
irradiated N. americanus has suggested a localised Th2 response with an increase 
in IL-4 and levels of IgGl, analogous to the situation described in human 
hookworm infection (Girod et al, 2003).
Immunoepidemiological evidence that indicates a group of individuals in 
endemic hookworm regions develop a Th2 humoral immune response to a 
specific secreted antigen that results in a lower intensity of infection indicates 
that individuals can develop a natural immunity that could be exploited through 
vaccination (Brooker et al, 2004). Very recent work has linked specific anti-L3
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antigen IgE titre with protection against hookworm in endemic areas of Brazil 
and China (Bethony et al, 2005). Thus there are several lines of evidence that 
development of a human hookworm vaccine is feasible.
Discussed in detail later, hookworms and H. contortus share a similar battery of 
proteins and enzymes that align the brush border of the alimentary canal, and 
may be involved in digestion. Over the past two decades, several antigen 
complexes have been isolated from the gut of H. contortus and these have been 
found to consistently elicit high levels of protection against homologous 
challenge in vaccine trials (Knox and Smith, 2001) proving vaccination against 
H. contortus a feasible strategy. H. contortus also has homologues of some of 
the hookwonn secreted antigens, and protein mixtures containing these have also 
elicited high levels of protection (Schallig et al, 1997).
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1.7 Potentially Protective Antigens
There are two major classes of proteins that are suitable vaccine targets: 
Excretory-secretory (ES) products, that are essential for parasite survival (for 
example for extra corporeal digestion), and somatic proteins that are accessible to 
host Ig (Knox, 2000). Of the latter, much research has been focused on the 
“hidden” antigens of the nematode gut, termed as such as they are not naturally 
exposed to the host immune system. However, Ig can be directed against such 
antigens and is ingested with the blood meal, a concept proven by the 
development of a successful vaccine against a gut antigen of the cattle tick 
Boophilus microplus (Willadsen, 1995). Antibodies directed at gut proteins 
essential for worm survival may inhibit protein function, and protection may be 
due to direct antibody inhibition of proteinases (Knox et al, 1999). There is also 
evidence that antigens secreted by hookworm infective larvae can elicit 
immunity. Therefore the HHVI has selected hookwoim antigens as lead 
candidates for vaccine testing on the basis of either the link with attenuated larval 
vaccines, or because they are orthologues of the major H. contortus vaccine 
candidates (Hotez et al, 2003). Protective antigens, and those deemed to have 
potential are discussed in the next section.
1.7.1 Gut-expressed antigens
Several, protective gut-expressed antigens have been isolated from H. contortus 
(Munn, 1997). H ll  (a 110 kDa integral membrane glycoprotein) is one such 
antigen, purified from contortin-enriched preperations from adult H, contortus 
(Smith et al, 1993). H ll  shows aminopeptidase activities and H ll  isotypes are 
encoded by at least 3 genes, exhibiting homology to those of mammalian 
microsomal aminopeptidases. Enzyme activity is localised to the intestinal 
brush border and can be inhibited in vitro by antisera raised against HI 1 (Smith 
et al, 1997). The level of this enzyme inhibition coiTelates with protection 
(Munn et al, 1997). In its native and purified foim, H ll  is the most efficient 
nematode immunogen, in protective terms, isolated to date (Knox and Smith, 
2001). Intriguingly, a homologue of H ll  in hookworms has not been identified 
to date.
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The H. contortus galactose containing glycoprotein complex H-gal-GP, isolated 
from the gut lumen, reduced woim burdens by 72% and mean faecal egg counts 
(FEC) by up to 93% when used in a sheep protection trial against homologous 
challenge (Smith et al, 1994). The complex is localised to the surface of the gut 
cells and has been implicated in blood feeding, Enzyme linked immunosorbent 
assay (ELISA) data implicates antibody-mediated protection (Smith et al, 1999). 
H-gal-GP has been shown to contain an aspartyl protease (Longbottom et al, 
1997) and at least 4 metalloendopeptideases termed MEPl, 2, 3 and 4 (Redmond 
et al, 1997; Smith et al, 1999) as well as thrombospondin (Skuce et al, 2001), 
cystatin, (Newlands et al, 2001) and galectin (Newlands et al, 1999) 
homologues. Recently Jones and Hotez (2002) have identified and characterised 
a 98 kDa MEP from A. caninum (AcMEP-1). Expression of the AcMEP-1 is 
restricted to the adult stage and activity is localised to the gut surface as in H. 
contortus. The elucidated amino acid sequence shows homology to the H. 
contortus MEP-1 component of H-gal-GP (66% similarity and 50% identity) thus 
making it a possible vaccine target for A. caninum protection studies. It is likely 
that MEPs ai’e involved in part of a proteolytic cascade of haemoglobin 
digestion, so antibody directed against them might inhibit parasite feeding 
(Williamson et al, 2003). Moreover, Culley et a l (2000) have demonstrated 
hookwonn MEPs which specifically cleave eotaxin, a potent eosinophil 
chemokine. Discussed in Section 1.4,2,1, eosinophils are believed to play a role 
in hookworm immunity, thus AcMEP may have an immunoregulatory function.
Aspartyl protease (APR) activity capable of digestion of skin macromolecules 
and haemoglobin has been reported in hookworms (Brown et al, 1999; 
Williamson et al, 2002; Williamson et al, 2003) and at least two distinct 
aspartyl proteases have been isolated from hookwoiTns; APR-1, a cathepsin D 
like protease and APR-2 (HaiTOp et al, 1996; Williamson et al, 2003), A 
homologue of aspartyl protease of H-gal-GP, the N. americanus aspartyl protease 
Na-APR-2 can cleave human haemoglobin and serum proteins in a host-specific 
manner. It is more similar to a distinct nematode specific family of aspartic 
proteases than to Cathepsin D like proteases, represented in hookworms by the 
APR-1 s (HaiTop et al, 1996), but, like APR-1, is localised to the gut surface and 
excretory glands (though was not detected in adult ES). As mentioned, both
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proteases can cleave haemoglobin and serum proteins, and it has been suggested 
that the enzymes may both play roles in the proteolytic cascade of haemoglobin 
degradation; APR-1 an upstream protease exposing other cleavage sites and 
APR-2 (and the host of other haemoglobinase enzymes) degrading the exposed 
cleavage sites (Williamson et al, 2003). Vaccination of dogs with a recombinant 
Ac-APR-1 resulted in a significant shift in adult worms from the normal site of 
predilection, the small intestine, to the colon; the significance of this in terms of 
potential protection is not understood (Hotez et al, 2002). Recently, vaccination 
of dogs with Ac-APR-1 led to a significantly reduced woim burden and FEC 
and, most interestingly, vaccinated dogs were protected against blood loss and 
did not suffer anaemia (Loukas et al, 2005). This evidence combined with 
protective capabilities of H-gal-GP certainly suggests these proteases are 
potential vaccine targets.
H. contortus and A. caninum both contain cathepsin B-like cysteine proteases 
(Tort et al, 1999). Cox et a l (1990) identified a 35 kDa cysteine protease in H. 
contortus water soluble extracts that showed anticoagulant qualities and 
degraded fibrinogen. Immunisation with this protease confeired marginal 
protection in lambs. A cysteine protease-enriched fraction of detergent soluble
H. contortus extracts. Thiol Sepharose Binding Protein (TSBP; purified by 
passage through a Thiol-Sepharose affinity column), proved protective in 
immunised lambs (Knox et al, 1999). The proteins were localised to the gut 
surface and the microvillar surface of worms recovered from vaccinated lambs 
was coated in sheep immunoglobulin. TSBP consists of a 60 kDa glutamate 
dehydrogenase and cysteine proteases encoded by three distinct genes, cDNAs of 
which have been designated hmcpl, 4 and 6 (Skuce et al, 1999). Further 
fractionation of TSBP has determined that the protection partitions to a 
protease-rich subfraction and is likely attributable to cysteine proteases (Knox et 
al, 2005). Using cystatin, a cysteine protease inhibitor, to specifically purify the 
cysteine proteases in TSBP, Redmond and Knox (2004) demonstrated the 
cysteine proteases to confer a substantial level of protection. Moreover, in a 
vaccine trial using recombinant hmcp 1, 4 and 6 expressed as GST-fusion 
proteins, sheep showed a highly significant 38% reduction in worm burden. Two 
cysteine proteases have been cloned from A. caninum AcCP-1 and AcCP-2
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(HaiTop et al, 1995). Vaccination of dogs with the latter, likely to be a gut 
expressed protease, resulted in reduced fecundity and a decrease in worm size 
cotxesponding to specific anti AcCP-2 antibodies binding to the worm gut and 
interfering with protease function (Loukas et a l 2004).
1.7.2 Excretory secretory antigens
Molecules released by the parasite in vivo or in vitro culture are refened to as ES 
products. They may be derived from the pai’asite surface, from specialised 
secretory glands or as by-products of digestion and represent antigen exposed to 
the host (Knox, 2000). ES products are often released in a stage specific manner. 
For example, an increase in the quantity of protein released by H. contortus L3 in 
vitro culture (as detected by gel electrophoresis and Coomassie staining) is 
associated with the onset of feeding (Gamble and Mansfield, 1996). H. contortus 
ES products include proteolytic enzymes probably involved in digestion of the 
blood meal (Knox and Jones, 1990). ES proteins usually display a simpler 
antigenic composition compared with somatic antigens and elicit a strong 
immune response, thus implying a possible protective value (Schallig et al, 
1994).
1.7.2.1 Adult ES
Schallig et a l (1994) showed ES products of adult H, contortus to provoke 
strong cellulai* and humoral immune responses in Texel sheep and to elicit an 
immunity characterised by a reduction in FEC of 32% and of worm burden by 
63%. In the same study, sera from primary infected and challenged sheep used 
to screen immunoblots of adult ES strongly identified a 24 kDa protein and a 15 
kDa protein, respectively. Later protection studies with the 15 kDa and 24 kDa 
ES proteins demonstrated a 72% reduction in FEC compared with control groups 
(Schallig et al, 1997a). These workers also found an increased mastocytosis to 
abomasal tissue and a primarily Th2 response to the ES antigen, leading them to 
postulate that ES antigens mimic natural immunity to H. contortus. Interestingly, 
when looking at conelations in protection, animal age and IgE and IgGl level, it 
would appear that protection is age related, but that when this is taken into 
consideration, it coiTelates with IgE antibody (Kooyman et al, 2000). Cloning
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and characterisation of these proteins demonstrated a 50% homology between the 
24 kDa ES (Hc24) and a 24 kDa protein secreted by A. caninum L3, Ancylostoma 
secreted protein 2 (ASP-2) (see section 1.7.2.2). ASP-2 is expressed with the 
onset of feeding and restricted to pai-asitic life stages suggesting a role in the 
transition to parasitism (Hawdon et al, 1999). Adult hookworm-derived ASPs 
also show homology with Hc24: two adult ASPs (ASP-3 and ASP-5) exhibit 
25% and 32% homology with Hc24, respectively (Hotez et al, 2003). More 
recently, trials of combined recombinant 15 kDa and 24 kDa ES with or without 
a glycan-rich insect cell extract gave a reduction in sheep worm burden of 55% 
and 65% respectively, though these results were not reproducible and protection 
was not apparent in young lambs (Vervelde et al, 2002).
The most abundant protein secreted by A. caninum adults is a 16 kDa tissue 
inhibitor of metalloproteases (TEMP), mRNA expression for which is restricted 
to the adult stage (Zhan et al, 2002). TIMP shows 33% identity and 50% 
similarity with the N-terminal of human tissue inhibitor of metalloprotease 2, and 
has homologues in C. elegans, although its function is unknown. Interestingly, 
an investigation into the humoral response of dogs vaccinated with iiradiated A. 
caninum showed that a dominant antibody response was elicited against a second 
TIMP protein (TIMP-2) (Boag et al, 2003). Vaccination with recombinant A, 
caninum TIMP had no effect on overall worm burden, but it did have a marked 
effect on the habitat of the adult worms; a proportion of woiTns appeared to 
migrate through the small intestine to the colon suggesting a genuine effect 
(Hotez et al, 2002). No homologue has been identified in the available adult H. 
contortus gene sequence database.
A number of other proteins are secreted by adult hookwoiTOs including a 
neutrophil inhibitor factor (NIP), which exhibits some homology with Ac-ASP-3. 
Vaccination of hamsters with an A. ceylanicum homologue of the AcNEP resulted 
in a significant reduction in fecundity of worms following homologous challenge 
(Ali et al, 2001). Secretion by adult A. caninum of a fatty acid and retinol 
binding protein has also been demonstrated (Basavaraju et al, 2003); inhibition 
of which might be detrimental to the worm indicating it as a possible vaccine 
candidate. Adult hookworms secrete a family of anticoagulant peptides
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(Cappello et al., 1995; Stassens et al., 1996), of which one (A. caninum 
anticoagulant protein, AcAP5) has shown slight promise in trials as a protective 
vaccine candidate (Hotez et al., 2002). Moreover, purified IgG specific for 
AcAP5 has been demonstrated to neutralise the anticoagulant nature of the 
protein in vitro, therefore antibody targeting in vivo might prevent hookworm 
feeding (Hamson et al, 2001).
In addition, adult hookworms have also been shown to secrete an aspartyl 
protease inhibitor (Delaney et al, 2005), a novel immunoreactive protein (AcES- 
2; Bungiro et al, 2004), acetylcholinesterases (Pritchard et al, 1991), a 
haemolysin (Don et al, 2004), a platelet inhibitor (Del Valle et al, 2003) and 
proteins that bind selectively to natural killer cells (Hsieh et al, 2004). 
Inhibition of some of these proteins, potentially essential for the parasite’s 
survival, might be feasible by antibody, indicating a possibility as vaccine 
candidates.
1.7.2.2 Larval ES
It has been demonstrated that larval infective stages (L3) of both hookworm and 
H. contortus contain or release proteins capable of protection against further 
infection; vaccination using inadiated larvae of both A. caninum and H. 
contortus will protect against homologous challenge (Miller, 1965; Smith and 
Angus, 1980). Developmentally arrested L3 larvae of both hookworm and H. 
contortus activate to resume development shortly after entry to the host. This 
can be achieved in vitro by culture of A. caninum with a low molecular weight 
fraction of dog serum to stimulate feeding (Hawdon and Schad, 1990). In the 
case of H. contortus, exsheathing in CO2 and culture in media results in the onset 
of feeding after 48-72 hours (Gamble and Mansfield, 1996).
On resumption of development, A. caninum L3 release several molecules into 
culture medium, the most abundant of which is a 42 kDa secreted protein termed 
ASP-1. A cDNA found to encode ASP-1 exhibits homology to the Antigen5/ 
Antigen3 (Ag5/Ag3) family of proteins from hymenoptera venom, a family of 
cysteine-rich secreted proteins (CRISPs) and pathogenesis-related proteins in
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plants (Hawdon et al, 1996). When antibodies to recombinant ASP-1 were used 
to probe the kinetics of expression, it was found that ASP-1 is released within 30 
min of activation in vitro, far earlier then the onset of feeding (6-8 hours post 
activation) (Hawdon et al, 1996). It was also shown that the serum stimulus 
essential for activation, was required constantly for ASP-1 release, but required 
only once to initiate feeding. This implied that ASP-1 had a function apart from 
feeding, leading Hawdon and co-workers to suggest an important role in 
transition to parasitism and infection. They found a 30% homology to the adult 
ES protein NIF mentioned above, pointing to a possible immunomodulatory role. 
Alternatively, on account of ASP-l’s homology to Ag5 of the wasp Vespula 
squamosa they suggest its function is one of an allergen to elicit an immediate 
type hypersensitivity response and a Th2 cytokine profile (Hawdon et al, 1996). 
Vaccination with a recombinant ASP-1 resulted in protection in mice against 
challenge infections manifested in a reduction in lung hookworm burdens and a 
reduction in hookworms in muscle (worms do not develop beyond L3 in the 
mouse). This decrease in worm burden was associated with an increase in all 
classes of Ig (Gosh and Hotez, 1999), leading the authors to conclude that burden 
reduction is antibody dependent, and may operate by blocking L3 entry to the 
lungs. Further weight is added to this hypothesis by their observation that ASP-1 
may be an amphidial protein in a plant nematode {Meloidigyne incognita) and 
that antibodies against this could alter certain amphidial functions, such as 
chemosensation.
A second A. caninum L3 ASP, ASP-2, is approximately half the size of ASP-1, 
and exhibits 54% identity and 68% similarity and aligns with the C-tenninal half 
of ASP-1 (Hawdon et al, 1999). Thus, there are two types of ASP molecules in 
A. caninum: a single domain type, represented by ASP-2 and a double domain 
type, represented by ASP-1, both belonging to the same family (Hawdon et al, 
1999). Since their discovery in A. caninum, representatives of both the single 
and double domain ASPs have been discovered in the human hookworm species 
(Bin et a l, 1999; Zhan et al, 2003) Like asp-l, asp-2 mRNA is synthesised in 
all life stages of the parasite, but its gene product is only released by activated 
L3. ASP-2 is represented in many species of nematode: as already mentioned, 
ASP-2 has a homologue in adult H, contortus in the form of Hc24, it also has
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homologues in the fil arid nematodes [an ASP-2 homologue in Brugia malayi has 
been demonstrated immunogenic (Muiray et a l, 2001)] and in at least 17 genes 
in C  elegans (Bin et al, 1999), The wide distribution of ASP-2 among 
nematode species suggests it serves an important function in development and 
physiology (Hawdon et al, 1999) thus making it a prime vaccine target. Vaccine 
trials have demonstrated a protective function of ASP-2; vaccination with 
recombinant A. ceylanicum ASP-2 lead to 30% reduced worm burden, and to a 
16% reduction in adult worm length and was associated with a high specific 
antibody titre (Goud et al, 2004). This protection was repeatable in a second 
trial, again accompanied by high specific antibody titres, and enhanced by 
concomitant vaccination with another hookworm protein (Mendez et al, 2005). 
Studies have also indicated that there is a relationship between human anti-ASP- 
2 antibody titre and reduced infection intensity in hookworm endemic regions 
(Hotez et al, 2005). Based on this evidence, a Pichia-Qxpv&ss&d recombinant N. 
americanus ASP-2 (Na-ASP-2) is now ready for use in human Phase 1 clinical 
trials (Goud et al, 2005).
Although ASP-1 has only 1 homologue identified in C. elegans, suggesting there 
aie fewer copies of this gene in the nematode genome than ASP-2 (Bin et al, 
1999), there is a single domain ASP-1 homologue in H. contortus: Hc40 
(Hawdon et al, 1999). This 40 kDa homologue, purified from a H. contortus 
cDNA library immunoscreened with a polyclonal serum against gut proteins 
(Rehman and Jasmer, 1998), is almost identical to a protein purified from H. 
contortus adults that was demonstrated to confer protection against homologous 
challenge in a guinea pig model (Sharp et al, 1996). A single domain ASP like 
protein, a homologue of the N-terminal of ASP-1 as opposed to an ASP-2 
homologue, has also been isolated from H. contortus, in this case from ES of 
cultured L3. This was shown protective in guinea pigs vaccinated with the native 
protein (80% reduction in worm burden) and with a baculovirus-expressed 
version (45% reduction) compared to controls (Shaip and Wagland, 1998). 
However, the guinea pig is a non peimissive host model and no published sheep 
vaccine trials have been carried out. Two ASP homologues have been described 
in O. ostertagi and, like the H. contortus L3 ES ASP-1, both are single domain 
ASPs but show homology to the N-terminal part of the A. caninum ASP-1 as
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opposed to the ASP-2; several other single domain ASPs have been found in the 
EST dataset (Geldhof et al, 2003). Of significance is that O. ostertagi ASP 
homologues are the most abundant proteins in a protective fraction from adult O. 
ostertagi ES (Geldhof et al, 2003).
Both A. caninum and H. contortus release metalloproteases (MTP) 
developmentally expressed in activated larval stages (Hawdon et al, 1995; 
Gamble et al, 1989; 1996). On gassing with CO2, H. contortus L3 release a 44 
kDa zinc MTP which mediates ecdysis in vitro (Gamble et al, 1989). The 
protease acts on an area 20 jim from the anterior tip of the nematode, and 
degrades the refractile ring allowing the L3 to escape its sheath (Gamble et al, 
1989). Secretion of another, likely distinct, H. contortus MTP occurs coincident 
with the L3 to L4 moult and the onset of feeding in vitro (Gamble et al, 1996). 
The authors postulate that although this 46 kDa metalloprotease may play a role 
in the L3 to L4 moult, it is not the enzyme’s exclusive function, as it is 
continuously released after the moult has taken place (Gamble et al, 1996). It 
may have a function in feeding or prevention of blood clotting.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) of cDNA from A. 
caninum larval stages found cDNA encoding the A. caninum (Ac) MTP confined 
to the L3 stage. The full length cDNA encodes a protein with a calculated 
molecular weight of 61 kDa and shows significant homology to members of a 
family of zinc MTPs called the astacins (Zahn et al, 2002). Homology was 
found with a group of astacin-like proteases in C. elegans, and astacin-like MTPs 
have since been identified in O. ostertagi (De Maere et al, 2005) and 
Strongyloides stercoralis (Gomez Gallego et al, 2005). MTP-like sequences are 
found in expressed sequence tag (EST) databases of N. americanus, T. 
circumcincta and A. ceylanicum indicating the ubiquitous nature of these 
proteases in nematodes, though no homologue has, as yet, been identified in the 
H. contortus EST dataset. Antibodies to recombinant AcMTP recognised a 
protein band of 47.5 kDa in activated L3 ES, most probably a form following 
removal of the pro-enzyme indicating that L3s release a processed form of MTP 
during in vitro activation (Zhan et al, 2002). The function of AcMTP is
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unknown, but it may have a role in regulating development (Zhan et al, 2002), 
or it may facilitate skin penetration and/or tissue migration (Williamson et al, 
2006). Whatever the function, its stage specificity and secretion during L3 
activation suggest a critical role in the infective process.
Regardless of the specific roles of these developmentally regulated astacin-like 
MTPs, possible in vivo interference of function may make them good vaccine 
targets, although the H. contortus exsheathing MTP is probably not expressed 
out with the cuticle, or for long enough to target it with antibody (Gamble et al, 
1989). At least two protection trials have been carried out using the recombinant 
AcMTP. In the first, utilising the dog A. caninum model, no difference in woim 
burden between Escherichia co/i-expressed MTP-vaccinated and control 
animals. However, a high specific AcMTP antibody was developed and there 
was a significant inverse correlation between antigen specific IgE titre and worm 
burden (Hotez et al, 2003). More recently, vaccinating hamsters with Pichia- 
expressed A. ceylanicum MTP resulted in a reduction in worm burden of 28%; 
when administered in a cocktail vaccine alongside ASP-2, the MTP significantly 
improved overall protection as measured by worm burden and FEC (Mendez et 
al, 2005). Thus, the larval MTP is a promising vaccine candidate.
Infective N. americanus L3 have been shown to secrete aspartyl proteases with 
an activity similar to that of the adult APRs discussed above (Brown et al, 
1999). This protease activity was demonstrated to degrade skin macromolecules. 
Furthermore incubation of L3 with protease inhibitors found Pepstatin A, an 
apaityl protease inhibitor, the only class of inhibitor to significantly inhibit larval 
skin penetration (Brown et al, 1999). In addition, antibody against APR-2 was 
shown to significantly inhibit L3 skin penetration. Though likely to be a result of 
cross reactivity with a larval APR (no APR-2 mRNA is detectable in the L3), this 
immune intervention with this protease might have a protective function.
Identified by immunoscreening cDNA libraries with serum from hookworm 
patients in China, A, caninum L3 secrete a protein with homology to the retinol 
binding-like proteins of C. elegans (Hawdon et al. Society of Protozoologists, 
53rd Annual Meeting, June 25-28, 2000). The 144 amino acid larval protein
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shows homology to the transthyretin-like proteins (AcTTR), which are a 
nematode specific family with at least 52 representatives in C. elegans, and a 
faint homology to the transthyretin-related proteins, a highly conserved gene 
family represented in plants, bacteria and animals (Eneqvist et al, 2003). 
Though the function of AcTTR is unknown, it may scavenge host retinol; 
vaccination of dogs with an E. co/i-expressed AcTTR lead to a significant 
inverse relationship between specific IgE and worm burden (Hotez et al, 2003), 
DNA homologues of TTR are abundant in the L4 and adult H. contortus EST 
dataset and are present at lower levels in the L3 dataset (DP Knox, personal 
communication). A study of the immunogenicity of adult H. contortus ES found 
a TTR-like protein to be the most immunogenic protein identified, suggesting it 
as a possible vaccine candidate (Yatsuda et al, 2003).
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1.8 Vaccine Requirem ents
Vaccination against GI nematodes, even with the most highly effective vaccine 
candidates discovered to date, is unlikely to produce sterile immunity. However, 
this may not necessarily be a problem. Mathematical models of vaccination 
against GI nematodes of sheep (for example, H, contortus) suggest that 
conventional antigen vaccines with an efficacy as low as 60% in only 80% of the 
flock will still produce substantial control and benefits (Barnes et al, 1995). 
This model suggests that a higher efficacy might be required for hidden antigen 
vaccines, but these vaccines would still be as good at worm control as standard 
control strategies if levels of protection of 80% were achieved in 80% or more of 
the flock (Barnes et al, 1995).
In the case of hookworm vaccine design, the aim of a vaccine would be to reduce 
the worm burden, and thus pathology associated with disease, rather than 
hookwomi infection per se, thereby diminishing the reliance on anthelmintics 
(Brooker et al, 2004). The efficacy required for this in man is, as yet, 
unquantified and awaits the outcome of clinical trials (Goud et al, 2005). 
However, it is worth pointing out that recent vaccine trials in hamsters showed 
that vaccination with two recombinant A. ceylanicum larval antigens not only 
reduced worm burden and egg output, but also increased the haemoglobin values 
and the weight of the hamsters significantly, thus reducing disease (Mendez et 
a l, 2005). Epidemiological studies on the feasibility of vaccination against 
schistosomiasis have indicated that a 75% reduction in egg count in 75% of the 
infected population could lead to control within 10 years (Chan et al, 1997).
It is ultimately assumed that a vaccine against hookworm will comprise a 
cocktail of protective antigens from the larval stage and those aligning the gut of 
the adult woiin and likely involved in blood meal digestion (Brooker et al,
2004). Certainly, it would seem that, by combining antigens that singularly 
promote modest protection, levels of protection can be increased (Mendez et al,
2005).
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Thus, further work is required to both discover novel antigens and to assess the 
levels of protection confeiTed by established antigens. The nature of the 
hookworm antigen discovery and testing programme is such that it is not feasible 
to assess protection levels of human hookworm antigens in the natural host, and 
thus reliance on adapted rodent and canine model systems is required. Due to the 
low levels of natural antigen produced in vitro by hookworms, it is also deemed 
unfeasible to trial the protective qualities of natural antigens, instead relying on 
recombinant antigens produced in a number of systems. Several studies point to 
the reduced efficacy of bacterial recombinant antigens compared to their natural 
counterparts because of loss of enzymatic activity or conformation and 
glycosylation (Knox and Smith, 2001). This can be circumvented to some extent 
by using eukaryotic expression systems, such as yeast or insect cells. However, 
eliciting the high titres of antibody potentially required for protection, as 
indicated in trials using both hidden antigens and ASP homologues, using such 
systems is difficult (Hotez et al, 2003). Certainly, the levels of protection 
established with the major hookworm vaccine candidates are still significantly 
below the levels achievable using natural antigens in the veterinary field (Hotez 
et al, 2003. HHVI 3'^ Annual Report). In the veterinary field, protection trials 
against GI nematodes, and H, contortus specifically, have established high levels 
of protection using the natural antigen in the natural host/parasite system, 
confirming their efficacy as vaccine candidates, prior to attempts to recreate this 
immunity using recombinant antigens.
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1.9 Overall Objective and Aims of the Study
Highlighted above, the adult hookworms share a similar niche in humans as H, 
contortus does in sheep. Furthermore, both nematodes are blood feeders and 
cause an anaemia-related disease directly attributable to the haematophagous 
adults. Of the already established and efficacious larval and adult vaccine 
candidates in H. contortus, several have homologues in the hookworms. Some 
of these hookworm antigens have been established as modestly protective in 
recombinant form; however, unlike their counterparts in H. contortus, have not 
been trialed in native form.
The overall objective of this body of work is to assess the usefulness of H. 
contortus as a “model” for human hookwoim vaccine discovery and 
development and in the process discover novel H. contortus vaccine candidates. 
More specifically the aims are:
i. To identify homologues of lead larval A. caninum vaccine candidates in
H, contortus,
ii. To study their biology, stage specific expression, site of expression and 
suitability as vaccine candidates.
iii. To attempt to purify hookworm homologues from H. contortus L3 ES
iv. To evaluate the protective properties of L3 ES and homologues therein in
sheep vaccine trials.
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Chapter 2
Materials and Methods
All chemicals and reagents were purchased from Sigma, UK or Fisher Scientific, 
UK, unless otherwise stated. Standard solution and buffer recipes are listed in 
Appendix 1. Centrifuges used were a bench top CR422 and an A14 microfuge 
(both from Jouan, France).
2.1 General Parasitology
2.1.1 Infective Larvae
The Moredun Ovine Susceptible (MOSI) isolate of H. contortus was used 
throughout this study. This is a worm isolate which retains full susceptibility to 
the three major classes of anthelmintic in current general use.
H. contortus L3 were obtained by coproculture of faeces collected from 
monospecifically infected sheep and larvae were stored at 4°C in distilled water, 
as described by Seaton et a l (1989). Larvae used throughout all the experiments 
were less than three months old and were kindly provided by D. Bartley 
(Moredun Research Institute).
2.1.2 Exsheathing L3
L3s were exsheathed by a method similar to that described by Gamble et al 
(1996). In brief, following centrifugation at 770xg in for 5 min, the L3 pellet 
was resuspended in Earle’s Balanced Salt Solution (EBSS, appendix 1) at a 
concentration of 20,000 L3/ml in a 500 ml conical flask. Prior to exsheathment, 
L3s were incubated at 39°C for 1 h in a waterbath (W14 Grant, UK); this 
increased the speed and synchronicity of larval exsheathment. Using naiTow 
rubber piping attached to a regulator on a CO2 cylinder, CO2 was bubbled 
vigorously through the solution containing the L3s for 10 min, whilst 
maintaining a temperature of 39“C. Immediately following CO2 gassing, the 
flask was sealed using nescofilm and incubated at 39°C with shaking at 150 rpm. 
Following incubation for 3 h, an aliquot of 100 pi was inspected by light 
microscopy at x20 magnification and greater than 90% of L3s had exsheathed at 
this timepoint.
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2.1.3 Culture of L3 for ES
Following exsheathment, L3 were centrifuged for 5 min at 770xg, the 
supernatant was collected, teimed the exsheathing fluid (EF) and this was stored 
at -20°C. L3s were axenised from cast sheaths by Baeimanisation (active 
migration through lint free filter paper immersed in EBSS with 0.2 mg/ml 
penicillin/streptomycin, 200 pg/ml gentamycin, and 25 pg/ml nystatin in a funnel 
with a run off tap), allowing larvae to move through the paper and to be 
concentrated by gravity. Following incubation at 37°C for 12 h, L3 were 
collected and resuspended in fresh pre-waimed (37°C) EBSS 4- antibiotics as 
above in 225 cm^ tissue culture flasks (Co-Star, USA) at a concentration of 
25,000 L3/ml, in a maximum volume of 50 ml. Cultures were incubated at 37°C 
in a humidified atmosphere of 5% CO2 for up to 120 h. L3 were sedimented by 
centrifugation at 770xg at 24 h intervals and the supernatant removed. This was 
designated excretory/ secretory product (ES) and was filtered through 0.2 pm 
pore filter (Millipore, UK) before being concentrated 50-fold by ultrafiltration 
using Amicon YM-10 membranes (Amicon, UK) and stored at -80°C until 
required. L3 were resuspended in fresh media as above and transfeiTed to new 
tissue culture flasks. Viability of L3 was examined visually (x20 light 
microscopy) at 24 h intervals and a 20 pi aliquot of culture supernatant was 
plated onto Luria-Bertani (LB, appendix 1) agar plates and incubated overnight 
at 37°C to monitor bacterial contamination.
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2.2 General Protein Techniques
2.2.1 L3 protein extracts
Protein extracts were made in 3 steps as described in the following paragraphs.
Step 1: 1 ml of ice cold SI buffer (0.186 g ethylenediaminetetra-acetic acid 
(EDTA) dissolved in 500 ml Phosphate buffered saline (PBS), pH 7.4 + 1 mM 
phenylmethylsulphonylfluoride (PMSF) final concentration (fc)) was added to 
0.5 g L3 in a 1.5 ml eppendorf and mixed. The worm suspension was transfeiTed 
to a 2 ml ribolysing vial containing glass beads (Hybaid, UK) and the vial was 
filled with SI buffer prior to ribolysing at 6.5 speed for 20 s in the ribolyser 
(Bio 101/Thermosavant Fastprep 120), The vial was removed and cooled on ice 
for 10 min. This was repeated three times. Disrupted worms were centrifuged at 
13,000xg in a bench top centrifuge at 4°C and the supernatant was removed; this 
was the S1 (water soluble) protein extract.
Step 2: The ribolysed L3 pellet was resuspended in 1 ml of S2 buffer (S1+ 0.1% 
Tween 20) and chilled on ice for 10 min prior to ribolysing as before for 5 s. The 
suspension was chilled on ice for a further 45 min then L3 pelleted and 
supernatant removed as in step 1 and this was designated the S2 extract, 
containing the membrane-associated proteins.
Step 3; This was carried out as in step 2 except the L3 pellet was resuspended in 
S3 buffer (2.5% v/v Triton X-100 in PBS + 1 mM PMSF) prior to ribolysing. 
Following centrifugation, the L3 pellet was discarded and the supernatant 
designated S3, containing the membrane-bound proteins.
All extracts were stored at -80“C until required.
Adult H. contortus extracts, prepared as above, were kindly provided by M. 
Oliver, Moredun Research Institute.
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2.2.2 Protein concentration estimation
Protein concentration was estimated using the Pierce method BCA assay, and the 
procedure was carried out as described in the manufacturer’s instructions (Pierce 
and Waniner, UK). Samples and bovine serum albumin (BSA) (Sigma, UK) 
standards were incubated in the BCA working reagent for 1 hour at 3TC  
allowing a colorimetric reaction to occur (based on the principal that a colour 
change in the BCA is brought about by the reduction of copper ions). The 
optical density (OD) at 562 nm was measured and the protein concentration of 
the sample (in triplicate) deteimined through comparison with a standard curve 
of the know BSA standards.
2.2.3 Protein visualisation by polyacrylamide gel
electrophoresis
Proteins in parasite extracts and ES were visualised by sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1977) using the 
Mini-protean cell system (BioRad, UK). Protein separation was carried out in 
10% or 15% polyacrylamide gels (appendix 1) or in 4-15% gradient gels (Biorad, 
UK). Approximately 10 pg of protein sample was mixed 1:1 with 2X reducing 
or non-reducing sample buffer (appendix 1), boiled for 5 min, and applied to the 
gel. Following electrophoresis at 150 volts (V) for 60 min in IX Laemmli 
electrode buffer (appendix 1), gels were stained with Coomassie blue (appendix 
1) for 15 min and destained 4 x 1 5  min in the same solvent. Protein bands and 
molecular weight marker (Mark 12 pre-stained markers, Invitrogen, UK) bands 
were then visible. Silver nitrate staining was used when a more sensitive 
visualisation method was required. Following electrophoresis, gels were fixed in 
50% (v/v) Methanol / 10% (v/v) Acetic acid for 10 min, then 5% (v/v) Methanol 
/ 7% (v/v) Acetic acid for 10 min and finally 10% (v/v) Gluteraldehyde for 10 
min before washing 4X 15 min in distilled water (dH20). Gels were then 
incubated in 5 pg/ml dithiothreitol (DTT) in CIH2O for 10 min prior to transfer 
into 0.1% (w/v) silver nitrate in dH20 for 10 min. Gels were washed briefly in
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dHzO prior to addition of developer (3% (w/v) Sodium carbonate in dH20 plus 
50 pi /lOO ml 37% (v/v) foiTnaldehyde. Gels were incubated in developer until 
protein bands became visible, approximately 3 min. The reaction was stopped by 
the addition of 5 ml per 100 ml developer of 2.3 M Citric acid. The molecular 
weight of proteins was approximated visually by comparison to the molecular 
weight standards or by measuring the distance in mm from the top of the gel to 
each standard of known molecular weight and plotting the molecular weight 
against the distance migrated. The distance migrated by the protein of interest 
was then measured and the molecular weight against distance plot used to 
estimate an approximate molecular weight for the band of interest,
2.2.4 Western Blotting
Proteins sepai’ated by SDS-PAGE were transferred onto polyvinylidene fluoride 
(PVDF) membranes (Immobilon-P, Millipore, UK) using a semi-dry graphite 
blotter (Milliblot Graphite electroblotter 1; Millipore, UK) at a constant power of 
50 mA for 45 min. Transfer set up consisted of pre-wetting the PDF membrane 
in methanol prior to equilibration for 5 min in anode buffer 2 (appendix 1). A 
sandwich was created with 1 piece of Filter paper soaked in anode buffer 1 
(appendix 1) on the anode. A second piece of filter paper soaked in anode buffer 
2, laid on top, followed by the equilibrated PDF membrane. The SDS-PAGE 
gel, having been equilibrated in anode buffer 2 for 5 min was then laid on the 
membrane. Finally a last piece of filter paper, soaked in cathode buffer 
(appendix 1) completed the transfer sandwich. Following protein transfer the 
membrane was incubated overnight in a blocking solution (5% (w/v) Non-fat 
Dried Milk Powder, Maiwel, UK; or 5% (w/v) Globulin Free Bovine Serum 
Albumin (Sigma, UK)) in Tris Buffered Saline (TBS, appendix 1) + 0.05% (v/v) 
Tween 20 (TBST) at 4“C.
2.2.5 Antibody detection of transferred proteins
Following overnight blocking, membranes were washed in TBST for 5 min prior 
to incubation of the primaiy anti-sera, diluted in TBST, for 2 h at room
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temperature (RT), Membranes were washed 4 x 5  min in TBST before 
incubation in the secondary, horse-radish peroxidase (HRP) labelled anti-sera, 
diluted in TBST, for 1 hour at RT. Following 4 x 5  min washes in TBST, 3, 3’ 
diaminobenzidine (DAB) substrate (One tablet set dissolved in 15 mi water; 
Sigma Fast DAB, UK) was added for 5-10 min until the proteins recognised by 
the anti-sera were visible. The reaction was terminated by washing with tap 
water.
When a more sensitive detection system of antibody binding was required, the 
Enhanced Chemiluminescence (ECU) plus system was employed (Amersham 
Pharmacia Biotech, UK). The protocol was as described by the manufacturer. 
Upon exposure to HRP, a chemi-luminescence reaction occurs and the 
luminescence can be detected by exposure to X-ray film. Exposure times were 
varied, depending on signal strength, between 5 s and 60 s.
2.2.6 Periodate Treatment
To oxidise cross-reacting carbohydrate epitopes from glycoproteins, thus 
allowing visualization of specific anti-protein reacting antibody following 
Western blotting, Periodate treatment was earned out. Following Western 
blotting (Section 2.2.4), membranes were washed 2X 20 min in 50 ml 50 mM 
sodium acetate pH 4.5. Membranes were removed and incubated for 1 hour in 
the dark in freshly prepared 50 mM sodium Periodate/ 50 mM sodium acetate pH
4.5 prior to washing 2X 10 min in 50 mM sodium acetate pH 4.5 and 2X 10 min 
in TBST. The membranes were then incubated in 50 ml freshly prepared 50 mM 
sodium borohydride in TBST followed by a final 3X 10 min washes in TBST. 
Membranes were then probed as described (Section 2.2.4).
2.2.7 Substrate Gel analysis of protease activity
Samples were fractionated under non-reducing conditions on 0.1% (w/v) gelatin- 
substrate SDS-PAGE gel slabs (10%). Approximately 10 pg of sample was
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mixed with an equal volume of non-reducing sample buffer before application to 
gel as before and electrophoresis at 150V for 90 min in ice-cold IX Laemmli 
buffer. Following electrophoresis, gels were washed 4 x 1 5  min in 2.5% (v/v) 
Triton X-100 to remove SDS. The gels were sliced and incubated overnight in a 
phosphate or acetate pH buffer (appendix 1) alone or in the presence of an 
appropriate protease inhibitor. After incubation, gel slices were stained with 
Coomassie blue. On destaining, regions of proteolysis appeared clear against the 
blue background of the gel.
Inhibitor studies were earned out by pre-incubating approximately 10 pg of 
sample in non-reducing sample buffer with the appropriate protease inhibitor(s) 
for 2 h on ice prior to application to the substrate gel as before. Following 
electrophoresis, gels were washed and sliced as above before incubation 
overnight in pH 8 buffer (appendix 1) with the appropriate protease inhibitor. 
Inhibitor concentrations during the pre-incubation and incubation were as 
follows: 1,10 Phenanthroline -1 mM; E-64 (L-trans-epoxysuccinyl-leucyl-amido- 
(4-guanidino)butane) -10 pM; AEBSF (4-2-Aminoethyl)benzenesulphonyl 
fluoride) - 2 mM; Pepstatin - 10 pM; EDTA (Ethylenediaminetetra-acetic acid) - 
4 p M .
2.2.8 Metalloprotease substrate assay
This assay is based on the premise that when a metalloprotease cleaves a specific 
substrate, a fragment released is further cleaved by leucine amino peptidase 
(LAP, Sigma, UK) to release 4-methoxy-2-napthyiamine (4-MNA), which on 
excitation causes fluorescence. This activity can then be measured.
For a standard curve, a dilution series from 8 pM to 0.125 pM of 4-MNA was 
made up in triplicate and fluorescence was measured at X425 nm following 
excitation at A.340 nm using a luminescence spectrometer (LS50B, Perkin Elmer, 
UK).
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Two pi of substrate, 50 mM Glu-Ala-Aia-Phe-4-MNA (Sigma, UK), was diluted 
in 88 pi 1 M Phosphate Buffer pH 7 (appendix 1), to which 10 pi (5 pg) of 
protein sample was added. Samples were set up in triplicate, as were blank PBS 
negative controls, and these were incubated at 37°C for 2 h. Seventeen pi of 
LAP was added to a solution of 1 pM phosphoramidon (Sigma, UK) in IX PBS. 
Thirty pi of the LAP/ phosphoramidon solution was added to the substrate and 
mixed and incubated for a further hour at 37°C. Following this incubation, the 
fluorescence released by the free 4-MNA was measured as before.
2.2.9 Lentil lectin affinity chromatography
Nematodes are rich in glycosylated proteins; these proteins are usually expressed 
on surface of cells or are excreted. Lentil lectin binds to certain carbohydrate 
moieties on glycosylated proteins; therefore, lentil lectin affinity chromatography 
was employed to purify the lentil lectin binding proteins from the crude mixture 
in whole H. contortus L3 ES.
A 3 ml chromatography column (Phannacia, UK) was prepared by filling with 
Lectin Wash Buffer (appendix I) plus 0.5% (v/v) Triton X-100 (LWBT). This 
was then packed with 3 ml of lentil lectin bound agarose slurry (Vector Labs, 
UK). The column tubing was connected to an LKB pump (Pharmacia, UK) and 
flow inducer (Watson-Marlow, UK) and LWBT was run through it at 11 ml per 
hour for 3 h at 4^C. Two and a half mg of pooled ES protein at a concentration 
of 130 pg/pl was diluted 1:1 with LWBT + MnCL and CaCL at 5 jxM and 50 pM  
fc, respectively (LWBT’*"*'), and the sample was run over the column at a rate of 7 
ml per hour for 8 h at 4°C, and the unbound sample was collected. The column 
was rinsed with LWBT’*"*' for 3 h until no more protein was eluted, when the 
protein readout, measured using a Pharmacia LKB Ultraviolet (UV) Optical Unit, 
returned to its baseline. The rinse was added to the unbound sample before being 
concentrated by ultrafiltration using Amicon YM-10 membranes, and these were 
stored at -80°C until required (the unbound fraction).
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Elution buffer (0.2 M a-mannopyranoside in LWB + 0.5% (w/v) CHAPS) was 
run through the column until the column was full (approximately 30 min at 6 
ml/h) and the bound protein was allowed to elute overnight at 4°C. Following 
the incubation, the eluate was run out of the column until the protein readout 
returned to the baseline. This fraction, termed the bound fraction, was 
concentrated and stored at -80°C until required.
2.3 General Molecular Biology Techniques
2.3.1 Total RN A extraction
Total RNA was isolated from exsheathed L3 (ExL3) or L4 H. contortus using 
TRIzol Reagent (Invitrogen, UK), according to the manufacturer’s instructions. 
Worms, which had been snap frozen in liquid nitrogen (LNi), were ground up to 
a powder in a pestle and moitar under LN2, The LN2 was allowed to evaporate 
and 2 ml of TRIzol per 100 mg womis was added and allowed to freeze onto the 
powdered L3. Grinding continued until the mix was fully liquid, transfeiTed to
1.5 ml eppendoifs and allowed to stand for 5 min. 0.2 ml chloroform, per ml 
TRIzol originally used, was added prior to mixing thoroughly and standing for 3 
min at RT. Phases were separated by centrifugation at 12,000xg for 15 min at 
4°C and the upper aqueous phase containing the RNA was removed. RNA was 
precipitated by adding 0.5 ml isopropanol per ml TRIzol originally used, 
incubating at RT for 15 min, centrifuging at 12,000xg for 10 min at 4°C and 
removing the supernatant. RNA was washed with 75% (v/v) ethanol before
being pelleted by centrifugation at 7,000xg for 5 min at 4“C. The RNA pellet
was briefly air dried and resuspended in 100 pi RNase-free water, RNA was 
stored at -80°C until required.
2.3.2 Reverse transcription (cDNA preparation)
First strand cDNA synthesis was carried out using the BD SMART RACE cDNA 
amplification kit (BD Clontech, UK), according to the manufacturer’s 
instructions. This kit is based on the switching mechanism at 5’ end of RNA 
transcript (SMART) technology that allows generation of full length cDNAs by 
reverse transcription. The BD Powerscript Reverse Transcriptase, upon reaching
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the end of the RNA template, adds 3-5 dC residues to the 3' end of the new F* 
strand cDNA. The BD SMART oligo contains a poly dG region that anneals to 
the dC at the 3’ end and serves as an extended template for reverse transcriptase 
thus allowing complete 5’ synthesis. Standard D* strand synthesis, reverse 
transcriptase used with a poly T primer that anneals to the poly A tail, results in 
cDNA ready for 3’ rapid amplification of cDNA end (RACE) PCR. Thus two 
separate cDNAs were prepared, a 5’ RACE ready cDNA and a 3’ RACE ready 
cDNA. Briefly, 1 pg of total RNA was used as the template for both the 3’ and 
5’ cDNA synthesis. For 3’ cDNA synthesis 3’ poly (dT) primer was added; for 
5’ reaction 5’ primer (the modified oligo (dT)) and the SMART IIA oligo were 
added. Reactions were incubated at 70°C for 2 min before cooling on ice. First 
strand buffer, DTT, deoxyribonuleotide triphosphates (dNTP) and the BD 
Powerscript reverse transcriptase were added and the reactions incubated at 42®C 
for 90 min. cDNA was diluted in Tris- EDTA (TE) buffer (BD Clontech, UK) 
and concentration of the transcribed cDNA was determined by 
spectrophotometry.
2.3.3 Concentration estimation of RNA and DNA
Concentration of RNA and DNA was determined by spectrophotometry using the 
OD 260:280 ratio as deteimined using a GeneQuant Pro spectrophotometer 
(GeneQuant, UK).
2.3.4 Polymerase Chain Reaction
Polymerase Chain Reaction (PCR) amplification of DNA was carried out using a 
Perkin Elmer 2400 GeneAmp thermocycler. Roche UK Taq polymerase was 
used as standard and reaction mixes were prepaied according to the 
manufacturer’s instruction: lOX buffer, 0.4mM dNTPs (Roche, UK), 1 pM 
Primer 1, 1 pM Primer 2, 1.75 units Taq polymerase (Roche, UK) and 50-500 ng 
DNA template in a total volume of 50 pi. A standard reaction consisted of 4 min 
at 94°C to denature the DNA; 25-35 cycles of 30 s at 94°C to denature, 30 s at 
50°C-72°C for primer annealing, 30 s per 500 bases at 72°C for extension; and a
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final extension of 7 min at 72'*C. PCR using a Taq polymerase results in a single 
dA at the 3’ end of the DNA which can be exploited for cloning purposes, as 
describe in Section 2,3,6. All oligonucleotides (primers) were purchased from 
MWG, Germany.
2.3.5 Agarose gel electrophoresis of nucleic acids
PCR products, RNA and DNA samples were analysed by conventional agarose 
gel electrophoresis, 0.8% (w/v) agarose gels were prepared in Tris-acetate-EDTA 
(TAE) electrophoresis buffer (appendix 1) containing 0.5 pg/ml ethidium 
bromide (Promega, UK). Agarose gels were run in TAE buffer at 80 V for 45 
min. Five pi of DNA was diluted 1:1 with DNA loading buffer (appendix 1). 
DNA fragments were visualised by UV illumination using an Alphalmager (GRI 
Alphalnnotech, UK) and product sizes were estimated in comparison to a DNA 
ladder molecular weight marker (Roche, UK).
2.3.6 Purification of PCR products
PCR products were purified using the Geneclean II kit (Q-bio gene, UK) 
according to the manufacturer’s instructions. Briefly, PCR products were 
excised from agarose gels and the gel piece was dissolved in Nal at 45°C. 
Following this, DNA was allowed to bind to 10 pi of glassmilk (Q-bio gene, UK) 
before washing with the manufacturer’s wash and ethanol. DNA was then eluted 
from the glassmilk in 10 pi water, the glassmilk pelleted at 13,000xg for 30 s and 
the DNA in water removed and stored at -20°C until required.
2.3.7 Ligation of PCR products into pGEM-T
Purified PCR products were cloned into pGEM-T, (Promega, UK), a propagation 
vector plasmid of E. coli with 3’ dT overhangs, allowing ligation of PCR 
products. Purified PCR products were ligated into pGEM-T overnight at 4*^ C at a 
3:1 ratio of insert: vector, according to manufacturer’s instructions. Insert DNA 
was incubated with T4 DNA ligase buffer, 50 ng of vector, insert DNA, and 1 
U/pl T4 DNA ligase in a total reaction volume of 10 pi. The following foimula
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was used to estimate the amount of insert DNA required for the ligation reaction: 
ng insert required = [(ng vector/ vector size (kb))] x insert size (kb) x ratio of 
insert:vector. Ligations were incubated overnight at 4°C.
2.3.8 Transformation of competent cells
E. coli competent cells (JM109 cells for vector propagation or BL21 codon plus 
cells for expression; Stratagene, UK) were transformed with plasmid DNA, 
according to the manufacturer’s instructions. Briefly, 50 pi of cells were mixed 
on ice with 50ng of plasmid/insert ligation mix for 20 min. Cells were heat- 
shocked at 42®C for 45 s and then transferred to ice for a further 2 min. Five 
hundred pi of SOC medium (appendix 1) was added to the cells before 
incubating at 3TC  in a shaking incubator (Infors AG, UK) for 90 min. 
Following this, 100 pi of transformed cells were plated out on LB agar plates 
containing ampicillin (50 pg/ml fc) (LB-Amp) and incubated overnight at 3TC.
In cases where competent cells were the JM109 strain and the plasmid was 
pGEM-T, blue/white colony selection was used to identify those colonies that 
contained plasmid with an insert. In this case, LB agar plates also contained X- 
gal (Bioline, UK; 5-bromo-4-chloro-3-indoyl-P-D-galactopyranoside; 80 pg/ml) 
and IPTG (isopropyl-1-thio-P-D-galactopyranoside; 0.5 mM). X-gal is a lactose 
analogue and IPTG is an inducer of the lac operon. The pGEM-T multiple 
cloning site (MCS) is in the a-peptide region of the p-galactosidase gene and 
protein expression is under control of the lac operon. Thus, when DNA is 
inserted into the MCS, the a-peptide is disrupted. Colonies containing plasmid 
with no insert synthesise P-galactosidase normally, which breaks down X-gal to 
produce a blue colony. Colonies containing plasmids with an insert synthesise 
an inactive foim of the enzyme and remain white in colour.
Following overnight incubation, colonies were picked to identify insert-positive 
plasmid colonies. White colonies were assumed to be positive for recombinant 
plasmids when pGEM-T was used for cloning puiposes, as previously 
mentioned. If blue/white selection was not possible 20 colonies were picked 
aseptically using pipette tips but, prior to amplification, colonies on tips were
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touched to the meniscus of 100 pi of sterile water. 1 pi of this water was used as 
a template in a PCR reaction to identify positive recombinants (termed Colony 
PCR).
Colonies were amplified by inoculation into 10 ml LB broth containing 
ampicillin (50 pg/ml) and incubated overnight in a shaking incubator at 3TC.
2.3.9 Purification of plasmid DNA
Following cell transformant amplification, 1-5 ml of the cell culture was 
centrifuged at 770xg for 5 min and the supernatant was removed. The Wizard 
Plus SV Miniprep kit (Promega, UK) was used for plasmid purification and the 
protocol was followed as described in the manufacturer’s instructions. Briefly, 
the cell pellet was resuspended in 50 mM Tris-HCl, pH7.5; 10 mM EDTA; 100 
pg/ml RNase A prior to bacterial lysing by addition of an alkaline lysis buffer 
(0.2 M NaOH; 1% (w/v) SDS). Addition of alkaline protease was added to 
inactivate the endonucleases released upon cell lysis and an acidic neutralisation 
solution (4.09 M guanidine hydrochloride; 0.759 M potassium acetate; 2.12 M 
glacial acetic acid) added. Bacterial lysate was centrifuged at 13,000xg for 10 
min and the clear supernatant containing the DNA was applied to the Wizard SV 
mini-column to which plasmid DNA binds and lysate is forced through upon 
centrifugation at 13,000xg for 1 min. Plasmid DNA bound to the column was 
washed twice with the wash solution (162.8 mM potassium acetate; 22.6 mM 
Tris-HCl; 0.109 mM EDTA in 95% (v/v) ethanol). Plasmid DNA was eluted in 
50 pi sterile RNase-DNase free-water (Promega, UK) and stored at -20°C.
2.3.10 Sequencing of plasmid inserts
All sequencing reactions were earned out by the Moredun Research Institute 
Functional Genomics Unit using a GE Healthcare MegaBACE 500 48-capillary 
sequencer using Sanger-Coulson dideoxy chain tenuinator reactions. When 
inserts were cloned into pGEM-T, the SP6 and T7 primer sites flanking the MCS 
were used for sequencing reactions. In all other plasmid vectors, insert gene
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specific primers were used. For sequencing of novel genes, a minimum of three 
independent sequencing reactions were earned out.
Sequencing results were analysed by Chromas software (Version 1.45) and DNA 
Star software packages to allow construction of contiguous sequences. Web 
based software and databases available from FBI (http://www.ebi.ac.uk) and 
NCBI (http://www.ncbi.nlm.nih.gov/) were used for homology analysis searches 
(using the basic local alignment search tool (BLAST). ClustalW and EMBOSS 
programmes were used for protein and nucleotide alignments programmes and 
protein motif seai*ches were earned out using Signal-? and Prosite websites. 
Phylogenetic analyses were carried out using the MEGA version 3.1 software 
(www.megasoftware.net).
2.3.11 Restriction enzyme digests of DNA
Restriction enzyme digests were carried out according to manufacturer’s 
instructions (Roche, UK). Ten U enzyme per pg DNA was used in each reaction 
and the appropriate buffer was included (Roche, UK). Enzymes were incubated 
with DNA at the appropriate temperature for 4 h, or until agarose gel 
electrophoresis indicated the DNA was fully digested.
2.3.12 Sub-cloning into a bacterial expression vector
Prior to recombinant protein expression, genes were sub-cloned from pGEM-T 
into an expression vector (either pET-22b (Novagen, UK) or pGEX-6P3 
(Amersham Biosciences, UK)). pGEM-T plasmids containing the gene insert 
were subjected to restriction enzyme digestion in order to cut the insert out of 
pGEM-T. The appropriate expression vector was also digested under the same 
conditions with the same enzymes. Following digestion, all reactions were 
subject to agarose gel electrophoresis and the appropriate bands on the gel 
excised and purified. The gene insert was ligated into the expression vector 
following purification, and JM109 cells were transformed and plated out on LB- 
Amp agar plates and incubated overnight at 37“C.
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2.3.13 Expression of recombinant protein
Following confirmation of the insert in the recombinant plasmid by colony PCR 
and that it was inserted in the coiTect reading frame, recombinant plasmids were 
propagated overnight in 10 ml LB-Amp broths. Plasmids were purified as 
described in Section 2.3.9 and cell transfoiTnations (Section 2.3.8) were carried 
out using the E. coli strain BL21 codon plus (Stratagene, UK). This is a 
competent cell line designed for protein expression, and containing an excess of 
those codons not normally used by E. coli to circumvent codon usage problems. 
Transformants were plated out on LB-Amp agar, incubated overnight at 37°C 
and confirmation of the insert DNA in the recombinant plasmids was sought by 
colony PCR.
Positive recombinant colonies were picked and propagated overnight in 10 ml 
LB-Amp in a shaking incubator at 37''C. Following this, 0.5 ml of the overnight 
culture was used to spike fresh 10 ml LB-Amp broth which was then incubated 
on a shaking incubator at 37^ ’C for 2 h, until the OD^oo reached 0 .6-1, as 
measured on a Mass Spectrometer (DU 650, Beckman, UK). One ml of culture 
was removed and centrifuged at 12,000xg for 5 min. The supernatant and cell 
pellet were stored at -20°C, protein extracts of this were the non-induced 
expression control. The remaining culture was induced by addition of IPTG to a 
final concentration of 1 mM and incubated at 37°C in a shaking incubator for a 
further 2 hours. Cells were pelleted by centrifugation at 770xg for 10 min and 
supernatant and pellets stored at -20°C.
Insoluble and soluble protein fractions were prepared from the cell pellets. 
These were resuspended in 50 mM Tris pH 8.5/ 2 mM EDTA in one tenth of the 
original volume. Lysozyme and Triton-X-100 were added to final concentrations 
of 100 pg/ml and 0.1% (v/v), respectively. Following incubation at RT for 15 
min, MgClz (8 mM f/c), DNase (10 pg/ml f/c) and RNase (10 pg/ml f/c) were 
added. The lysed cell suspension was incubated for a further 15 min, to allow 
full nucleic acid degradation, and then centrifuged at 13,000xg for 10 min. The 
supernatant constituted the soluble proteins and the pellet, resuspended in 50 mM 
Tris pH 8.5/ 2 mM EDTA, was the insoluble protein fraction. Protein fractions
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were analysed by SDS-PAGE electrophoresis and the success of recombinant 
protein expression determined by comparison to empty vector and non-induced 
recombinant vector controls. The size of the putative recombinant protein was 
estimated by comparison with molecule weight standard markers (Invitrogen, 
UK). Confirmation of 6X histidine (6 His) tagged protein expression was sought 
by Western blotting and screening with an anti-6 His monoclonal antibody 
(Sigma, UK).
2.3.14 Purification of recombinant protein
Large format standaid SDS-PAGE electrophoresis was used to separate the 
proteins. Blue G dye (Serva, Germany) was used in the IX Laemmli buffer in 
the cathode buffer reservoir to stain proteins. A constant voltage of 50 V was 
applied for 12 h. The band corresponding to the recombinant protein was 
excised from the gel with a scalpel blade and finely chopped up. Electroelution 
was carried out using the AE-3590 Max Yield electroelution apparatus (Atto, 
USA), as described in the manufacturer’s instructions. Finely chopped gel peices 
containing protein was placed in the cathode cup of the electroelution chamber 
on a semi-permeable dialysis membrane. The bottom of the cup of the 
electroelution chamber on the anode side was also sealed with dialysis 
membrane. The electroelution chamber was placed in the electroelution tank, 
which was filled with O.IX Laemmli buffer, creating a seal between the cathode 
and anode sides of the tank. The cathode cup was filled with O.IX Laemmli and 
the anode cup filled with 0.05X Laemmli buffer, until the buffer flowed, without 
disturbing the contents, into the cathode cup. A constant current of 50 V was 
passed across the apparatus for 10 hours or until all the protein had been eluted 
from the gel pieces and cairied across to the anode. The protein in the anode cup 
was collected by pipette and concentrated across YM-10 filters (Amicon, UK) 
and stored at -20°C.
2.3.15 High molecular weight genomic DNA preperation
Approximately 0.5 g of adult H, contortus (a kind gift from Dr D. Redmond, 
Moredun Reseaieh Institute) were ground up under LN2 and the powder
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resuspended in 4.5 ml 25 mM EDTA/ 75 mM NaCl pH 8. To this, 0.5 ml 10% 
(w/v) SDS and 0.5 ml 10 mg/ml stock Proteinase K were added and the solution 
was mixed very gently and incubated overnight at 55°C. The lysate was 
transferred to a tissue culture flask (Co-Stai', USA) and 55 ml of phenol in 0.1 M 
Tris pH 9 were added and the solution incubated overnight at 4°C with gentle 
agitation to mix the phases. Phases were separated by centrifugation at 770xg for 
10 min and the aqueous phase containing the DNA was transfeiTed to dialysis 
tubing using a wide bore pipette to prevent sheaiing. The DNA solution was 
dialysed against TE buffer overnight at 4°C (with 2 changes of buffer) to remove 
the SDS. DNA was transferred to a 50 ml Falcon tube (BD Biosciences, UK) 
and stored at 4°C. DNA concentration was measured (Section 2.3.3) at 74 ng/ul 
and agarose gel visualisation demonstrated it of a high quality and molecular 
weight.
2.3.16 Southern Blotting
Digoxygenin-dUTP (DIG) labelling of a 600 base pair fragment of the target 
gene was earned out using the DIG high prime DNA labelling and detection 
starter kit II (Roche, Germany). The target gene was excised from the pET22b 
plasmid, into which had previously been cloned, by a double restriction enzyme 
digest (Section 2.3.11). One pg of DNA was made up to a final volume of 16 pi 
in sterile water and denatured by boiling for 10 min and cooling rapidly in ice. 
DIG labelling was carried out overnight according to the manufacturer’s 
instructions; the DNA is random prime labelled with DIG-dUTP by the DIG- 
High Prime (containing dNTPs, a labelling Klenow enzyme and reaction buffer). 
The DIG-dUTP is alkali labile, so the reaction was stopped the following day by 
addition of 2 pi 4 M lithium chloride, 2.5 pi 0.2 M EDTA in 70 pi 100% ethanol. 
The solution was incubated at -20°C for 2 h, centrifuged (12,000xg for 10 min) to 
pellet the precipitated DNA and the pellet washed in 70% ethanol, allowed to dry 
and resuspended in TE buffer. This was the DIG-labelled DNA probe.
High moleculai’ weight H. contortus genomic DNA was digested completely 
using one of EcoRl, BamHI, HindHl or Notl restriction enzymes (Roche,
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Germany) (Section 2.3.11). Thirty pi of each digest, in DNA sample buffer, was 
applied to a 0.8% (w/v) agarose gel, alongside 1 pi of unlabelled DNA probe (a 
positive control). Southern blotting was earned out by capillary transfer method 
onto a positively charged nylon membrane, in 0.4 M sodium hydroxide, as 
described by the manufacturer (Roche, UK). Pre-hybridization, hybridization 
and washing was carried out according to the manufacturer (DIG high prime 
DNA labelling and detection starter kit II; Roche, UK). Prehybridization, 
hybridization and wash conditions were as follows; 42°C for 2 h in the DIG Easy 
Hyb Buffer (prehybridization); hybridization was earned out with approximately 
100 ng of probe in 10 ml DIG Easy Hyb buffer overnight at 42°C. For 
stringency washing, blots were washed with 2X Sodium citrate (SSC, 0.3 M 
NaCl; 30 mM sodium citrate, pH 7) buffer + 0.1% (w/v) SDS for 5 min followed 
by 2 X 15 min washes in 0.5X SSC (75 mM NaCl; 7.5 mM sodium citrate, pH 7) 
+ 0.1% (w/v) SDS at ôS'^C. Chemiluminescence detection by exposure to X-ray 
film for 10 min to 2 hours was earned out according to the manufacturer.
2.3.17 Matrix Associated Laser Desorption Ionisation- Time of 
Flight Mass Spectrometry (MALDI-TOF M/S)
Protein samples were separated by SDS-PAGE as before (Section 2.2.3) under 
reducing conditions and gels were fixed in 40% (w/v) methanol; 10% (w/v) 
acetic acid in dH20 for 30 min prior to staining for 2 h in Colloidal Coomassie 
Blue stain and destaining in 25% (w/v) methanol overnight. Bands of interest 
were excised using a sterile scalpel blade. Reductive alkylation using DTT and 
iodoacetamide followed by overnight digestion with Trypsin (porcine, Promega, 
UK) and MALDI-TOF analyses (Voyager De-Pro MALDI-ToF) were carried out 
by the Moredun Research Institute Functional Genomics Unit. Output was 
evaluated using the EXP AS Y search tool. An in house MASCOT database was 
created with the suspected protein sequences and this was searched with the 
MALDI-TOF output to ascertain whether the excised and digested protein was a 
match.
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2.4 Cloning of H, contortus Transthyretin-like protein
2.4.1 Identification of a TTR homologue in H. contortus
The H. contortus EST dataset (available on the Nembase website: 
http://nema.cap.ed.ac.uk/nematodeESTs/nembase.html) was searched using the 
tBLASTn search tool (a BLAST algorithm that allows a nucleotide database to 
be searched with an amino acid sequence by caiTying out a conceptual six 
reading frame translation of the nucleotide database) with the amino acid 
sequence of the A. caninum TTR-like protein (AcTTR) that was undergoing 
vaccine testing by the HWVI (P. Hotez, personal communication). Several H. 
contortus ESTs showed homology to the AcTTR; the EST that was of highest 
homology (HcTTR) came from a library constructed by Dr D. Redmond at 
Moredun Research Institute from H. contortus egg cDNA 
(Hc_egg_21G10„SKPL). The clone containing the sequence was available in a 
X uni-Zap XR phage vector (Stratagene, UK) and kindly provided by Dr C. 
Whitton at the University of Edinburgh (GenBank Accession number: 
CA994587).
2.4.2 In vivo excision and plasmid rescue of the HcTTR clone
Serial dilutions from 1:10 to 1:1,000,000 of phage stock were made in SM buffer 
(Appendix I). XLl strain E. coli cells (Stratagene, UK) were grown overnight at 
37°C in 10 mM MgS04 to an ODeoo of 0.5. Ten pi of each dilution of phage 
stock was added to 200 pi of cells and incubated at 37°C for 15 min. Three ml of 
NZY (appendix 1) top agar, melted and cooled to 48°C, was added to 200 pi of 
cells/ phage, mixed and immediately poured onto LB agar plates and incubated 
overnight at 37"C. Single plaques were cored from the 1:10  ^plate and inoculated 
into 500 pi of SM buffer + 20 pi chloroform and stocks were stored at 4°C. To 
plasmid rescue the phage insert, the ExAssist Interference resistant helper phage 
kit (Stratagene, UK) was used. This allows in vivo excision of the insert in the X 
uni-Zap XR phage vector into a pBluescript phage plasmid (phagemid), allowing 
plasmid purification. Briefly, 250 pi phage stock was combined with 200 pi XLl
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cells (ODôoo of 1 in 10 mM MgS04) and ExAssist helper phage (Stratagene, UK) 
in a 10 ml polypropylene tube at 37°C for 15 min prior to addition of 3 ml LB 
broth and incubation at 3TC  for a further 3 h. The suspension was then heated to 
65®C for 20 min, and cell debris pelleted by centrifugation at lOOOxg for 15 min. 
The supernatant was removed and stored at 4°C; this contained the excised 
phagemid. For plasmid DNA preparation, 1 pi of the excised phagemid stock 
was added to 200 pi of SOLR E. coli cells (Stratgene, UK) (an overnight stock 
grown in LB broth supplemented with 10 mM MgS04 , 0.2% (v/v) maltose and 
50 pg/ml Kanamycin at OD^oo of 1), incubated at 3TC  for 15 min then plated out 
on LB-Amp and incubated overnight at 37°C.
2.4.3 Cloning, sub-cloning and expression of HcTTR
Colonies were picked and propagated and plasmid DNA prepared as described in 
Section 2.3.9. PCR confirmation of an insert of the predicted size was carried 
out using the vector primers T3 and T7, and plasmid sequenced as described in 
Section 2.3.10. Primers were designed and primer sequences adapted to include 
appropriate restriction enzyme sites to allow the cloning into either pET or pGEX 
E. coli expression vectors (Table 2.4.1) as described in Sections 2.3.7 and 
2.3.12. PCR amplification with the appropriate primer pairs (see Table 2.4.2) 
were earned out using the annealing temperature (Tm) as indicated. All 
reactions were earned out under the conditions described in Section 2.3.4 with 
30 cycles of 30 X 30 s denaturing, annealing and extension. Products were 
purified, ligated into pGEM-T and sub-cloned into the appropriate expression 
vector as described in sections 2.3.6- 2.3.12.
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Table 2.4.1: PCR primers for the alternative TTR cloning and expression 
strategies, restriction enzyme sites shown in bold.
TTR amplicon and 
primer name
Expression
Vector
Restriction 
Enzyme site
Primer Sequence 
(S' to 3')
Full length. Forward 
(TTR-1)
pET 22b Eco RI ccg aat teg atg aaa gcg gtc 
att ctt ctt ttg
Full length. Reverse 
(TTR-2)
pET 22b Xhol age teg agg tea tea tag tea 
tea tct aaa aag ta
Full length. Forward 
(TTR-3)
pET 22b no 
peLB leader
N del ta cat atg atg aaa gcg gtc att 
ctt ctt
No Signal Peptide. 
Forwai'd 
(TTR-4)
pET 22b no 
peLB leader
N del ta cat atg atg agg gat caa tcc 
ata get
pGEX-6P3 Forward 
(TTR-5)
pGEX-6P3 Eco RI ccg aat teg atg aaa gcg gtc 
att ctt ctt ttg
pGEX-6P3 Reverse 
(TTR-6)
pGEX-6P3 X hol age teg agt cag tea tea tag 
tea tea tct aaa aag ta
Table 2.4.2: TTR primer pairs and PCR conditions for amplification.
Primers Tm CO Ultimate Expression Vector
TTR-1 / TTR-2 55 pET-22b
TTR-3/TTR-2 55 pET-22b (no peLB leader sequence)
TTR-4/TTR-2 55 pET-22b (TTR without signal peptide. No 
peLB leader sequence)
TTR-5 / TTR-6 55 pGEX-6P3
Following sub-cloning into the appropriate expression vector, all TTR inserts 
were confirmed by sequencing to be in the correct reading frame as the plasmid
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vector prior to expression attempts (Section 2.3.13). Expression and 
recombinant protein purification were as described in Section 2.3.13 -2.3.14
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2.5 Cloning of H. contortus Metalloprotease
2.5.1 Identification, cloning and expression of
Metalloprotease fragment
Degenerate primers designed to the highly conserved astacin like region of the 
known nematode astacin-like metalloprotease (MTP) sequence, based on a 
clustal alignment of the A. caninum and O, ostertagi MTP sequences (See 
Figure 2,5.1), were kindly provided by Dr A. Nisbet, Moredun Research 
Institute.
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ACMTPOoMTPlOoMTP3
AcMTPOoMTPl0OMTP3
MRVLLLLLLLSICASAGFLDTK---------- FGQKIK-KTLDKIKAVLNGTALIAIREK 49MRLILLXLLLWATNGGIIDKLKGLFTGEGG-FGQKVKNATAVSFKKLPENTALFRINDK 59 MRLILLLLVLAVTTQAGLLDIGKVKDFFKGGKYGEKIKNATLLKFKKLFEKTGILSLGSK 60
* * * * * *  * . *
FIRLREKIKAICLTLSPARKAILDEVMKHIKMIKKDKIQEKGDSIDEINEKSAIGQLLYQG 109 IRSMKEKVLKTLELSPAMMKSLQERLKKWRPLKNDKVHEMGDTITEVNKNSKVDQYLYQG 119 LSEMRSKLMKKLELPKLKKVEVDRRIKEILAKRDDTVEKAINTIFDINAGNNVGQLLYQS 120
AcMTPOoMTPl0OMTP3
AcMTPOoMTPl0OMTP3
AcMTPOoMTPlOOMTP3
AcMTPOoMTPlOOMTP3
AcMTPOoMTPl0OMTP3
AcMTPOoMTPl0OMTP3
AcMTPOoMTPl0OMTP3
AcMTPOoMTPl
DIVLTEKQAQQITEDIENDK--GDREKRQAFRDRNYPRTLWSKGVYFHFHRNATPEVRSV 167 DMVLTEEQADEIVEDIEDQVAGGNRTKRQAPKDHKYPKTLWSQGVNYYFHDMASKQMKSV 179DILLTKKQAEEVIESIEGKN GQMKRQAVNRDYNPDSIWVDGVFYRFDESTDPRTKKI 177
* . » * * ► .  * * * * *  * , * * , *  * *  *  *  *  *  .  . *  *  *  * *  «  ^ , «
FVKGAKLWMKDTCIDFFESNS--APDRIRVFKENGCWSYVGRLGGEQDLSLGEGCQSVGT 22 6 FVKGAKWWEKDTCINFTENRS--AEDRIMVFPQKGCWSNIGKIGGEQKISLGGGCHSVSI 237 FELSAKQWENATCIDFTEDKEEKEPHFISWKSEGCFSEIGRVGFDQWLSLGKGCDXIGI 237 * * * * * ****** * * ***** .*.,* . * .***** .
-------^  MTP-deg-f
3FYHTHARHDRDNFITPNAQNVKPDWLDQFTLQTPATNENYGITYDYGSIM 285 3FFHTMSRXDRDEFITVMMHNVDVHWLSQFNKETTKRNDNYGMTYDYGSIM 297 ÎEFHTMARYDRDDFITWIDNWDNFVDQYIPQTEETSDNYGLTYDYGSIM 297
* » * * * * * * • * •  * *  *  * *  * * * * * * * • *  *  *  , * * * * * * * *
HYGANSASQ--NGRPTMVPHDPKYVETLGSP11SFYELLMINKHYDCTKNCDPATSAQCK 343 HYGGTSASY--NNKPTMVPFDVDYQQTLGSPFISFIELSMINEHYKCKENCNPAKSAKCE 3 55 HYGASSATFSRNGEPTMIANDPLYQKTMGSYILSFLDKSLINEHYECKAKCPQETSAPCQ 357
. * * « * *  *  * *  *  *  *  ,* *  *  * * *  *  * * * * *  . . * *
MGGFPHPRDCTRCICPSGYGGKLCDQKPAGCGSIYQATNQYQTLHDEIGDKRAGQRPRED 403 MGGFPHPRDCSKCICPGGYAGARCTERPSGCGSAIQASSDWKTLQDTLG--KDDDEERED 413 NGGFPHPRKCSECICPSGYGGALCNERPAGCGQTLTATDKKQFLINKLGHGQVPSDCRDD 417
* * * * * * *  *  . *  *  *  *  *  *  *  *  .  * * * * * *
MTP-deg-r
MDFCYYWITAPKGSKIEIKIAGLSOGAAVEQCOYWGVEIKTHADORtJBHMHBWPF.DVGV 463 FETCNYWIESPAGTEIEVRLLDFTRGVSVDGCKFAGVEIKTNKDQTL^^^MaGAAGI 473 YLFCNYWIEAPKGKRIEVKINAISHGYDXDGCVLQQVEIKSSADOTRlTOiHHTKDKNT 477 * * * * « * * * * * . .  *••* * * * ****** * * ******* ^
RLVSNFNIVPIITYNIFYATYVDIQYRIVGDNVGGPMPQP--------------- QPNS- 507ALRSYTNRVPIMTYNRFGQSTTVLEYRHVPASAPRTPSPPSATTRASITTTTTTKKPSST 533VLVSATNRMPVIMFNRSGEQQIILEYKIVS-------------------------------  507* * - * * ; *
 NCVDNEQCATLVRTKNFCQSRFFTESVKRGLCPKSSGFCR 547AAFKCEDNHTCPSLVASG-FCKG-PLSEATKKKVCPKSCGLC- 573
Figure 2.5.1 : A clustal W alignment of the AcMTP and OoMTPs 1 and 3 
(for which full sequence is available). Degenerate primers were designed 
to the highly conserved regions highlighted in black, the forward 
degenerate primer was termed MTP-deg-f; the reverse termed 
MTP-deg-r.
Degenerate PCR was earned out using primers MTP-deg-f and MTP-deg-r (see 
Figure 2.5.1 and Table 2.5.1) on H, contortus ExL3 cDNA, (from a stock of 
Moredun Research Institute cDNA prepared by M. Oliver) under the following 
amplification conditions: 35 cycles of 30 s denaturing, 30 s annealing (Tm 52°C), 
1 min extension and the expected product size was 650- 750 base pairs (bp). 
Following visualization of the PCR product by agarose gel electrophoresis, the 
approximately 700 bp product was purified, ligated into pGEM-T and sequenced
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as described in Sections 2.3,6-2,3.10. Sequence analysis demonstrated the 
product to be a novel 687 bp MTP fragment and allowed design of gene specific 
primers (gsp) for cloning purposes and for sequence extension at the 5’ and 3’ 
ends. Primers are shown in Table 2.5.1.
Table 2.5.1: Primer designs for discovery, cloning and expression of 
HcMTP gene. Restriction enzyme sites are shown in bold.
Primer
pair
Sequence 
(5' to 3')
Tm
T
Purpose of primers/ 
amplicon
Mtp-deg-f
Mtp-deg-r
get gc(g/a) ca(t/c) ga(g/a) at(t/a) 
gg(c/t) ca
gc(a/g) cag aa(c/t) ctg tag cc(a/g) gt
52 To attempt to amplify a 
novel mtp from H. 
contortus larval cDNA
Mtp-f-1
Mtp-r-1
gaa etc ggc cac get ctt 
cga ttt gat ttc gac tcc
52 GSP to clone fragment 
into pGEM-T for 
sequence confiiTnation
Mtp-f-2
Mtp-r-2
ggt get acg ggt get tct cat aac aag 
aaa cet aca
tgg gtg agg gaa tcc acc att etc gca 
ctg gtg aga
>72
>72
To use with the SMART 
RACE (BD Clontech, 
UK) pi mers for 5’ and 3’ 
end sequence.
Mtp-Nde
Mtp-Xho
ata cat atg gaa etc ggc cac get ctt 
ac etc gag cga ttt gat ttc gac tcc
55 To clone into pET for 
expression of 
recombinant protein
Mtp-F-Nde
Mtp-R-Z/îo
gat tag tac ata tgg get tac ttg aaa 
aag caa aa
gat tag cgc teg agt teg gca att ttg 
tact cc ag
55 To clone into pET and 
express full length MTP 
gene (without signal 
sequence)
Mtp-F-
v^ho\e~Nde
ta cat atg agg etc act ata eta ctg 55 To clone into pET and 
express full length MTP 
gene
Using gsps mtp-f-1 and mtp-r-1, the novel mtp sequence was amplified by PCR 
from L3 and L4 cDNA (Section 2.3.1- 2,3,2) as described (Section 2.3.4) under
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the following amplification conditions: 30 cycles of 30s denaturing, 30s 
annealing (Tm= 52°C), 1 min extension. The products were purified, ligated into 
pGEM-T and sequenced for sequence confirmation (see Sections 2.3,6-2.3.10). 
The MTP fragment PCR amplified from L4 cDNA using primers mVg~F~Nde and 
mtp~R~Xho, was cloned into the pET 22b expression vector and expressed as 
described in sections 2.3.5- 2.3,13. The recombinant protein was purified 
(section 2.3,14) and stored at -20°C.
2.5.2 Identification of fuli length HcMTP by extension of 3’ 
and 5’ ends using RACE PCR
Utilizing the RACE ready L4 cDNA (see section 2.3.2), extension of the MTP 
fragment at the 3’ and 5’ end was attempted using gene specific primers and the 
universal primer (UPM) (that anneals to the 3’ or 5’ adapted ends of the RACE 
ready cDNA) provided by the kit manufacturer (BD Biosciences, UK). The 
primers MTP-F-2 and MTP-R-2 were designed such that the products of the 
reactions would give products which overlapped by 200 bp. Mtp-f-2 was used in 
conjunction with the UPM and 3’ RACE ready cDNA; mtp-r-2 in conjunction 
with the UPM and 5’ RACE ready cDNA, Reactions were essentially earned out 
according to the kit protocol (SMART RACE cDNA amplification kit, BD 
Biosciences, UK). A PCR mastermix was prepaied (lOX BD Advantage 2 PCR 
buffer; 50X BD Advantage 2 polymerase mix; 0.2 mM dNTP mix in sterile 
water. Reactions were set up as in table 2.5.2.
Table 2.5.2: Recipe for 3’ and 5’ RACE PGR reactions.
5’ RACE reaction 3’ RACE reaction
2.5 pi 5’ RACE ready cDNA 2.5 pi 3’ RACE ready cDNA
5 pi UPM 5 pi UPM
1 pi mtp-r-2 1 pi mtp-f-2
41.5 pi Mastermix 41.5 pi Mastermix
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PCR conditions were as follows:
5 cycles (94°C 30 s; 72°C 3 min)
5 cycles (94°C 30 s; 70°C 30 s, 72°C 3 min) 
30 cycles (94°C 30 s; 68°C 30 s, 72°C 3 min)
A schematic diagram of the RACE PCR reaction is shown in Figure 2.5.2.
5* U niversal
B D  S M A R T  M tp-f-2
sequence _______ . _______
B D  SM A R T
. . .  , sequenceU niversal
P rim er
Figure 2.5.2: A schematic diagram of the primers used for RACE PCR 
extension of the 5' and 3’ ends of the amplified HcMTP fragment. GSPs 
designed to the confirmed sequence of the HcMTP fragment (shown in 
red) were used in conjunction with the BD UPMs, that anneal to the BD 
SMART sequence added to the 5' and 3’ ends of the RACE ready cDNA 
(black shaded box). Mtp-r-2 was used with the universal primer mix and 
5’ RACE ready cDNA to extend the 5' end; Mtp-f-2 was used in 
conjunction with the universal primer mix and 3' RACE ready cDNA to 
extend the 3’ end.
PCR products from the 5’ and 3 ’ reactions were purified, ligated into pGEM-T 
and sequenced (sections 2.3.6-2.3.10). Following sequence analysis and 
confirmation of a 5 ’ start codon followed by a putative signal sequence and 3’ 
stop codon followed by a poly dA tail, gene specific primers were designed to 
amplify the full length novel MTP coding sequence (see Table 2.5.1) to allow 
cloning into pGEM-T for sequencing confirmation and to allow expression of the 
full length HcMTP (without signal sequence) in the pET 22b expression vector.
82
2.6 Cloning of H. contortus Ancylostoma secreted protein
(Ho ASP-1)
2.6.1 PCR amplification of cloning of HcASP
To PCR amplify the single domain H. contortus larval ASP homologue (PIcASP- 
1), primers were designed to the 5’ and 3’ ends of the published sequence (Shaiq) 
and Wagland, 1998). There was no start codon at the 5’ end, so primers were 
designed to either the beginning of the available sequence or to the nucleotide 
base after the putative cleavage site of the signal peptide. PCR primers, adapted 
to include an appropriate restriction enzyme cleavage site, were designed to 
allow sub-cloning into an expression vector as before. Primers used are shown in 
Table 2.6.1.
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Table 2.6.1: Primer designs for cloning and expression of HcASP-1 gene. 
Restriction enzyme sites are shown in bold sequence.
HcASP amplicon 
(and primer name)
Expression
vector
Restriction 
enzyme site
Primer sequence 
(5' to 3')
Published Full length 
(ASP-1 -forward)
pGEX-6P3 Bam HI ctg gat cct teg tac taa cga ttc 
tg
Published Full length 
(ASP-2-reverse)
pGEX-6P3 Xhol cgc teg agg tta ata taa gtt tgt 
ctt
Published Full length 
(ASP-3-forward)
pET 22b m e  I tac ata tgt teg tac taa cga ttc tg
Published Full length 
(ASP-4-reverse)
pET 22b Xhol cgc teg aga tat aag ttt gtc ttt tt
No signal peptide 
(ASP-5- forward)
pET 22b Ndel tac ata tga cga aaa att gcg aga 
ctt cag aa
Published Full length 
(ASP-6- forward)
pIVEX2.3d 
(Roche, UK)
N col ate atg tcc atg ggc ttc gta eta 
acg att ctg
Published Full length 
(ASP-7 -reverse)
pIVEX2.3d 
(Roche, UK)
Sma I agt ata ccc egg gag ata taa gtt 
tgt ctt ttt
ASP-5’ RACE n/a n/a tgc ata ttt etc age caa gca gga 
gta
Primers were used in the combinations described in Table 2.6.2. Reactions were 
carried out under the conditions described in Section 2.3.4 with an amplification 
cycle of 30 X 30 s denaturing, 30 s annealing and 1 min extension. Products 
were purified, ligated into pGEM-T and sub-cloned into the appropriate 
expression vector as described in Section 2.3.7. Following sub-cloning into the 
appropriate expression vector, all ASP inserts were confirmed to be in frame 
with the plasmid vector prior to expression attempts (Section 2.3.13).
i
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Table 2.6.2: Primer pairs, Tm and expression vectors for cloning and 
expression of HcASP-1 gene.
Primers Tm C O Ultimate Expression Vector
ASP-3 / ASP-4 55 pET-22b (without peLB leader sequence)
ASP-5 / ASP-4 55 pET-22b (no signal sequence, without peLB 
leader sequence)
ASP-1 / ASP-2 55 pGEX-6P3
ASP-6 / ASP-7 55 pIVEX 2.3d
2 .6.2 Expression of recombinant HcASP-1
Once in-frame cloning of the HcASP-1, with or without signal sequence, was 
confirmed by sequence analysis, attempts at recombinant protein expression in 
pET 22b and pGEX-6P3 were carried out as described in section 2.3.13.
To attempt to express HcASP-1 without the putative signal sequence in the 
pGEX system, it was cloned into pGEX-6Pl (a similar plasmid to pGEX-6P3, 
but with a frameshift in the MCS). Following PCR amplification by primers 
ASP-3 and ASP-4 and cloning of the full length HcL3ASP-l product into 
pGEM-T, the restriction enzymes EcoRl and Xhol were used to cut the insert out 
of pGEM-T and ligate into the MCS of pGEX-6Pl (Sections 2.3.11 and 2.3.12). 
EcoRI cuts the HcASP-1 sequence just after the putative cleavage site of the 
signal peptide, thus allowing the sub-cloning of the gene without the signal 
sequence. Attempts at expression of recombinant protein were earned out as 
previously described.
2.6.3 Expression of HcASP-1 using an in vitro cell free 
translation system
Following cloning the HcASP-1 into the pIVEX 2.3d expression system (Roche, 
UK) and sequence confirmation that the insert was in frame, plasmid was 
propagated and purified (Sections 2.3.8 and 2.3.9) and 10 (xg of pure plasmid
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was used for protein expression in the Rapid Translation System E. coli HY kit 
(Roche, UK) using the RTS 500 Instrument (Roche, UK) according to the 
manufacturers instructions. Protein was analysed by SDS-PAGE electrophoresis 
(Section 2.2.3).
2.6.4 Extension of 5’ HcASP-1 end by RACE PCR
A gsp (ASP-5’-RACE, Table 2.6.1) was designed to a region of the published 
HcASP sequence approximately 230 bp from the start of the published sequence 
to attempt amplification of the 5’ end with start codon by RACE PCR. The BD 
Biosciences SMART RACE cDNA amplification kit was used and the protocol 
and PCR conditions were identical to those described in section 2.5.2. The PCR 
product was purified, ligated into pGEM-T, and sequenced (sections 2.3,6- 
2.3.10).
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2.7 Im m unohistochem istry on worm sections
2.7.1 Raising antibodies to recombinant protein in rabbits
Fifteen-30 pg of electroeluted, purified recombinant protein, diluted in 300 pi of 
sterile PBS containing 50 pg of Quil A (Brenntag Biosector, Denmark) adjuvant, 
was injected subcutaneously into a rabbit on 3 occasions, 3 weeks apart. Five to 
10 ml blood was collected by venepuncture of the marginal ear vein immediately 
prior to the first vaccination, centrifuged at 770xg for 10 min and sera removed 
(pre-vaccinate sera) and stored at -20°C. Two weeks following the 3"" 
vaccination rabbits were terminally anaesthetised with Halothane and Oxygen 
and blood was collected by cardiac puncture and sera collected as before 
(vaccinate sera) and stored at -20°C.
2.7.2 Preparation of L3 sections
Ex sheathed H, contortus L3s were fixed in zinc salts fixative (ZSF; 0.5% (w/v) 
Zinc acetate, 0.5% (w/v) ZnCE, 0.05% (w/v) Calcium acetate, 0.1 M Tris, pH 7- 
7.4), 4% (v/v) paraformaldehyde (in PBS) or Modified Bouin’s (2.5% glacial 
acetic acid; 5% (v/v) formaldehyde (37%); 92.5% (v/v) saturated aqueous picric 
acid) solution for 24-28 h at 4”C. L3s were pelleted by centrifugation 
(10,000xg), mixed in 10% (w/v) gelatin which solidified to a soft malleable 
pellet, and then fixed in 70% (v/v) ethanol for a further 48 hours at 4°C. 
Following dehydration using graded alcohols, samples were embedded in 
paraffin wax at 56°C. Sections were cut as required for immunohistochemical 
analysis.
2.7.3 Antibody labelling of worm sections
H. contortus L3 or adult (a kind gift from M. Oliver, prepared as above) sections 
(5 pm; on Superfrost slides; Merck, UK) were de-waxed in xylene and 
dehydrated in a series of alcohols (100%, 75% (v/v) and 50% (v/v) ethanol). 
Non-specific binding was blocked by incubation in 5% horse serum in PBS
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(PBS/5% HS) overnight at 4°C. All antibody incubation and wash steps were 
carried out five times in PBS/5% HS. Primary anti serum (both pre-vaccinate 
(negative control) and vaccinate sera) was prepared at a range of dilutions 
(1:100-1:2000) and slides incubated in the appropriate serum overnight at 4“C. 
Secondary serum control slides were incubated in PBS/5% HS. Slides were 
washed by gentle agitation in PBS/5% HS for 4 x 1 5  min. Slides were incubated 
with a secondary fluorescein isothiocyanate (FITC) labelled sheep anti-rabbit 
IgG polyclonal sera (Sigma, UK) diluted at 1:500 in PBS/5% HS for 3 h at RT 
and washed as before. Sections were mounted in Citifluor (Chemical Labs, UK) 
under a coverslip and incubated at 4^ 'C in the dark for 1 h. Adult sections were 
examined under a fluorescent microscope (Axiovert 25) at xlOO and 
photographed using a digital camera. Larval sections were examined using an 
Olympus BX50 fluorescent microscope at xlOOO and photographed onto Kodak 
Ektachrome tungsten 320T film. Images were cropped in Microsoft Powei-point.
88
2.8 Sheep vaccine trial
2.8.1 Vaccination and challenge strategy
A protection trial was conducted using 11-month-old Suffolk-Greyface cross 
lambs, assigned into groups of seven balanced for sex and weight. All animals, 
housed in loose boxes and fed on hay, concentrate and water ad libitum, 
received 3 immunisations at 3 weekly intervals and were challenged with 5000 
Haemonchus L3s one week after the final immunisation. Antigens were 
administered with 5 mg of Quil A in PBS in a total volume of 2 ml, 1 ml being 
given intramuscularly into each hind leg. The control group received adjuvant 
alone. The unbound (Section 2.2.9) group received 35 pg of the non-binding ES 
fraction and the bound (Section 2.2.9) group received 5 pg of the bound and 
eluted ES fraction. Blood samples were taken at weekly intervals by jugular 
venepuncture and sera was prepared as described (Section 2.4.1) and stored at - 
20°C until required. Pre-vaccinate sera were defined as sera taken from blood 
samples collected immediately prior to the first vaccination, vaccinate sera as 
that collected 1 week post final vaccination.
2.8.2 Parasitological parameters
EEC were earned out 3 times a week starting 17 days post-infection until post 
mortem 36 days post infection. Methods for EEC and worm enumeration were as 
described in Smith and Smith (1993). Briefly, for worm counts, animals were 
stunned using a captive bolt gun and exsanguinated. At necropsy the abomasa 
were collected, opened along the lesser curvature and contents washed into a 
bucket. A saline digest was made of the abomasum, following which the 
abomasum was rinsed thoroughly to ensure all worms were washed out. Male 
and female worms were recovered from a subsample of 2% of the total abomasal 
wash volume for counting and worm measurements. EEC were carried out by 
adding 10 ml of water per gram of faeces and emulsifying, removing faecal 
matter by straining through a sieve and taking a 10 ml subsample for counting. 
The remaining faecal matter in the sub sample, containing the worm eggs, was 
pelleted by centrifuging at 770xg for 2 min and then mixed in a saturated salt 
solution. Upon repeat centrifuging, the eggs floated in the salt solution and the
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top 2 ml was poured into a polystyrene spectrophotometer cuvette (Sigma, UK) 
and the number of eggs deteimined by visual inspection and enumeration under 
light microscopy (x20 magnification).
2.8.3 Worm measurements
Worm measurements were made as described in Redmond and Knox (2004). 
Male and female adult woims recovered from individual animals in each group 
were pooled into their respective groups. Wonn length was measure for a 
random sample of 50 worms (male or female) from each pool. Worms were 
photographed individually under lOX light microscopy and the length 
determined using the semi-automated Image-Pro Express (Media Cybernetics, 
UK) software programme.
2.8.4 Egg hatch assay
Following individual animal egg counts, eggs were emptied from the cuvette and 
washed in a 38 pm sieve with tap water for 1 min to remove any excess salt 
solution. Eggs were resuspended in 2 ml dHzO in a Petri dish and allowed to 
develop at room temperature for 3 days. Following 3 days of incubation, the 
culture was fixed by addition of 10 pi helminthological iodine and mixed by 
pipetting. One hundred pi of the 2 ml culture was removed and streaked onto a 
microscope slide. The number of unhatched eggs and LI larvae were enumerated 
under x20 light microscopy and the percentage of eggs hatched worked out as 
follows: eggs unhatched/ LI larve X 100. This assay was peiformed on eggs 
collected on days 20, 22, 29 and 36 post infection.
2.8.5 Detection of circulating total IgG levels in vaccinated 
animals by enzyme linked immunosorbent assay
An ELISA method was used for the detection of systemic total IgG and IgE 
antibody in sera in response to vaccination. IgG ELISA assays were carried out 
by Kay Hall (Moredun Research Institute). Microlon (high binding) 96 well 
ELISA plates (Greiner/Bio-one, UK) were coated with 5 pg/ml of pooled L3 ES 
in 50 pi of bicarbonate buffer pH 9.6 (appendix 1) per well and incubated 
overnight at 4“C. Plates were then washed 6 times with TBST and non-specific
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binding blocked by incubation with 200 pi per well in 10% (w/v) non fat dried 
milk in 50 mM bicarbonate buffer pH 9.6 overnight at 4°C. Primary antibody 
samples (vaccinate sheep sera from individual animals) were made up in a 
dilution series ranging from 1:100 to 1:102,400 in TBST for IgG ELISA or 1:20 
to 1:20480 for IgE and 50 pi was added per well. A 1:1280 for IgG or 1:20 for 
IgE dilution of pre-vaccinate control sera was also made and 50 pi was added per 
well. Following incubation at RT for 2 h, plates were washed as before 6 times 
in TBST. Secondary HRP-labelled goat anti-sheep IgG antibody or mouse anti­
sheep IgE (Sigma, UK) was diluted 1:2000 in TBST, 50 pi added per well and 
plates were incubated at RT for 2 h. Following a further 6 washes in TBST, the 
HRP-labelled secondary antibody was detected by the addition of 100 pi per well 
of Sigma Fast-O-phenylenediamine dihydrochloride (OPD, Sigma, UK) and 
colour allowed to develop (approximately 10 min) and the reaction stopped by 
addition of 50 pi per well of 2.5 M sulphuric acid before reading the OD492 of 
each well using a microtitre plate reader (Labsystems iEMS Reader MF, UK). 
IgG and IgE levels were calculated as a titre against the IgG levels in the dilution 
of control sera.
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2.9 RNA interference
2.9.1 Production of double stranded RNA
To produce double stranded RNA, gene specific DNA was cloned into pGEM-T, 
then subcloned into the vector L4440 (kindly provided by J. Ahringer, University 
of Cambridge) (section 2.3.12) using restriction enzymes that flank the MCS, 
and cells transformed and plasmid propagated as described in sections 2.3.8- 
2.3.9, Each side of the MCS of L4440 is flanked by a T7 promoter and gene 
specific double stranded RNA (dsRNA) can be produced by transcription with a 
T7 polymerase. dsRNA was prepared using the T7 Ribomax RNAi kit 
(Promega, UK), according to the manufacturer’s instructions. Briefly, plasmids 
were linearised by digestion with one of Xbal and Xhol (on opposite sides of the 
insert). Separate reactions were set up using 1 pg of the linearised DNA, the T7 
polymerase mix (Promega, UK) and 2X buffer (Promega, UK) and incubated for 
30 min at 37°C thus allowing transcription of single stranded RNA (ssRNA). 
Following ssRNA transcription in both directions, both reactions were mixed 
incubated at 70°C for 10 min and then allowed to slowly cool to RT to allow 
annealing. The resulting dsRNA was purifed, ethanol precipitated and resolved 
in sterile water according to the manufacturer’s protocol.
2.9.2 dsRNA production of C. elegans genes
Genes highlighted through homology to H. contortus proteins as potential 
candidates for RNAi loss of function studies in C. elegans were cloned from 
mixed stage C. elegans cDNA (prepared previously by methods similar to those 
described fori/, contortus cDNA production Section 2.3.1- 2.3.2) as described in 
Section 2.9.1. The genes cloned were a transthyretin-like protein (Genebank 
Accession number Q18878, CeTTR) identified as the closest homologue to the 
HcTTR (Section 2.4) and two members of the nematode astacin-like family 
(NAS) of C. elegans {nas-3l and nas-32) that were homologues of the HcMTP 
(Section 2.5). Primers were designed to PCR amplify the whole CeTTR 
sequence and to unique regions approximately 200 bp in length of nas-3l and 
nas-32 of the published sequence. dsRNA was produced as in Section 2.9.1 
The Primers that were used are described in Table 2.9.1.
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Table 2.9.1: Design of primers for dsRNA production of C. elegans target 
genes.
Gene Primers Sequence TmCC) Product Size (bp)
CeTTR CeTTR_f
CeTTR_r
atg cag act tta ctg tta get 
eta gaa get ate ttc etc att
58 471 base pairs
nas-3l nas-3 l_f 
nas-31_r
eta tcc tgg aag ccc gcg atg 
tct gca tta tat tga tgc aag
56 208 base pairs
nas-32 nas-3 2_f 
nas-32_r
att tga ata aca acc aaa teg 
tea att cga att tea age atg
54 212 base pairs
2.9.3 RNA interference of C. elegans
C. elegans were maintained on nematode growth medium (NGM) agar under 
standard conditions (as described by Sulston and Hodgkin (1988)) and RNAi 
soaking carried out essentially as decribed by Tarbara et a l (1998). Twenty L4 
worms were soaked in 1 ng of target dsRNA in PBS + 1 pi lipofectin (Gibco- 
BRL, UK) in a total volume of 11 pi for 12 hours. Worms were re-plated on to 
NGM agar (seeded with a lawn of E. coli strain OP50) and grown overnight. 
The worm phenotype was inspected visually and compared with wonns 
incubated in PBS and lipofectin alone (negative control) and worms soaked in 
RME-2 dsRNA (a positive control, RNAi with which leads to a phenotype of 
reduced progeny; a kind gift from Dr C. Britton, University of Glasgow). Fifteen 
adult worms were picked for RT-PCR analysis to establish that RNAi had 
resulted in a reduction in the mRNA expression of the targeted gene.
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2.9.4 One-step Reverse Transcription-PCR
Total RNA was prepai’ed from 15 C. elegans adult worms that had undergone 
RNAi. Worms were added to 200 pi of lysis buffer (10 mM Tris-HCl pH 7.5; 
0.5% (w/v) SDS; 5% (v/v) p mercaptoethanol; 10 mM EDTA) and stored at - 
80°C for 10 min. Following this, 0.5 mg/ml Proteinase K was added and the 
solution mixed then incubated at 55°C for 1 h. To this, 100 pi of Total RNA 
reagent (AB Gene, UK) was added, the solution mixed and incubated on ice for 5 
min. Zero point two ml chlorofomi was added; the solution mixed and incubated 
on ice for 5 min prior to centrifuging at 12,000xg for 15 min. The upper phase, 
containing the RNA, was collected to which an equal volume of isopropanol was 
added followed by 10 min incubation on ice. Following precipitation, RNA was 
pelleted by centrifugation at 12,000xg for 10 min, the RNA was washed with 
75% (v/v) ethanol, and the RNA pellet dissolved in 50 pi sterile water. To 
ascertain that target gene expression had been reduced, a one step RT-PCR was 
earned out using the Superscript One Step RT-PCR with platinum Taq kit 
(Invitrogen, UK) and appropriate gene specific primers, according to the 
manufacturer’s instructions with an amplification of 29 cycles. This system 
allows the combining of cDNA synthesis and PCR in a single reaction. One step 
RT-PCR was also carried out on negative control worm RNA using gene specific 
primers to the experiment’s tai'get gene to act as a PCR control. A second control 
one step RT-PCR using gene specific primers to amplify a known expressed C. 
elegans gene from RNA prepared from the RNAi treated worms confirmed RNA 
quality.
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2.10 Direct challenge assay
To investigate the ability of specific antisera directed against H. contortus 
proteins to inhibit larval penetration of the gut mucosa, a direct challenge assay 
was caiTied out. The protocol was based on that described by Jackson et al 
(2004). The abomasum from a wonn free sheep was removed, cut along the 
lesser curvature and the contents gently rinsed off with physiological saline 
(0.85% w/v). Folds were removed, cut into 2 cm^ sections and placed into wells 
of a 6 well plate (Corning, UK). Hank's medium (Sigma, UK) supplemented 
with 20 mM Hepes (Boehringer Mannheim, Germany) pH 7.6, pre-warmed to 
39°C, was added to sumound, but not submerge the explant. An isolation 
chamber was provided by the bainel of a 5 ml syringe and this was placed on the 
centre of the explant firmly to create a seal. A challenge dose of 2,500 
exsheathed H. contortus L3 in 0.5 ml of PBS or sera, which were pre-incubated 
with appropriate sera (see Table 2.10), was added to the isolation chambers. 
Plates were transferred to an incubator (Stuart Scientific S I60) and maintained at 
39°C in an oxygen rich environment for 3 hours. All samples and controls were 
set up in triplicate.
Following incubation, isolation cylinders were removed and rinsed into a 50 ml 
Falcon tube (Wash 1: worms that were not associated with the tissue). The 
explant was removed and washed vigorously by plunging 30 times in to a 50 ml 
Falcon tube containing 25 ml of saline, this was termed Wash 2: worms that were 
associated with, but had not penetrated the tissue. The explant was transferred to 
a third 50 ml falcon tube containing 1% (w/v) Pepsin (1:2500 (w/v) Porcine 
pepsin, Sigma, UK) and 1% (v/v) HCl. Tissue was allowed to digest thoroughly 
overnight at 3TC. This third tube, tenned the digest, contained woiTns that had 
penetrated the gastric tissue. Thus, there were 3 tubes for each piece of abomasal 
tissue, and each of these was fixed with 2 ml of helminthological iodine (250 g 
Potassium iodide; 50 g resublimed iodine dissolved in 500 ml distilled water) and 
the final volume was adjusted to 50 ml with distilled water. The number of 
larvae present in a 2% aliquot of each was counted using a 9 cm Petri dish with a 
1 cm grid drawn on it under x 100 light microscopy.
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The percentage of larvae that had penetrated the tissue was worked out by 
dividing the number of lai’vae in the digest by the total number of recovered 
larvae and multiplying by 100.
Table 2.10: Sera used to pre-inoubate exsheathed H. contortus L3 for the 
direct challenge experiment.
Experimental
Group
Antibody used for pre-incubation Antibody 
Dilution Factor
Positive Control None (PBS) Not applicable
Unbound Pooled Unbound sheep vaccinate 
sera
Neat
Bound Pooled Bound sheep vaccinate sera Neat
Pre-vaccinate sheep Pooled sheep pre-vaccinate sera Neat
Metalloprotease Rabbit anti rMTP vaccinate sera Neat
Pre-vaccinate rabbit Rabbit pre-vaccinate sera Neat
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Chapter 3
H. contortus larval somatic and 
excretory/ secretory proteins
3.1 Introduction
Third stage larvae of both hookworm species and H. contortus contain and/ or 
release proteins that can induce protective immunity (Miller, 1965; Smith and 
Angus, 1980). As discussed in Chapter 1, developmentally arrested L3s 
reactivate upon entry to the host as a result of certain stimuli. This can be 
mimicked in vitro by culturing A. caninum L3 at 37°C with host serum (Hawdon 
and Schad, 1990), and by exsheathing H. contortus L3 with CO2 and 
subsequently culturing at 37°C (Gamble and Mansfield, 1996). Upon activation 
and culture, A. caninum release a variety of proteins into the culture fluid, some 
of which ai'e promising vaccine candidates (discussed in section 1.7.3.2).
Following a period of “dormancy” on the pasture and upon ingestion by the 
ruminant host, L3 H. contortus exsheath in the rumen and develop in the 
abomasum to LA stage larvae within approximately 72 hours. This is reported to 
be replicated in vitro and during culture L3 release proteins (ES products) 
(Gamble et al, 1996). Proteases are released during exsheathing, one of which, a 
metalloprotease, digests a refractory ring on the sheath that allows the L3 to 
escape from the 2“^  stage cuticle or sheath (Gamble et al, 1989). Proteins have 
also been reported to be released concomitantly with the molt from the ExL3 to 
the LA (Gamble et al, 1996) including a protease of metallo-nature and a number 
of unidentified proteins. Evidence from the analogous situation in hookwonn 
would suggest that some of these H. contortus proteins may be potential vaccine 
candidates; in particular' those proteins that are homologous to the already 
identified L3 ES hookworm candidate antigens.
Studies carried out by Sharp and Wagland (1998) demonstrated that H, contortus 
L3 ES could be fractionated by lentil lectin affinity chromatography and that the 
resulting lectin binding fraction was highly enriched for a 40 kDa protein. 
Subsequent analysis showed that this 40 kDa protein corresponded to single 
domain A. caninum ASP-1 homologue.
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This chapter describes work that was undertaken to harvest the ES proteins of L3 
H. contortus and to define the protease content as well as to seek homologues of 
the lead hookworm larval vaccine candidates. In addition, it was the intent to 
obtain sufficient ES protein to enable its fractionation with selected sub-fractions 
evaluated in a vaccine trial in Chapter 4. Lentil lectin binding was evaluated 
here because this had been used with success previously (Sharp and Wagland, 
1998) to enrich for the H, contortus ASP-1 homologue.
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3.2 Results
3.2.1 Characterisation of H. contortus L3 proteins and
proteases : 
■ii
To investigate the proteins released by H. contortus, L3 were ex sheathed and |
cultured and ES collected as described in Section 2.1.3. H. contortus ExL3 
extract (prepared as described in Section 2.2.1), exsheathing fluid (EE) and ES 
products were analysed by SDS-PAGE electrophoresis. The profile of proteins 
released by L3 following exsheathing and during culture was compared to that of 
the soluble (SI), membrane associated (S2) or membrane bound (S3) somatic 
extracts (Figure 3.2.1). The profile of the protein extracts appeared distinct to 
and more complex than that of the ES. The profile of the SI, S2 and S3 were 
also distinct to one another, the SI appearing most complex.
The protein profile of EF was quite distinct to that of both ES and extracts with a 
prominent band at approximately 100 kDa and a doublet running at 
approximately 45 - 50 kDa. These proteins may correspond to the previously 
described major exsheathing protein at 98 kDa (Gamble et al., 1989a) and a 44 
kDa metalloprotease thought to mediate ecdysis (Gamble et at., 1989a).
Parasites released ES proteins into the culture media and the protein profile 
increased in both concentration and complexity as culture time progressed as 
judged by SDS-PAGE (Figure 3.2.1).
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Figure 3.2.1: Coomassie stained SDS PAGE Gel of H. contortus L3 
extracts, EF and ES products. The gel profile is representative of all the 
cultures carried out.
Mr- Molecular weight markers (kDa); Extracts: 1 - Soluble (S1); 2 - 
Membrane associated (S2); 3 - Membrane bound (S3); 4 - Exsheathing 
fluid; 5 - 24hrES, 6 - 48hrES, 7 -72hrES, 8 -96hrES, 9 - 120hrES.
On average, 10 million L3 released 250 pg protein in the first 24 hours of the 
culture period with a total of approximately 2.5 mg released during the 120 hour 
culture period, although it is worth noting that the quantity of protein released did 
vary between cultures therefore several very large (10 million L3) cultures were 
required to produce a manageable quantity of protein. Concentration of protein 
from the cultures resulted in a slight loss of protein and a further compounding 
factor was that early cultures were carried out in EBSS with a phenol red dye 
which required dialysing out prior to concentration measurement resulting in a 
further loss of protein. In total, 5 cultures (amounting to 50 million L3) were 
required to produce a total of 4 mg of concentrated ES protein.
Greater than 95% of larvae remained viable, as evaluated by visual inspection, up 
to 120 hours in culture. Following this period the viability decreased. Very few 
or none depending on the culture, of the worms developed into L4 larvae. This 
was in contrast to reports by Gamble et al. (1996).
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Assessment of protease activity in protein extracts, EF and ES was carried out as 
described in Section 2.2.6. Exsheathed L3 extracts were made as described in 
Section 2.2.1 however protease inhibitor (PMSF) was not added. Exsheathing 
fluid contained several regions of protease activity, as indicated by digestion of 
gelatin in substrate gel SDS-PAGE (Figure 3.2.2). The most active proteolysis 
occurred in a region of 100-140 kDa, with other prominent bands visible at 
approximately 80 kDa and 50 kDa (Figure 3.2.2). A band of proteolysis was 
also apparent, upon visual inspection of the gel, at approximately 37 kDa that is 
clearer in Figure 3.2.5 ES contained protease activity that appeared following 
72 hours in culture, and this activity was more intense at 96 and 120 hours in 
culture. The protease activity appeared to be limited to a band of activity that 
migrated with a weight of approximately 40 kDa (Figure 3.2.2) and was most 
active at a pH of 8 (Figure 3.2.3). Protease activity was not visible in any of the 
somatic extracts (Figure 3.2.2).
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Figure 3.2.2: EF and ES Substrate Gel. 0.1% w/v Gelatin Substrate, 
10% SDS PAGE gel showing protease activity in H. contortus larval EF, 
ES collected at 24 hour intervals during culture and larval extracts. 
Regions of proteolysis detectable in EF and 72, 96 and 120 hour ES are 
boxed.
1 - Exsheathing fluid; 2 - 24hrES; 3 - 48hrES; 4 -72hrES; 5 -96hrES; 6 - 
120hrES;7 -S1 ;8 -S2 ;9 -S3 .
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Figure 3.2.3: ES Substrate gel at various pHs. 0.1% gelatin substrate, 
10% SDS PAGE gel showing protease activity in 120 hour H. contortus 
larval having been incubated at various pH.
1 -  pH 5; 2 -p H  6; 3 - pH 7; 4 -p H  8
To confirm that the protease activity observed in ES could be ascribed a 
metalloprotease nature, inhibition studies involving pre-incubation with a range 
of specific protease inhibitors were carried out as described in Section 2.2.6. 
The range of inhibitors used combine to inhibit all four classes of protease: 1,10 
Phenanthroline and EDTA are both metal loprotease inhibitors, E-64 is a cysteine 
protease inhibitor, AEBSF inhibits serine proteases and Pepstatin is an aspartyl 
protease inhibitor. The only inhibitor that reduced activity was 1, 10 
Phenanthroline, (Figure 3.2.4a). A combination of 1, 10 Phenanthroline and 
EDTA (another metalloprotease inhibitor) completely abrogated activity (Figure 
3.2.4a) implying the protease to be of a métallo nature. Substrate gel analysis of 
96 hour ES pre-incubated in increasing concentrations of 1, 10 Phenanthroline 
(Figure 3.2.4b, pH 8) demonstrated a dose-dependant reduction in protease 
activity confirming that the visible protease activity in H. contortus L3 ES be 
attributable to metalloprotease activity.
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Figure 3.2.4: Substrate gel of ES with protease inhibitors. 0.1% Gelatin 
Substrate, 10% SDS PAGE gel showing protease activity in H. contortus 
larval ES collected after 96 hours in culture. Bands of proteolysis are 
marked by arrows. Panel A; 96hr ES incubated with a range of specific 
protease inhibitors. 1 -  pH 8 buffer; 2 - AEBSF (2 mM); 3 - E-64 (10 pM); 
4 - 1, 10 Phenanthroline (1 mM); 5 - Pepstatin (10 pM); 6 - 1, 10 
Phenanthroline (1 mM) + EDTA (4 pM).
Panel B: 96hr ES incubated with increasing concentrations of 1, 10 
Phenanthroline. 1 - pH8 buffer; 2 -1  mM; 3 -1 0  mM; 4 -100  mM.
Similar inhibitor studies carried out with EF demonstrated 1,10 Phenanthroline to 
be the most effective protease inhibitor, reducing the intensity of all activity 
compared with the control and in particular being the only class of protease 
inhibitor tested to completely abrogate the band of activity at approximately 
37 kDa implying this band to be attributable to metalloprotease activity (Figure 
3.2.5). Interestingly all classes of protease inhibitor led to a slight reduction in 
protease activity compared with the control perhaps suggesting a range of 
proteases to be present in EF.
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Figure 3.2.5: Substrate gel of EF with protease inhibitors. 0.1% Gelatin 
Substrate, 10% SDS PAGE gel showing protease activity in H. contortus 
larval EF. 1 - pH 8 buffer; 2 1, 10 Phenanthroline (ImM); 3 - AEBSF
(2mlVI); 4 - E-64 (lOpM); 5 - Pepstatin (lOpM). The prominent band at 37 
kDa
Further confirmation of metalloprotease activity in H. contortus L3 ES came 
from a metalloprotease specific assay (see Section 2.2.7). Metalloprotease 
activity was measured by the release of a 4-methoxy-2-napthylamine substrate 
following cleavage of an amino acid substrate between the alanine and 
phenylalanine residues. This was compared to a standard curve of fluorescence 
detectable by serial dilutions of 4-MNA (Figure 3.2.6). Some enzymatic 
activity, expressed as pM 4-MNA per pg protein per hour, was found in all ES, 
with the highest activity in 96 hr ES (Table 3.2.2). Notably, the levels of 
metalloprotease activity were far higher in EF and in the positive control, the 
metallo-endopeptidase containing H-gal-GP complex.
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Figure 3.2.6: The standard curve showing the fluorescent absorbance 
detected at A 425 nm of a diluted series (from 0.125 |jM to 8 pM) of 4- 
MNA standards
Table 3.2.1: The mean enzymatic activity of H. contortus L3 ES, EF and 
H-gal-GP (positive control) as a measure of the 4-MNA released when a 
metalloprotease cleaves a specific substrate. (Fluorescence +/- SEM)
Sample
24 hr
ES
48 hr
ES
72 hr
ES
96hr
ES
EF H-gal-
GP
Fluorescence 11.5 7.7 12 31 148 200
(A 425 nm) (4.2) (5.45) (1.28) (12) (1.8) (9.7)
4-MNA
concentration
1.36
tiM
1.17
tiM
1.41
tiM
2.38
tiM
8 tiM >8 tiM
Protein 
quantity (tig)
15 15 15 15 15 10
Enzymatic 
activity (piM 
4-MNA / tig 
protein / hour)
0.05 0.04 0.05 0.08 0.27 >0.40
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3.2.2 Lentil lectin affinity chromatography of H. contortus L3
ES
Previous reports have indicated that Lentil lectin binds specifically to an ASP-1 
homologue in H. contortus L3 ES (Sharp and Wagland, 1998). Therefore, 
attempts were made to identify this homologue by Western Blot and enrich for it 
by affinity chromatography. A Western blot of H. contortus L3 ES and somatic 
extracts, probed with biotinylated Lens culinaris lentil lectin identified several 
bands of reactivity in L3 ES that tended to become progressively more intense as 
culture time proceeded. The most intense region of reactivity was at 
approximately 40 kDa (Figure 3.2.7) and may represent the 40 kDa ASP-1 
homologue. This band appeared after 48 hours in culture and was most intense 
in the 72 hour and 120 hour cultures, the reason for the apparent decline in 
abundance in the 96 hour culture are unclear. Other prominent bands reacting 
with the lentil lectin included those at approximately 60 kDa and a smear at 
approximately 90- 120 kDa. These appeared after 72 hours in culture and
were most intense in the 120 hour culture. Strikingly, no prominent binding was 
detected in SI, S2 and S3 larval extracts produced immediately following 
exsheathing (Figure 3.2.7) and those produced from worms cultured for 96 hours 
(data not shown) implying the lectin binding proteins to be of a genuinely 
excreted/secreted nature.
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Figure 3.2.7: Western Blot of H. contortus larval ES proteins and
somatic extracts probed with biotinylated lentil lectin.
1 - 24hrES; 2 - 48hrES; 3 - 72hrES; 4 - 96hrES; 5 -120hrES; 6 - 81; 7 - 
82; 8 - 83.
To enrich for the lentil lectin binding proteins and in particular the putative 40 
kDa ASP-1 homologue, affinity chromatography of H. contortus L3 ES was 
carried out. A total of 2.5 mg of pooled 24-120 hr H. contortus L3 ES was 
applied to a chromatography column containing agarose-bound lentil lectin as 
described in Section 2.2.8, The bound and eluted protein fractions were clearly 
enriched for the lentil lectin-binding proteins, and the non-binding fraction 
exhibited no reactivity with lentil lectin as judged by SDS-PAGE gel and 
Western blot (Figure 3.2.8). Seven hundred and fifty pg of unbound protein and 
105 pg of bound protein were recovered following concentration (amounting to 
an approximately 3 fold loss of protein during the entire process). A band of 
protease activity, corresponding in size to the previously described 
metalloprotease, was visible only in the unbound fraction (Figure 3.2.9).
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Figure 3.2.8: A 10% SDS-PAGE profile of whole ES, lentil lectin binding 
ES, and unbound ES (Panel a). Panel b shows a Western blot of 
identical samples probed with biotinylated lentil lectin. Molecular weight 
standards are in kDa. Panel a: 1 - bound and eluted ES; 2 - unbound; 3 - 
unfractionated ES. Panel b: 1 - unfractionated ES; 2 - unbound ES; 3 - 
bound and eluted ES.
- 5 0
- 3 6
1 2
Figure 3.2.9: Substrate gel of unbound and bound fractions. 0.1%
gelatin substrate, 10% SDS PAGE gel showing protease activity in H. 
contortus larval ES unbound fraction. Molecular weights indicated in kDa. 
Arrow points to band of proteolysis in unbound ES.
1 -  unbound ES; 2 -  bound and eluted ES
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3.2.3 Attempts to seek A. caninum homologues by
immunoblot
Western blots of H. contortus ES and somatic extracts were screened with sera 
raised against some of the lead lai’val hookwoim vaccine candidates to attempt to 
identify potential homologues in H. contortus and to confirm the 40 kDa lectin 
binding protein as an ASP-1 homologue. Sera raised against the following E, 
coli expressed recombinant A. caninum proteins were kindly supplied by P. 
Hotez (HHVI); ASP-1, ASP-2, transthyretin-like protein (TTR) and the larval 
metalloprotease (MTP). Western blots were carried out with primary antibodies 
at a range of dilutions (from the recommended 1:4000 to 1:100) and developed 
using both DAB and the more sensitive ECL substrates (Section 2,2.6) (data not 
shown). Upon screening H. contortus whole ES, larval and adult extracts, an 
immune reaction was only observed using the TTR sera, which recognised a 
band at approximately 15 kDa, and more faintly at 60 kDa (see Chapter 6). 
Interestingly, the only sera to recognise a band in A, caninum L3 extract, a 
positive control kindly provided by P. Hotez (HHVI), was the ASP-1 sera, which 
very faintly labelled a band at 45 kDa (data not shown). A more accurate 
positive control of A. caninum L3 ES was unavailable. Due to the nature of the 
recombinant proteins, it may be that antibody raised against a potentially 
incorrectly folded E, co/Lexpressed protein would not cross-react with the native 
homologous protein.
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3.3 Discussion
Resumption of development from the quiescent environmental L3 to the parasitic 
nematode occurs in response to entry into the host, and the environmental 
changes therein (Rogers and Sommerville, 1968). In the case of H, contortus, 
entry to the host is by ingestion and the larvae exsheath in the rumen in response 
to various factors, likely to include an increase in temperature and exposure to 
CO2 and carbonic acid in the rumen prior to migration into the slightly acidic 
environment of the abomasum (Rogers and Sommerville, 1968). During or prior 
to the exsheathing process, L3 release a 44 kDa zinc-metalloprotease (Gamble et 
al. 1989a). Following exsheathment, L3 move from the rumen into the 
abomasum where they become closely associated with the gastric glands and 
develop into the blood feeding L4 by shedding their third stage cuticle (Urquhart 
et al., 1987). Initiation of exsheathing and culturing L3 through to the moult to 
L4s can be replicated in vitro and the proteins released by L3 following 
resumption of development attained from culture (Gamble and Mansfield, 1996; 
Shaip and Wagland, 1998).
The results reported here confiiTn the secretion of a range of proteins (Figure
3.2.1), including active proteases (Figure 3.2.2), during the exsheathing process 
with secretion or excretion of proteins being apparent for up to 120 hours. As 
indicated by Gamble and Mansfield (1996), the quantity and complexity of 
proteins released into culture increases with time, proteins released following 24 
or 48 hours in culture being barely detectable by Coomassie staining. After 72 
hours in culture, a range of proteins was visible including an active protease with 
a molecular weight of approximately 40 kDa. Interestingly, the quantity of 
protein produced by lai’vae in culture in this study was 5-fold less than reported 
by Gamble and Mansfield (1996). The difference in ES quantity is difficult to 
explain as the exsheathing and culture methods were very similar, but may be 
due to a difference in H. contortus strains used (an American Belts ville strain 
versus the MOSI strain used in this study). There have been several reports of 
variation in the activity and character of adult gut-associated and ES proteases 
between different strains (Redmond and Windham, 2005; Karanu et at., 1997); 
however there are no publications detailing a difference in the actual quantity of
111
proteins released. Throughout the culture period, worms remained viable and no 
physical deterioration was visible. Indeed, Gamble and Mansfield (1996) 
demonstrated that L3 maintained in culture for 96 hours remain infective to 
sheep.
The MTP (Figure 3.2.4) activity that appeared in ES after 72 hours (Figure 
3.2.2) in culture is likely to be similai' to that which was characterised, but as yet 
unidentified, by Gamble et a l in 1996 in that it appears at the same time point in 
culture has a pH optima of 8 and is of an approximately similar molecular weight 
(Figure 3.2,3). The difference in observed estimated size of the ES MTP in this 
report (approximately 40 kDa) and that of the previously reported ES MTP (46 
kDa) is likely due to the substrate gels in this study necessitating the 
electrophoresis of proteins under non-reducing conditions. Because of the non­
reduced nature of the protein, it may run slightly faster in comparison with the 
already reduced molecular standard. This had been reported for other H. 
contortus proteins (Dr G. Newlands, personal communication).
Gamble et a l (1996) proposed that the ES MTP is released coincidentally with 
the molt from the L3 to the L4. This molt corresponds with the onset of feeding 
of larvae in culture and the general increase in proteins released by the larvae as 
ES (Gamble and Mansfield, 1996). During the cultures canied out in this study, 
most larvae did not appear, by visual inspection, to have developed to the L4, 
even after 120 hours; similar findings have been reported by other groups (C. 
Britton, personal communication). Although no feeding assay was carried out, 
larvae at all culture time points were evaluated for development to the fourth 
stage visually by an expert in the field (D. Bartley, Moredun Research Institute). 
The reason for the apparent lack of development to L4 is unknown and may be 
due to the different strains of worm involved. However it does question the 
theory that secretion of significant amounts of protein and appearance of the 
MTP occur coincident with the third moult and transition to the fourth larval 
stage (Gamble et al, 1996). It might be that the metalloprotease described, or 
other unidentified pro teases, are involved in an early step in the L3 to L4 moult 
but that other later factors essential for completion of the moult do not occur. It
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is also possible that the small numbers of worms that successfully moult to L4 
are releasing the protease although this seems unlikely.
MTP activity was much higher in EF compared to the ES timepoints (Table
3.2.1), the levels of the latter remaining relatively constant throughout the culture 
period, despite the observed appearance of MTP activity after 72 hours in 
culture. As noted earlier, a 44kDa EF MTP has been implicated in larval 
exsheathment (Gamble et a l, 1989) and the relatively high levels of activity 
detected in EF compared to ES could reflect the synchronous release of enzyme 
induced by the exsheathing process. Alternatively, the EF and ES MTPs may be 
distinct enzymes as suggested by studies by Gamble et a l (1989) and Gamble et 
al, (1996) where the enzymes had slightly differing molecular weights of 44 kDa 
and 46 kDa in EF and ES respectively. The results described here also suggest 
the EF and ES MTPs to have different molecular weights (37 kDa versus 40 
kDa); in combination with the temporal expression patterns this does suggest the 
enzymes to be distinct. This leads to the possibility that the enzymes have 
differing substrate specificities with the result that the EF enzyme cleaves the 
assay substrate used here more efficiently than its ES counterpart. This 
possibility could be addressed by a detailed substrate preference comparison of 
the purified EF and ES enzymes and, ultimately, by analysing the genes encoding 
them. In C. elegans there is a gene family of 39 astacin-like MTPs, one of which 
(NAS-37) has been demonstrated to be important in ecdysis, and can actually 
mediate refractile ring formation in H. contortus (Davis et al, 2004). This 
suggests that there aie likely to be a number of astacin-like MTPs with distinct 
functions.
No protease activity was detected by substrate PAGE analysis of L3 extract made 
following exsheathing, and no activity is reported in L4 extract by Gamble and 
Mansfield (1996). This would indicate that at least some of the proteins within 
the ES are genuinely secreted, the proteins being processed to yield active 
enzyme during secretion, and not products of larval degradation during in vitro 
culture.
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Contrary to expectations, sera raised against A. caninum ASP-1, ASP-2 and MTP 
failed to cross-react with H. contortus larval ES, lai'val extract or adult extract. 
This meant that the A. caninum sera could not be used to identify and localise the 
homologues in H. contortus. Interestingly, the sera, with the exception of the 
ASP-1, failed to cross-react with proteins in the provided positive control A. 
caninum L3 extract. The ASP-1 sera did recognise a protein in the A. caninum 
extract, but this was very faint. This result might question the quality of the sera 
following trans-Atlantic transport, although a better positive control would have 
been A. caninum L3 ES. The results of the TTR labelling are discussed in 
Chapter 6.
Glycosylated nematode proteins are very immunogenic with the carbohydrate 
component being particularly immunogenic. Indeed it has been proposed that a 
substantial part of the host immune response to H. contortus is likely to be 
directed against carbohydrate epitopes on parasite antigens (Schallig and Van 
Leeuwen, 1996). The protective gut-associated antigen complexes isolated from 
H. contortus [TSBP (Knox et al, 1999), H-Gal-GP (Smith et a l, 1994) and H ll 
(Munn et al, 1997)] are heavily glycosylated with the glycan being highly 
immunogenic. Glycoproteins are normally found in the plasma membrane, are 
extracellular proteins (as in the case of the gut associated-complexes) or secreted, 
like those found in ES. Adult ES contain several N-linked glycoproteins that 
afford significant protection against homologous challenge (Schallig and Van 
Leeuwen, 1997).
Lectin-binding studies carried out to investigate the carbohydrate moieties in H, 
contortus extracts showed several lectins to bind to a variety of glycoproteins in 
both adult and L3 soluble extract (Schallig et al, 1996). Lentil lectin is specific 
for terminal a-D-mannosyl and a-D-glucosyl residues and has been reported to 
specifically enrich H. contortus L3 ES for the 40 kDa larval ASP-1 homologue 
(Sharp and Wagland, 1998). In this study, lentil lectin reacted strongly with 
glycoproteins in the region of 40 kDa, which appeared in L3 ES after 48 hours 
and tended to increase in intensity as culture time progressed (Figure 3.2.6). 
This protein is in the appropriate size region to be the larval ASP-1 homologue. 
No such protein was detected in L3 extracts made either before or after culture,
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indicating that the 40 kDa protein is of a genuinely ES nature, and is transcribed 
and released quickly, rather than stored by the woi*ms prior to secretion.
Lentil lectin-affinity chromatography allows fractionation of whole ES into a 
lentil lectin-binding and a non-binding fraction. This cleaiiy enriched for the 
protein/s at 40 kDa, but also for the other proteins (Figure 3,2.7). With the 
exception of 40 kDa proteins that might be the putative ASP-1 homologue, the 
identification of the proteins within the bound or unbound fractions remains 
unknown; although it would appear that the MTP activity partitions with the 
unbound fraction (Figure 3.2.8). Previous reports (Sharp and Wagland, 1998) 
suggest that lentil lectin chromatography enriches for only the 40kDa protein, 
however this does not seem the case in this study. This result has implications 
for the interpretation of vaccine trial outcomes with reference to selecting 
protective proteins for recombinant expression.
In summary, upon exsheathing and culture, H, contortus L3 release a range of 
proteins, including pro teases, that increase in both quantity and complexity as 
culture time persists. Despite earlier reports to the contrary, in this study L3 
larvae did not molt to the fourth stage; however, they did release into culture 
proteins that have been previously associated with this moult and the resumption 
of feeding, including a metalloprotease. Probing L3 ES with lentil lectin 
confirmed strong binding to a protein or proteins with a molecular weight of 
approximately 40 kDa. This may include the ASP-1 homologue, and lentil lectin 
affinity chromatography allowed partial purification and enrichment of these 
proteins.
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Chapter 4 
Sheep Protection Trial
4.1 Introduction
Vaccination with irradiated H. contortus and A. caninum larvae can achieve high 
levels of protection against homologous challenge (Smith and Angus, 1980; 
Miller, 1965). However, attempted vaccination with H. contortus somatic larval 
antigens failed to induce immunity in sheep (Smith, 1977); yet, as vaccination 
with in'adiated larvae induces immunity, it is likely L3 and possibly L4 secrete 
proteins that can elicit immunity. Indeed, metabolites secreted by H. contortus 
during the molt from L3 to L4 were effective immunogens in sheep (Ozerol and 
Silverman, 1970) although no attempt was made to isolate the protective 
component(s).
Hookworm L3, on transition to parasitism, release a number of developmentally 
regulated proteins, several of which have been identified as vaccine candidate 
antigens (see Chapter 1). Protection trials with hookworm antigens have been 
carried out using recombinant proteins and some of the most promising antigens 
identified to date include members of the ASP family, ASP-1 and ASP-2 (Hotez 
et al, 2003). H. contortus 13 release a single domain ASP-1 homologue into ES 
and this can be partially purified by lentil lectin chromatography and has been 
shown to confer protection against homologous challenge in guinea pigs (Sharp 
and Wagland, 1998). Several other hookworm candidate larval antigens are 
likely to have homologues in H. contortus, including the hookworm larval MTP; 
MTP activity in H, contortus ES has been reported previously (Gamble et al. 
1997) and confiimed in Chapter 3. It would be of benefit to evaluate the 
protective potential of L3 H. contortus ES components in a sheep vaccine trial. 
Adult H. contortus ES components do induce protective immune responses 
(summarised in Knox, 2000), but similar trials with L3 ES have not been 
reported.
This chapter describes a sheep vaccine trial to evaluate the protective efficacy of 
H. contortus L3 ES fractions with the aim of indicating the worth of the native 
proteins therein as potential vaccine candidates. L3 ES were harvested and 
subsequently fractionated into lentil lectin-binding [potentially enriched for the
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ASP-1 homologue (Sharp and Wagland, 1998)] and unbound fractions, 
containing MTP activity, these fractions being used as immunogens in the 
protection trial. The trial design and execution were described in Chapter 2 and 
the peptide content of the immunogens described in Chapter 3.
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4.2 Results
4.2.1 Serological response to vaccination
The vaccine trial was earned out as described in Chapter 2. Briefly 3 groups of 
7 animals were vaccinated on 3 occasions 21 days apart intramuscularly with 
either 5 pg of the lentil-lectin binding ES fraction plus Quil A (bound group), 35 
pg of the non-binding lentil lectin ES fraction plus Quil A (unbound group) or 
Quil A in PBS (Control group). One week following the final immunisation 
animals were challenged with a single dose of 5,000 L3 H. contortus.
To examine the serological antibody response to immunogens, sera was collected 
(as described in Section 2.8.1 prior to initial vaccination and 1 week post the 
third and final immunisation) and used in ELISA and Western blot analyses. All 
sheep in both the unbound and the bound vaccine groups had a significant 
(jP<0.01, data not shown) circulating IgG response to whole ES (Table 4.2.1). 
The response varied between individuals with an approximate 3-fold difference 
between the highest and lowest responders. The vaiiation in IgE analysis was 
much more pronounced both within and between groups (Table 4.2,2). Animals 
vaccinated with the bound ES fraction showed only a very low IgE response, the 
group mean of which was not statistically different to the control group (data not 
shown). All sheep in the unbound group, except animal 2, had a significant 
(P<0.01, data not shown) circulating IgE response. Both ELISA analyses and 
Western blot analyses were earned out using whole ES, rather than the 
appropriate fraction that animals received during the vaccine trial, due to the 
difficulty in obtaining large amounts of protein.
As can be seen from the ELISA data (Tables 4.2.1 and 4.2.2), those animals 
vaccinated with the unbound fraction generally had a higher total IgG and IgE 
titre than those vaccinated with the bound fraction. Western blots of whole ES 
probed with pooled pre-vaccinate sera from either group showed only a very 
faint reaction with the ES, likely to be due to non-specific binding (Figure
4.2.1). With pooled sera from the unbound vaccinate group, the intensity of 
staining increased with ES culture time, reflecting the increasing quantity and
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perhaps complexity of proteins released into culture over time (Figure 4.2.1A). 
Twenty four hour ES was strongly recognised by anti serum from the unbound 
vaccinate group, despite the fact that ES proteins are barely visible following 
staining of protein gels (Chapter 3, Figure 3.2.1). There was particularly 
pronounced recognition of a peptide at -48 kDa, also seen in 48 hour ES. Other 
peptides that were prominently recognised in later time point ES included those 
at 33, 47, 50, -60, 93 and -100 kDa. Western blot analysis of whole ES probed 
with pooled vaccinated sera from the bound group (Figure 4,2.IB) demonstrated 
a distinct pattern of recognition compared with the unbound group sera. Again 
the complexity of peptides recognised increased with culture time of ES with 
peptides at 36, 50, -60, -95 and -130 kDa being recognised most strongly by the 
antiserum. As seen in the lentil lectin binding profile (Chapter 3, Figure 3.2.7), 
a protein coiresponding in size with the putative ASP-1 homologue, (Sharp and 
Wagland, 1998) at approximately 40 kDa was recognised by bound antisera in 72 
hour and later time point ES cultures, however this band is not particularly 
prominent. Periodate treatment of blots prior to antibody probing reduced the 
number of bands recognised by both unbound and bound sera, indicating that a 
proportion of the antibody was directed against caitohydrate epitopes (Figure
4.2.2), Reduction of reactivity was more pronounced with sera from animals 
vaccinated with the bound fraction, perhaps not unexpectedly as this fraction was 
enriched for glycoproteins. However, this treatment revealed three peptides 
(-42 kDa, 60 kDa and 98 kDa) which were distinctly recognised by the bound 
sera although antigens of similar size were also recognised in the unbound 
fraction.
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Table 4.2.1: Total IgG analysis from individual animals following 
vaccination with either the bound or unbound antigen. IgG values are 
expressed as the dilution factor required to obtain the mean of the group 
pre-immune serum values at a dilution of 1:1280. * The mean was
calculated using the value of 104,200 where appropriate; the real mean 
would likely be higher.
Group Bound Unbound
Animal
No.
IgG Titre IgG Titre
1 36,272 65,021
2 69,581 91,532
3 40,433 >104,200
4 68,615 92,742
5 18,263 >104,200
6 23,581 >104,200
7 19,543 >104,200
Mean 39,470 95,156*
Table 4.2.2: IgE analysis from individual animals following vaccination 
with either the bound or unbound antigen. IgE titres are expressed as the 
dilution factor required to obtain the mean of the group pre-immune 
serum values at a dilution of 1:20. * The mean was calculated using the 
value of 20,480 where appropriate; the real mean would likely be higher.
Group Bound Unbound
Animal
No.
IgE Titre IgE Titre
1 1227 6012
2 11 918
3 187 >20,480
4 2448 7301
5 46 >20,480
6 262 >20,480
7 192 >20,480
Mean 624 13,736*
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Figure 4.2.1: Western blots of whole ES probed with 1:1000 diltuion of 
pooled pre-vaccinate or vaccinate sera from unbound group (panel A); 
and bound group (panel B). An HRP labelled rabbit anti-sheep IgG 
secondary antibody (1:1000) detected the sheep total IgG. The arrow in 
B marks peptide at 40 kDa recognised by antibody. Lane 6 shows silver 
stained 10% SDS PAGE profile of the appropriate ES fraction animals 
were vaccinated with alongside the Mr markers appropriate for this gel 
(see also Figure 3.2.8).
Culture time of ES: 1 - 24 hr; 2 - 48 hr; 3 - 72 hr; 4 - 96 hr; 5 - 120 hr; 6 -  
ES fraction used as immunogen.
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Figure 4.2.2: Periodate treated Western blots of whole ES probed with 
1:1000 pooled vaccinate sera from unbound group (panel A); and bound 
group (panel B).
Culture time of ES: 1 - 24 hr; 2 - 48 hr; 3 - 72 hr; 4 - 96 hr; 5 -120  hr.
4.2.2 Levels of protection
To quantify any protective affect of vaccination, individual animal FEC were 
made during the trial; at the end point animals were sacrificed and final adult 
worm burdens enumerated, male to female ratios established and a sub-sample of 
worms measured (as described in Sections 2.8.2 and 2.8.3). The FEC for the 
trial are plotted as group means in Figure 4.2.3. Although not found to be 
statistically significant by one way analysis of variance (ÀNOFÀ), there was a 
clear trend towards reduced egg output compared with the adjuvant alone control 
group in both vaccinate groups. Cumulative FEC was reduced by 10% for the 
bound group and 17% for the unbound group.
123
11000
10000
9000
^  8000 
§™ 7000
S« 6000
u. 5000aII 40003000
2000
1000
17 20 22 24 27 29 31 34 36
adjuvant —• —bound —A—unboun(^ Infection
Figure 4.2.3: Mean group faecal egg counts plotted against day post 
infection. Standard error of mean (SEM) is shown by error bars above 
and below each point.
Mean cumulative egg counts and final adult worm burdens for the individual 
animals in each group are summarized in Table 4,2.2. Lambs immunised with 
the bound and unbound fractions had reduced group mean final worm burdens of 
16% (P<0.01) and 12% (not found to be statistically significant by one way 
ANOVA) respectively, when compared to the control group.
In vaccinated groups the male to female ratio (m:f) did not differ significantly 
from that of the control (control 45:55; bound 43:57; unbound 43:57). Despite 
there being no effect on the length of surviving male worms in either of the 
groups, there was a small, yet statistically significant reduction in female worm 
size in the bound group (mean length of 19.89 mm SEM +/-0.18, n=50).
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amounting to a decrease of 6.2%, compared with the controls (21.20 mm SEM 
+/-0.18, n=50 P<0.01 by one way ANOVA). To investigate a potential affect of 
vaccination on the capability of eggs to hatch successfully an egg hatch assay 
was earned out (Section 2.8.4). The viability of eggs, evaluated by egg hatch 
assay on days 20, 22, 29 and 36 post-challenge, was >80% at all time points with 
no statistical differences between the viability of eggs from control and 
vaccinated animals were observed (Table 4.2.4).
Table 4.2.3: Individual animal mean FEC and abomasal worm counts. 
Reductions in egg counts and worm counts are expressed as a 
percentage reduction compared to the control, adjuvant group. SEM is 
shown. One-way ANOVA P values are reported on cumulative group 
means following logio transformation of data. * marks a statistical 
significance of P<0.05
Group Unbound Bound
Animal FEC Adult FEC Adult FEC Adult
Number counts counts counts
1 4129 3800 3610 4500 2218 3800
2 3631 4550 2797 3000 3320 3050
3 2467 4450 5984 4850 1239 3800
4 3126 4350 3815 3050 8711 4350
5 5707 5700 2474 4500 6027 4700
6 3773 4100 2686 4000 2707 3750
7 7257 5350 3675 4500 2734 3650
Mean 4299 4614 3577 4057 3851 3871
S.E.M. 621 256 449 283 984 199
Reduction n/a n/a 17 12 10 16'''
(%) (P=0.47) (P=0.08) (P=0.46) (P=O.OI).
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Table 4.2.4: Egg viability assay. Percentage of eggs that hatched 
following collection from individual animals on days 20 to 36 post 
challenge, expressed as a group mean +/- SEM.
Group Percentage of eggs that hatched (+/-S.E.M)
Day 20 Day 22 Day 29 Day 36
Control 88 (+7-2.6) 97 (+7-0.9) 99 (+7-0.6) 98 (+7-1.2)
Unbound 96 (+7-1.4 ) 98 (+7-0.7) 98 (+7-0.6) 95 (+7-1.9)
Bound 89 (+7-6.9) 96 (+7-1.4) 97 (+7-1.0) 95 (+7-2.4)
4.2.3 Direct challenge assay
To establish whether sera from vaccinated animals could inhibit larval 
establishment within the abomasal tissue, a direct challenge assay was earned out 
as described in Section 2.10. ExL3 were pre-incubated with PBS alone, pooled 
pre-vaccinate, bound or unbound vaccinate sera, and their ability to penetrate 
abomasal tissue in vitro evaluated. The results are summarised in Table 4.2.5. 
The percentage of the larval population that were tissue associated was 
calculated using the formula:
N o. o f  L3 in d igest
P ercen t tissue associated  L3
T otal N o. o f L3 in 
w ashes + digest
X 100
While pre-incubation with bound sera was without effect, worthy of note is that 
pre-incubation with unbound vaccinate sera resulted in a highly significantly 
lower percentage of tissue associated larvae compared to pre-vaccinate sera 
(mean of 64% versus 79%, jP=0.001 by chi-square test on original counts).
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Table 4.2.5: The worm counts in a 2% sub-sample of washes or digests 
(tissue associated) from abomasa! tissue chaiienged in vitro with H. 
contortus ExL3 foliowing pre-incubation with sera. Mean percentage of 
L3 that were tissue associated are reported with the SEM, n=3 in each 
sample. * marks statistically significant result compared to the pre­
vaccinate control group (P=0.001 by chi-square test on count data).
^Îveatm^^
L3 in Washes
Tissue 
associated L3
Total L3 
recovered
Mean 
% Tissue 
associated
Pre­ 19 68 87
vaccinate 17 47 64 79%
sera 11 58 69 (+A3.1)
28 37 65
Unbound 16 28 44 649b*
sera 22 54 76 (+/- 4.1)
12 72 84
Bound sera 6 56 62 87%
9 48 57 (+/-1.8)
41 55 96
PBS (no 26 33 59 60%
sera) 37 68 105 (+/- 2.7)
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4.3 Discussion
This chapter described the outcome of a protection trial where lambs were 
immunised with L3 ES fractions prepared by lentil lectin chromatography. 
Antigens binding to this matrix included the 40 kDa likely ASP-1 homologue 
while the MTP homologue did not bind (see Chapter 3). The trial had two 
puiposes; 1) to repeat the purification protocols described in Sharp and Wagland, 
(1998) and to evaluate the protective efficacies of the fractions in sheep 
(previously only guinea pig trials had been carried out) and 2) to attempt to 
provide an indication as the whether the ASP-1 homologue or the MTP, 
partitioning in the bound and unbound fractions respectively, or both may be 
involved in inducing protective immunity. The results provided some evidence 
that vaccination with either lentil lectin-binding, or non-binding fractions of H. 
contortus L3 ES can promote a modest level of protection against homologous 
challenge as judged by a reduction in final worm burdens and a clear trend 
towards reduced egg production. Vaccination with the bound fraction resulted in 
a small reduction in female worm length while an intriguing observation was that 
sera from animals vaccinated with the unbound fraction containing the MTP 
inhibited in vitro larval penetration of abomasal tissue.
There was a trend towards lower egg counts in both the bound and unbound 
groups amounting to an overall reduction of 10% and 17% respectively, although 
this was not statistically significant. Worthy of note is the pattern of reduction in 
egg counts in the bound group between days 24 and 29 post-challenge and to a 
greater extent in the unbound group between days 24 and 31. This might 
correspond to a delay in maturation of larvae to adult, or to a postponement of 
egg production by the adult female worms. A similar EEC pattern, during the 
equivalent time points, was observed by Redmond and Knox (2004) following 
vaccination with a cysteine protease fraction and the corresponding recombinant 
proteins. In the UK, H, contortus has been reported to undergo a hypobiosis at 
the early L4 stage, though the trigger for this is unknown. It may be speculated 
that some factor of an immune response, stimulated through vaccination, might 
have delayed the onset of development to the gravid adult stage, though this
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would require extensive further investigation. A feature of this study, and many 
other studies investigating the protective potential of nematode extracts or ES, is 
the large variability between animals in the same group in terms of egg count and 
woiTn burden. This does complicate interpretation of results and often makes it 
difficult to define statistically significant differences, particularly with relatively 
crude antigen extracts (D.P, Knox, personal communication).
Both vaccinated groups showed a reduction in abomasal worm count, the 
reduction of 16% in the bound group being statistically significant. Also of note 
was the detected 6% reduction in mean female worm length in this group. As 
discussed in Chapter 3, and above, lentil lectin binding purportedly enriches H. 
contortus L3 ES for a single domain ASP-1 homologue, larval Hc40 (Sharp and 
Wagland, 1998), Several vaccination studies with recombinant hookworm ASP- 
1 and ASP-2 have been earned out in a variety of model systems. Bacterially 
expressed recombinant A. caninum ASP-1 in the murine model reduced lung 
worm burden by up to 57% and this protection could be passively transfeired 
with antibody (Ghosh et ai, 1996; Ghosh and Hotez, 1999). However, the 
mouse is a non-peiTnissive host, and the relevance of a reduction in lung worm 
burden to a natural infection is unknown, though the antibody mediated nature of 
protection does indicate ASP-1 as a potential vaccine candidate. Vaccination 
with Pichia pas'rom-expressed recombinant A. ceylanicum ASP-1 in the hamster 
model (permissive) had no effect on woim burden (Goud et al, 2004), though P. 
pa.storâ-expressed N. americanus ASP-1 showed a trend towards a reduction in 
egg counts in vaccinated dogs challenged with A. caninum (Hotez et al, 2003 
HHVI 3'  ^ Annual Report). ASP-2 has shown slightly more promise in vaccine 
trials; levels of protection conesponding to a 32% reduction in worm burden and 
56% reduction in egg count have been achieved using P. pa^^orA-expressed A. 
ceylanicum protein in the permissive hamster model (Mendez et al, 2005). 
Results have been more variable in dogs, with protection using P. pastoris- 
expressed Ac-ASP-2 ranging from an 8% to 47% reduction in worm burden, 
with a similar inconsistency in egg counts (Hotez et al, 2003 HHVI 3'  ^ Annual 
Report).
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Reductions in female worm lengths induced by vaccination are common 
observations, particularly with vaccines targeting digestive processes, for 
example gut associated cysteine proteases (Redmond and Knox, 2004). In this 
situation, it is thought female worm growth and egg production are compromised 
by nutrient depletion, the latter imposing a considerable metabolic burden on 
female worms which is not experienced by the males. A similar level of size 
reduction in adult worms to that found in this study has been reported in A. 
ceylanicum recovered from hamsters vaccinated with ASP-2 (Goud et al, 2004). 
This is also similar to the significant reduction in length (10%) of female H. 
contortus indueed by previous infection of sheep with Oestrus ovis (Terefe et al, 
2005). The authors explain this phenomenon by the enhanced recruitment of 
activated inflammatory cells.
Pre-incubation of H. contortus ExL3 with neat sera from the group vaccinated 
with the unbound fraction significantly reduced the penetration and 
establishment of larvae in explanted abomasal tissue compared with L3 
incubated in pre-vaccinate sera. The addition of sera generally increased the 
percentage of larvae becoming tissue associated, possibly reflecting activation of 
the larvae in coming into contact with host fluids. In vitro bioassays have been 
used to investigate the effect of mucous from immune cattle on O. ostertagi 
larval migration (Claerebout et al, 1999); the authors reported that both mucous 
and sera from partially immune cattle contain larval migration inhibitory activity. 
The results reported here are the first to use an abomasal in vitro direct challenge 
assay to assess the effect of pre-incubation of larvae with sera on larval 
establishment. The level of reduction fell short of the levels seen when 
incubating T. circumcincta L3 with abomasal explants from immune animals; of 
course in this case the tissue will contain local antibody and immune cells primed 
by previous infection (Jackson et al, 2004). Nonetheless, the level of reduction 
in larval establishment is similar to the level of larval migration inhibition 
immune sera had on O. ostertagi L3 in comparison to naive sera (Claerebout et 
al, 1999). Also worth noting is that the larval establishment is reduced by 
unbound sera compared to not only pre-vaccinate control sera but also to bound 
vaccinate sera. In analogous experiments with hookworm larvae, incubation 
with sera from dogs vaccinated with in*adiated L3 (Fujiwara et al, 2005),
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AcASP-2 or AcMTP (Williamson et al, 2006) reduced skin penetration by up to 
60%; it is noteworthy that the H, contortus MTP activity partitions with the 
unbound fraction. Perhaps, immune inhibition of the MTP prevents larval 
penetration of the abomasal glands?
The protection achieved was considerably lower than that reported in a similar 
study where the protective efficacy of similar sub-fractions of L3 ES proteins 
were evaluated using a guinea pig model (Shaip and Wagland, 1998). These 
authors reported levels of protection of up to 85% as judged by worm numbers 
although the statistical significance was not reported. Also, the guinea pig is an 
unnatural and non permissive host for H, contortus (worms do not develop to 
adults, Wagland et al, 1989) and as such is far from ideal as a vaccine model. 
Computer modelling predicts that a vaccine which stimulates 60% protection in 
80% of the flock on the basis of wonn burdens would provide effective control in 
the field (Barnes et al, 1995). Against this background, it is clear that the L3 
lentil lectin affinity binding fraction tested here would be an ineffective vaccine. 
Future work could focus on further purifying ES components in an attempt to 
more closely define the proteins responsible for the protection observed here. It 
is possible that only trace amounts of the actual protective protein were actually 
injected here and that increasing this may increase the magnitude of the 
protective immune response. It is also possible that 2 or more protective 
components that might act in a synergistic manner in whole ES partition into 
different lectin chromatography fractions.
Animals vaccinated with bound or unbound material showed a strong IgG 
response with those animals vaccinated with the unbound fraction having a 
higher titre (at least a 2-fold higher mean titre) than those vaccinated with the 
bound fraction. Animals vaccinated with the unbound fraction also showed a 
strong IgE response whereas those vaccinated with the bound fraction did not, 
These results aie most likely explained by the fact that animals vaccinated with 
the unbound fraction received 7 times the quantity of protein than those 
vaccinated with the bound fraction. However, previous vaccine trials using 
Haemonchus have resulted in a protective effect using less than 3 pg of antigen 
(Redmond and Knox, 2004); in this trial, animals vaccinated with the bound and
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unbound fractions received 5 pg and 35 pg protein per immunisation 
respectively. Circulating antibody titres have been closely con'elated with 
successful immunisation against Haemonchus using gut-expressed antigens 
(Smith et al, 1994; Smith et a l, 1996). Here, there was no correlation between 
circulating IgG or IgE levels and egg counts or wonn counts. This may simply 
reflect the small differences in the parasitological parameters observed when 
vaccinates were compared to controls as well as the small number of animals 
used in the trial. However, it is worth noting that vaccination studies using a 
Thiol Sepharose-binding fraction of adult ES (Bakker et al, 2004) and a purified 
larval surface antigen (Jacobs et al, 1999) found no con elation between 
circulating or mucus antibody levels and protection.
Vaccination with the adult H, contortus ES proteins He 15 and Hc24 (an ASP-2 
homologue) promoted good levels of protection with 70 and 99% reduction in 
EEC and worni count, respectively (Schallig and Van Leeuwen, 1997; Schallig et 
al, 1997; Kooyman et al, 2000). Again vaccination was accompanied with a 
general increase in total IgG levels but no correlation with protection was found. 
Of interest though is that protection with this fraction in lambs is, when age is 
controlled for, correlated with IgE, not IgGl (Kooyman et al, 2000). This, 
combined with the increase seen in abomasal eosinophil and mast cell 
infiltration, led the authors to suggest that vaccination with ES proteins mimics a 
natural immunity with the hallmarks of a Th2 response. These studies suggest 
that the local immune response may play an important role. The present study 
could be extended to analyse other circulating antibody isotypes and those found 
at the abomasal surface as well as examining the cellular response to vaccination. 
In other vaccination studies which used QuilA as adjuvant, significant local 
antibody and cellular responses were observed (Redmond and Knox, 2004; 
Geldhof et al, 2002).
Western blot analysis with vaccinate sera from individual animals (data not 
shown) and pooled sera from each group (Figure 4.2.1) demonstrated that a 
variety of whole ES antigens were recognised following vaccination with either 
the bound or unbound ES fractions. The antigens that were strongly recognised 
with antisera were not necessarily the most prominent on a peptide profile of the
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immunogen used; a greater variety of proteins were recognised by the sera than 
were visible on SDS-PAGE profiles of ES (compare Figures 4.2.1 and 3.2.1). 
Some parallels could be drawn between areas of highest immunogenicity when 
probed with the bound sera and proteins most visible in the lectin binding profile 
at -60 kDa and 98 kDa (Figure 3.2.7), although it is notable that the highly 
lentil lectin reactive -40 kDa protein was only weakly recognised by bound sera. 
The proteins most highly recognised by the unbound sera are not visible in the 
unbound immunogen, however a protein at -33 kDa is visible in later ES protein 
profiles (see Figure 3.2.1). The bulk of the bound and unbound sera reactivity 
was abolished by periodate treatment (Figure 4.2.2), a treatment which oxidises 
carbohydrate epitopes (Woodward et a l, 1985). Clearly, the glycan components 
of L3 ES are highly immunogenic. Periodate treatment did reveal that a limited 
number of ES peptides was recognised by the pooled sera of both groups and, 
somewhat surprisingly, that the prominent immunogenic peptides in each 
fraction were similar in size (Figure 4.2.2). Peptides at -40 kDa, 60 kDa and 98 
kDa were recognised by sera from both groups, although the 40 kDa ASP 
homologue was expected to partition in the bound fraction (Sharp and Wagland, 
1998). Of course these antigens could have the same molecular weight but be 
distinct and unrelated proteins. This could be clarified by undertaking a 
proteomic-based analysis of each extract. Moreover, the recognition profile of 
the unbound vaccinate group did differ from the bound with, for example, 
peptides between 22 and 31 kDa and above 98 kDa being recognised by sera 
from the unbound vaccinate group only.
In this study, a systemic immunisation regime, injecting the antigen intra­
muscularly with the saponin adjuvant Quil A, was chosen. This protocol has 
been used successfully in several vaccine trials against H, contortus (Knox et ai, 
1999; Redmond and Knox, 2004; Bakker et a l, 2004; Geldhof et al, 2003) and 
Quil A is a commercially acceptable adjuvant (Cox and Coulter, 1997). Quil A 
induces both a Thl and Th2 type response, associated with induction of 
circulating IgG (Cox and Coulter, 1997). As it is likely that the naturally 
protective response is Th2, inducing a Th2 response using an alternative adjuvant 
may increase protection with natural antigens (Geldhof et al, 2004). It was 
previously found that sheep immunised with a larval surface antigen in Quil A
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were not protected, however when immunised with the same antigen in a Th2 
only inducing adjuvant (aluminium hydroxide) sheep were significantly 
protected (Jacobs et al, 1999). However, Geldhof et a l (2004) found that 
protection against O. ostertagi in calves induced by vaccination with a subset of 
adult ES proteins using Quil A as adjuvant was not repeatable when antigen was 
delivered with aluminium hydroxide. It is quite possible that by switching 
adjuvant, protection levels using the bound (or unbound) fraction could be 
increased considerably.
A further feature of the vaccine trial was the single challenge dose of 5,000 H. 
contortus L3. Though routinely used for testing adult antigens it is perhaps not 
the best vaccination strategy for testing larval antigens as it may overwhelm the 
naive animal with a high one-off dose, though it should be pointed out that a dose 
in this region or even higher may be expected during the high transmission 
season in the tropics. A trickle infection might be more suitable as in this study 
(using larval antigens), antibody/cells primed by vaccination will only target 
developing larvae; by the time worms have developed into adults the vaccine 
may not work. However as a vaccine evaluation strategy this would have 
drawbacks; it would be very difficult to distinguish between any potentially 
protective effects of the vaccine as opposed to an acquirement of immunity from 
the trickle infection, which has been demonstrated in H. contortus (Emery et al, 
2000).
Because of the lack of availability of the native protein, ASP vaccine trials in 
hookwomns have relied upon the use of recombinant proteins; the relatively low 
levels of protection may well be due to the recombinant proteins not performing 
as the native protein would. Trials using protein fractions enriched for ASP 
homologues in either H. contortus (He24, Schallig and Van Leeuwen, 1997; 
Schallig et al, 1997; Kooyman et al, 2000) or O. ostertagi (Geldhof et al, 2003) 
have achieved much higher levels of protection. In the fomner study, the He 24 
enriched ES fraction provided a far higher degree of protection than whole ES. 
In the latter, a fraction enriched for O. ostertagi ASPs protected calves against 
homologous challenge with a 60% reduction in egg count and a 16% reduction in 
worm burden. Interestingly, the ASP homologues identified in this fraction were
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single domain, like the hookworm ASP-2, but showed homology to the N- 
teiminal of hookworm ASP-1, reminiscent of the H, contortus larval Hc40 ASP- 
1 homologue (Geldhof et ai, 2003; see Chapter 5). Assuming the bound 
fraction is enriched for the L3 H. contortus ASP-1 homologue, the results 
reported here add to the evidence that native nematode fractions, enriched for 
ASP homologues, can confer significant protection; thus confirming the status of 
ASPs as lead hookwoiTn specifically, and nematode generally, vaccine 
candidates. In this study, alternative adjuvant formulation and further
fractionation might increase the protective efficacy of the lentil lectin-bound and 
unbound fractions. It is likely that the H. contortus larval ES also contains other 
homologues of hookworm vaccine candidates (for example, MTP activity has 
been identified, yet the protein responsible remains unknown) thus further 
fractionation and identification of some of these antigens would allow more 
evaluation of their potential efficacy.
In summary, vaccination with a non lentil lectin-binding fraction of H. contortus 
L3 ES resulted in a reduced EEC and final worm burden that, whilst not 
statistically significant, was lower than the adjuvant control group and pre­
incubation of L3 with vaccinate sera significantly reduced larval establishment in 
an in vitro assay. The reduced egg count, significantly reduced adult wonn 
burden and reduction in female worm length culminate to suggest that 
vaccination with the lectin binding fraction had a genuine, albeit modest, 
protective affect against homologous challenge.
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Chapter 5 
Further Characterisation of 
the H. contortus 
larval ES ASP-1 homologue.
5.1 Introduction
Members of the Ancylostoma secreted protein (ASP) family have been identified 
in a variety of parasitic nematodes since their discovery in A. caninum (Hawdon 
et al, 1996). As described in detail in Section 1.7.3.2, upon activation in vitro, 
A. caninum L3 secrete two distinct types of ASP: a double domain type (ASP-1) 
with two pathogenesis-related domains and a single domain type with one 
pathogenesis-related domain (ASP-2), which shows homology to the C-terminal 
of ASP-1 (Hawdon et al, 1996; 1999). Orthologues of both the double and 
single domain ASPs have been identified in the L3 stage of A. duodenale, A. 
ceylanicum and V. americanus (Zhan et al, 1999). These sequences exhibit very 
high degrees of amino acid identity to the original A. caninum ASP-1 or ASP-2 
sequences, for example the N. americanus ASP-1 is 97% identical to the A. 
caninum ASP-1. Despite being originally associated with the transition to 
parasitism, ASPs are also expressed by adult A. caninum worms: ASP-3 
represents a homologue of the single domain protein; ASP-4, -5 and -6 represent 
double domain protein homologues (Zhan et al, 2003). It is now recognised that 
ASPs are ubiquitous in many parasitic nematode species: single domain ASPs 
have been identified in filarial nematodes including O. volvulus (Tawe et al., 
2000) and B. malayi (Murray et al, 2001) and in O. ostertagi (Geldhof et al, 
2003). Both single and double domain ASPs have been recognised in H. 
contortus (Rehman and Jasmer, 1998; Sharp and Wagland, 1998). The ASPs are 
related to the venom allergen-like proteins (VAP) of C. elegans.
The recent characterisation of the X-ray structure of N. americanus ASP-2 has 
indicated a structural and charge mimicry of chemotaxins, suggesting a possible 
immunomodulatory function (Asojo et al, 2005) although, there is little 
experimental evidence for this. Early vaccination studies with A. caninum ASP- 
1 in the murine model suggested that antibody against recombinant ASP-1 might 
inhibit larval migration, indicating a chemosensory role for ASPs (Ghosh and 
Hotez, 1999). ASPs from O. volvulus can stimulate angiogenesis in the blood 
vessels of the cornea (Tawe et al, 2000), though this is likely to be an indirect 
effect (Higazi et al, 2003). Interestingly, O. volvulus ASP-1 is also a potent 
adjuvant, eliciting a high Ig titre of a mixed Thl/Th2 type (MacDonald et al,
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2005) perhaps suggesting an immunomodulatory role. Despite the function of 
the ASPs remaining poorly understood, they are likely to have an affect on host 
cells, and thus remain potential vaccine targets.
Discussed in both Sections 1,7.3.2 and 4.3, ASPs, both of the single and double 
domain type, induced protective immune responses in a number of vaccination 
models. O. ostertagi ASP-1 and ASP-2 were the most abundant proteins in a 
host-protective fraction of adult ES (Geldhof et al, 2003); O. volvulus ASP-1 
can induce an anti-larval protective immunity (MacDonald et al, 2004). Of the 
hookworm species, vaccination with A. caninum, A. duodenale and N. 
americanus ASP-1 reduced worm burdens in the mouse model (Ghosh and 
Hotez, 1999; Liu et al, 2000), and vaccination with N. americanus ASP-1 
reduced mean EEC in dogs challenged with A. caninum (Hotez et al, HHVI 3''^  
Annual Report). A. caninum, N americanus and A. ceylanicum ASP-2 have all 
shown considerable promise as vaccine candidates (Hotez et al, 2003; Goud et 
al, 2004). The H. contortus ASP-2 homologue, Hc24, protects sheep against 
homologous challenge (Schallig et al, 1997a; Vervelde et al, 2002) and ES 
enriched for the L3 ASP-1 homologue can reduce worm burden in guinea pigs 
(Sharp and Wagland, 1998). Described in Chapter 3, vaccination of sheep with 
a fraction of H. contortus ES purported! y enriched for the larval He ASP-1 
significantly reduced adult worm burden and led to a reduction in female wonn 
length and a trend towards reduced faecal egg output. It would be of benefit to 
establish whether this lectin binding fraction was genuinely enriched for the 
larval He ASP-1 protein.
This chapter describes the work that was undertaken to ascertain the temporal 
pattern of expression and to obtain full length sequence of the previously 
described H. contortus larval ASP-1 homologue. Eurthermore it was the aim to 
express the larval He ASP-1 as a recombinant protein and produce an antibody 
probe thus enabling localisation studies.
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5.2 Results
5.2.1 Temporal expression of HcASP-1 mRNA
RT-PCR using primers ASP-3 forward and ASP-4 reverse (Section 2.6.1) was 
carried out on approximately 50ng of cDNA made from various life stages of H. 
contortus (egg, L3, ExL3, L4, day 11 immature adults, day 28 adults). A product 
of the appropriate size (660 bp) was amplified from ExL3, L4 and adult stage 
cDNA (Figure 5.2.1). Despite the bands being visibly brighter in the L4 and day 
1 1  samples, a conclusion about levels of template expression cannot be drawn 
due to the non-quantitative nature of this PCR.
Figure 5.2.1: Expression of ASP-1 homologue in different life stages of 
H. contortus. PCR on cDNA prepared from various stages of H. 
contortus using primers designed to the larval HcASP-1 homologue.
1 -  DNA ladder (bp); 2 -  egg; 3 -  L3; 4 -  ExL3; 5 -  L4; 6 -  day 11 adults; 
7 -  day 28 adults.
5.2.2 RACE PCR to obtain full 5* sequence
The published He ASP-1 (Sharp and Wagland, 1998) sequence lacked a 5’ 
initiation codon. The 5 ’ end containing the ATG (Met) start codon was isolated 
from ExL3 cDNA by 5 ’ RACE PCR (Sections 2.5.2 and 2.6.4) using a gene 
specific primer (ASP-5'-RACE) designed to a region of the published sequence 
(Figure 5.2.2). Three 5’ end clones were sequenced and found to encode 
identical sequences that were in frame with and overlapped the published 
sequence. The full length amino acid sequence (Figure 5.2.2) encodes an open
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reading frame (ORF) of 226 amino acids and a predicted molecular weight of 
24.7 kDa with a pi of 5.02. The amino-terminal 19 amino acids are highly 
hydrophobic and analysis using the Signal-P software indicates this a signal 
peptide with a predicted cleavage site between positions S 19 and A20. The full 
length protein contains 4 potential A-linked glycosylation sites and 12 cysteine 
residues (Figure 5.2.2).
ASP-1
ASP-3
ASP-6 ► a s p -5 ^
f v l t i l v a s a s s a t k n I e t s e p p p d e f h I q i H H m t p e k r k l s v m l
GNAYRTLATSGVFGYPPSQNMYQLjSHIBLAEKYAMVLiNQQAPLKPVGYjSE^I
M---------------
ASP-5’ RACE
PLAAAFELWWGNHDFGAF S PNFD YTVFTQMVSG Y A V SI G |T D T |y GK
OQAY#AFEV#TAMTYFGMIYEAGSGP#MADSE#TTYPGST#NMANGL#VKQPNT 
PLCPKKTNLY
ASP-2
ASP-4
ASP-7
Figure 5.2.2: Amino acid sequence of the elucidated full length HcASP-1 
protein. The signal peptide sequence is boxed in grey. The 7 amino 
acids extended by 5 ’ RACE PCR are boxed in dark grey. Predicted N- 
linked glycosylation sites are boxed in black and cysteine residues are 
boxed in blue. Primer sites are marked above or below indicating the 
forward or reverse nature as appropriate. The primers differed slightly as 
they were designed for different expression systems or RACE extension 
as detailed in tables 2.6.1 and 2 .6 . 2  in Chapter 2 .
A BLAST search (February 2004) of the published H. contortus EST sequences 
(http://zeldia.cap.ed.ac.uk/nematodeESTs/nembase) showed 17 clusters that 
contained sequences that demonstrated a significant homology to the He ASP-1 
protein, including a sequence matching the published 5’ truncated HcASP-1 
exactly, indicating a gene family (Table 5.2.1). Of note, all the sequences were
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from adult cDNA libraries and the areas of greatest divergence were at the 
amino-tenninal end.
Table 5.2.1: HcASP-1 like sequences from the H. contortus ESI dataset. 
All ESTs are from adult cDNA libraries.
EST
Cluster
Accession numbers Identity to 
HcL3ASP-l
Contig
Length
(aa)
Closest
homologue
HCC00180 A30245 100% 219 Identical to 
HcL3ASP-l
HCC00248 BF059782, BF060135, 
BF662831, BM173860, 
BU665925
77% 217 AAM54195 
VAP-1 protein
(C. elegans)
HCC04130 CB012540 72% 228 AAC69015 
VAP-1 protein 
(C elegans)
HCC00248 BE496784 73% 220 AAM54195 
VAP-1 protein 
(C. elegans)
HCC00248 BE496761, CB014990 73% 218 AAC69015 
VAP-1 protein 
(C. elegans)
HCC00548 CBO15234, CB015315 72% 219 AAM54195 
VAP-1 protein
(C. elegans)
HCC01296 BF422978, BF423346, 
CB015186, CA868666, 
CA869655
70% 164 No Hit
HCC00548 CB015570 71% 216 No Hit
HCC04130 CA869697 71% 206 No Hit
HCC00248 CB016123, CA869755 71% 198 No Hit
HCC00548 BF060300, BF423I91, 
CB015942, CB016035, 
CB016213
66% 225 No Hit
HCC01296 CA033884 71% 197 No Hit
HCC04130 CB015930, CA870089, 
CA958015
72% 185 No Hit
HCC00248 BF060342, BF422799, 
BF423385, CA957984
72% 187 No Hit
HCC04130 CA958199 75% 182 No Hit
HCC00248 CA959003, CB019980 72% 181 No Hit
HCC03964 CA869433 83% 116 No Hit
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Multiple alignments of the full length He ASP-1 protein sequence with the A. 
caninum ASP-1 and ASP-2 sequences showed the HcASP-1 to align closer to the 
N-terminal of the ASP-1 protein (Figure 5.2.3), despite having a total length that 
would infer it is a single domain type ASP (like ASP-2). He ASP-1 showed 26% 
identity and a 39% similarity to the N-terminal of A. caninum ASP-1 and a 21% 
identity and a 35% similarity to A. caninum ASP-2. As is typical within the ASP 
family, the cysteine residues are highly conserved.
H C L 3 A S P - 1  m f v § n a l f | l t | l v a s a s s a t k n | e t | e | p p | e | h | q i i ^ | t | m t p e k r k l
A c A S P - 1  m I s P V i I s v I f T I A F - - - - - - - - - - - - - - # ) A #  -  # A R # G # G # S N ^  I  #  -  D K D R Q A F
H C L 3 A S P - 1  S V M L G g Y # r i # - - - - - - - - - - - - - - - T > | V F G Y P I S Q H | | Q | N Y S | L A I K Y - - - I M V L
A c A S P - 1  L D F H N # R # t \ # ( G V E D S r # # K L N -  - m M ^ K # S W D g A f # O Q L O D # I O S
H C L 3 A S P - 1  | - N Q Q | P L K P | G Y f e - - - - - - - - - - - - - - - - - - - - - - - - - - - - S # [ P L A A A F E L g G N H D F g F I # E
A c A S P - 1  I P S A F l G I Q G l A Q l V M S W S S S G G F P D P f V K l E Q T L S G B s  ■ k k | g
H C L 3 A S P - 1  T # V Y S # N F D # T  V 1 T Q | B S G Y A V S I | | H t D T C Y G K Q Q B | -  - I a F E V C
A c A S P - 1  V #  # 3 N K # N G G G L F A # S N # Y S E T T K t M - - - - - - - - - - - - - - - - - - - - - - # K V # G T K L A
H C L 3 A S P - 1  T A M T Ë F a * - - - - - - - - - - - - - - - - - - ^ ' 4 M S G P g M A D S Q T # P G # T m w i A l # g v # Q # N
A C  A S  P  - 1  V S C I  # # V G Y I  T N Q  P M W # T # O A  g K T G A # g S # K N # G % E  -  -  D # 0 T # G # D
H C L 3 A S P - 1  T #  L g K K # N L Y
A c A S P - 1  v | e t n q q H s n | g m t d s v r d t f l s v h n e f r s s v a r g l e p d a l g g n a p k a a
A C A S P - 1  K M L K M V Y D C E V E A S A I R H G N K C V Y Q H S H G E D R P G L G E N I Y K T S V L K F D K N
A c A S P - 1  K A A K Q A S Q L W W N E L K E F G V G P S N V L T T A L W N R P G M Q I G H Y T Q M A W D T T Y K
A c A S P - 1  L G C A W F C N D F T F G V C Q Y G P G G N Y M G H V I Y T M G Q P C S Q C S P G A T C S V T E G
A C A S P - 1  L C S A P
Figure 5.2.3: EMBOSS alignment showing regions of homology between 
the N-terminal of A. caninum ASP-1 and the HcASP-1 proteins. Regions 
of amino acid identity are shaded in dark grey; regions of high similarity 
scores are shaded in light grey; conserved cysteine residues are boxed in 
blue.
Phylogenetic analysis was carried out using the published A. caninum, O. 
volvulus, B. malayi and O. ostertagi ASPs and the H. contortus He24 and Hc40 
and He ASP-1 proteins. A dendrogram was created using the neighbour-joining 
method in the MEGA version 3.1 software and is shown in Figure 5.2.4. There 
was strong support (8 8 %) for a clade containing the A. caninum ASP-1 and -2, 
the H. contortus He 24 and Hc40, and the C. elegans VAP-1. The He ASP-1 
would appear to fit best within the clade containing the filarial ASPs (69% 
bootstrap support).
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67
41
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46
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93
55
--------------  Hc40
------------- Hc24
Ac ASP-2 
—  CeVAP-1
AcASP-1
100
100
O.wiASP-2 
— O.wlASP-1 
 BmASP
AcASP-5
 AcASP-4
---------------AcASP-3
AcASP-6
100
HcLSASP-l
- OoASP-1 
OoASP-2
Figure 5.2.4: Dendrogram of the ASPs from A. caninum (Ac), O.
ostertagi (Oo), O. volvulus (O.vol), B. maiay (Bm)i, C. elegans (Ce) and 
H. contortus. Numbers indicate bootstrap support values for the groups 
distal to the labelled node. Divergence is indicated by length of line.
5.2.3 Attempted expression of HoASP-1
The published, slightly 5’ truncated, form of He ASP-1 was successfully cloned 
into the pET 22b and the pGEX-6P expression vectors either with or without the 
putative signal peptide and the pIVEX2,3d vector with the signal sequence, as 
indicated in Sections 2.6.1 and 2.6.2 and Table 2.6.2 Successful amplification 
of HcASP-1 using adapted primers from ExL3 cDNA, cloning into pGEM-T and 
subcloning into an expression vector is shown in Figures 5.2.5 and 5.2.6 for the 
He ASP-1 with no signal peptide into pET22b. Sequencing of the correct insert 
in the expression plasmid sequence (Figure 5.2,6) demonstrated conect in frame 
cloning.
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4 0 7 2
3 0 5 4
20 3 6
1636-
1018-
517-
1 2  3 1 2  3
Figure 5.2.5: Cloning strategy of HcASP-1 without signal sequence into 
pET 22b for expression of recombinant protein.
Panel A shows PCR of HcASP-1 using primers ASP-5 -forward/ ASP-4- 
reverse from ExL3 cDNA. 1- DNA ladder (bp); 2- PCR on ExL3 cDNA; 3- 
no template negative control. Arrow points to product of 630 bp.
Panel B shows restriction enzyme digests using Nde-\ and Xho-\ of empty 
pET 22b and of pGEM-T containing the HcL3ASP-1 amplified in A. 1- 
DNA ladder (bp); 2- linearised pET22b plasmid; 3- linearised pGEM-T 
and HcL3ASP-1 (without signal peptide) cut out of plasmid following 
Nde-\ /Xho-\ double digest. Top arrow points to pET22b (5493 bp); 
middle arrow points to pGEM-T (3000 bp); bottom arrow points to 
HCL3ASP-1 (620 bp).
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E G D I  H M T K N C E T S E P P P D E F H C Q
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Figure 5.2.6: Nucleotide sequence and amino acid translation 
demonstrating successful in frame cloning of HcASP-1 without signal 
sequence into pET 22b for expression of recombinant protein. Boxed 
regions indicate plasmid vector sequence and the restriction enzyme 
sites used for cloning are highlighted by a black line above the sequence.
Following sequencing reactions to confirm the He ASP-1 sequence was cloned in 
frame within the vector in all instances, competent cells (BL21 and BL21 codon 
plus cells were both tried) were transformed with plasmid containing the HcASP- 
1 sequence and expression was attempted as described in Section 2,3,13. 
Soluble and insoluble cell fractions and supernatants were analysed by SDS- 
PAGE and the presence of recombinant protein sought by comparison with cell 
fractions made from induced cells containing the appropriate vector with no
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insert, and non-induced cells. In the case of the Rapid Translation expression 
system, protein was analysed as before, and a band at the estimated molecular 
weight sought by visual inspection. In all attempts, no expression of the HcASP- 
1 protein was observed using any of the aforementioned systems (data not 
shown). Western blot analysis of cell fractions, probing with an HRP labelled 
anti-Histidine tag antibody also proved negative (data not shown).
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5.3 Discussion
Originally identified in A. caninum larvae and now recognised as ubiquitous 
throughout the parasitic nematodes, the ASPs are promising vaccine candidates 
in a number of species (Hotez et al, 2003). The single domain type ASP-2 is the 
most promising larval vaccine candidate against hookworms and as such is going 
into Phase 1 clinical trials (Goud et al, 2005). The double domain hookworm 
ASP-1 has also shown promise as a vaccine candidate, and both single and 
double domain ASP-1 homologues in other species are hopeful vaccine 
candidates (Shaip et al, 1992; Sharp and Wagland, 1998; Geldhof et al, 2003). 
Here, further characterisation of the H. contortus L3 ASP-1 (HcASP-1) 
homologue, identified in a non-permissive host-protective fraction (Sharp and 
Wagland, 1998) and potentially enriched for in the modestly host-protective 
lectin-bound ES fraction described in Chapter 4, is provided. The He ASP-1 was 
cloned, full length sequence confirmed by comparison to the described sequence 
(Shaip and Wagland, 1998), and PCR earned out to investigate temporal 
expression. Bacterial expression of the recombinant protein was attempted with 
the aim of conducting a vaccine trial in sheep but this failed in several systems.
PCR using cDNA prepared from the different life stages of H. contortus 
demonstrated expression of the He ASP-1 mRNA transcript in the ExL3, L4 and 
adult stages. This concurs with the protein being expressed by the larvae 
following the transition to parasitism as reported by Sharp and Wagland (1998), 
though these workers did not investigate the possibility of the protein being 
expressed by the adult stages. A. caninum ASP-1 and ASP-2 proteins are 
secreted following L3 activation (Hawdon et al, 1996; 1999), and protein 
expression is confined to the L3 stage. However, the mRNA transcript for the 
ASP-2 is present throughout all life stages of the parasite (Hawdon et al, 1999).
The published He ASP-1 sequence lacked a 5' initiation codon. Here, the 5’ end 
containing the ATG (Met) start codon was isolated by 5’ RACE PCR. Like the 
other members of the ASP family. He ASP-1 contains a signal peptide, indicating 
it is likely to be secreted. The predicted molecular weight of the full ORF,
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including the signal peptide, is 24.7 kDa; however the native protein migrates 
with a molecular weight of approximately 40 kDa on an SDS-PAGE gel 
(Chapter 3; Sharp and Wagland, 1998). The mature protein has 4 predicted N- 
linked glycosylation sites which, if occupied, would account for some of the 
difference between the predicted and observed molecular weights. The adult A. 
caninum ASP-4 and ASP-6 have 2 and 1 A^-linked glycosylation sites 
respectively, and both migrate with a larger molecular weight than that predicted 
by sequence alone; the former with a relatively larger weight increase reflecting 
the 2 glycosylation sites (Zhan et al, 2003). A feature of the ASP family is the 
high conservation of cysteine residues (Hawdon et al, 1996). As the cysteine 
residues are involved in protein structure through disulfide bonding, it is possible 
that, despite the relative divergence in other parts of the sequence, a similar 
secondary structure is shared by the ASP-like proteins and HcASP-1. Although 
the function of ASPs remains unknown, the recently elucidated X-ray structure 
of the N. americanus ASP-2 led the authors to suggest a chemokine-like 
function, perhaps as an extracellular ligand of an as yet unidentified receptor 
(Asojo et al, 2005). The ASPs are represented in C. elegans by a protein family 
with at least 20 members designated venom allergen-like proteins (VAPs) or 
testis-specific proteins, the vast majority of which are of the single domain type. 
Nothing is known of the function and RNAi experiments, the results of which are 
published on http//:www.wormbase.org, have not indicated a phenotype other 
than wildtype.
A search of the H. contortus EST dataset with the He ASP-1 sequence identified 
16 contiguous sequences with a significant identity over the length of the EST 
indicating that the HcASP-1 is a member of a gene family. Interestingly all these 
sequences were identified from adult cDNA libraries inferring these genes are 
expressed by adult stage worms and were not present in the L3 EST dataset. 
However, there are some 15,000 adult ESTs compared to 1,100 from L3 and L4s. 
Given that the native protein has been confirmed in L3 ES (Sharp and Wagland, 
1998), that transcript is detectable by RT-PCR (Figure 5.2.1) and that the latter 
assay indicates a lower abundance compared to 11 day and adult woims, it is 
likely that the absence of ASPs from the L3 EST dataset simply reflects low
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transcript levels. The construction of the L3 EST dataset from sheathed rather 
than ExL3s may also provide an explanation for the He ASP-1 not being present.
The ASPs belong to a phylogenetically diverse group; analyses using 
representative ASPs from several nematode species including the hookworms, 
filarids, C  elegans and O. ostertagi imply the He ASP-1 to group in a clade with 
the filarid ASPs. The H. contortus Hc24, Hc40 and the A. caninum ASP-1 and 
-2 proteins comprise a different and distinct clade perhaps suggesting a function 
different to that of the HcASP-1.
Despite repeated attempts, with both the full length available sequence and a 
truncated version without the signal peptide, bacterial expression of the ASP-1 
homologue continued to evade success. Constructs in the pET22b and pGEX 
vector systems were exhaustively sequenced to confiiin correct in frame cloning. 
A final attempt at expression, using a Roche cell free rapid translation expression 
system, also proved unproductive. Difficulty in expressing bacterial recombinant 
ASPs have been reported by several workers (Zhan et al, 2003; P. Geldhof, 
personal communication; M. E. Botazzi, personal communication). In spite of 
this, successful bacterial expression of several ASPs, including the He ASP-1 
without the signal peptide, has been reported (Shaip and Wagland, 1998; Murray 
et al, 2001; Hawdon et al, 1999). The He ASP-1 protein was cloned into the 
pBTA721 vector and expressed as a fusion protein in E. coli (Sharp and 
Wagland, 1998) and the Ac ASP-1 and AcASP-2 were cloned and expressed 
using the pET vector system and BL21 cells (Hawdon et al, 1996; 1999). 
Reasons for the failure of He ASP-1 expression in this study are unclear as the 
pET and BL21 system have worked for other ASP family proteins. The same 
system used in this study has also resulted in successful expression of other H. 
contortus genes (see Chapters 6 and 7). Codon usage, a problem sometimes 
encountered when attempting to express H. contortus proteins (D. Redmond, 
personal communication), was addressed by also using a codon plus cell line 
(BL21 DE3 RIPL codon plus). This is a cell line that contains extra copies of the 
genes that encode tRNAs that are rarer in E. coli (arginine, leucine, isoleucine 
and proline) and is designed to allow expression of non-E. coli proteins that 
contain these amino acids. Zhan et a l (2003) found expression of the protein
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without the signal peptide successful when the full length protein failed to 
express; this was attempted without success. ASPs are cysteine rich and 
recombinant production could result in abenant folding due to the high number 
of disulphide bridges; however this is more likely to affect the solubility of an 
expressed protein, rather than prevent expression per se. An alternative to this 
might have been expression in a eukaryotic system such as the methane utilizing 
yeast {P. pastoris) system or an insect cell line, as these have both proved 
successful for ASP proteins (Hotez et al, 2003). However, attempting 
expression with a eukaryotic system was deemed beyond the time constraints of 
this project. The lack of a recombinant HcASP-1 prohibited antibody probe 
production. Anti serum to ASP-1, kindly provided by Professor Peter Hotez, did 
not recognise any proteins in Haemonchus adult woiTn extracts or L3 ES 
indicating a, somewhat surprising, lack of antigenic cross-reactivity. Thus it was 
impossible to caiTy out localisation studies to confirm the presence of the 
He ASP-1 in the fractionated ES used in the Chapter 4 vaccine study.
In summary, the work described in this chapter shows that He ASP-1 is more 
homologous to ASPs from filarial nematodes than those from hookworms and 
those already identified in the ES products of adult H. contortus. RT-PCR 
indicated that the transcript is present at in adult woiTns, L4 and exsheathed L3, 
suggesting that the protein product has functional significance for adults as well 
as larvae. Attempts to express the protein in bacteria failed and future work 
would focus on expression in yeast or insect cells. Another possibility would be 
to synthesise the gene with E. coli codon usage. Recombinant protein can be 
used to raise antibodies to permit the identification of the protein in the L3 ES 
fractions discussed in chapter 4 and for immunolocalisation in L3 and adult 
worms. The latter experiments might provide an indication of in vivo function. 
Finally, a recombinant protein could be used as an immunogen in a vaccine trial.
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Chapter 6
Identification and characterisation 
of an 4. caninum 
transthyretin-like protein 
homologue in H. contortus
6.1 Introduction
Upon activation in vitro, A. caninum L3 release several proteins likely to be 
important in the transition to parasitism, thus prime vaccine candidates. These 
include the previously discussed ASP-1 and ASP-2, a MTP and a transthyretin­
like protein (TTR) (Hotez et al, 2003). The latter was originally identified by 
screening an A. caninum L3 cDNA library with sera from patients naturally 
infected with hookworm (Hawdon et al, Society of Protozoologists, 53rd Annual 
Meeting, June 25-28, 2000). The A. caninum TTR belongs to a large nematode- 
specific protein family, represented by at least 52 genes in C  elegans, that show 
a loose homology to mammalian transthyretin (19% amino acid identity to 
human TTR) and a family of transthyretin-related proteins (TRPs) represented in 
nematodes, plants, bacteria and animals (Eneqvist et al, 2003).
Transthyretin in mammals acts as a transport protein for thyroid hormones. In 
conjunction with retinol-binding protein it also transports retinol (Schreiber ei 
al, 1997). The TRP family are, as the name suggests, related to transthyretin 
(approximately 35% identical) and likely to have a similar homotetrameric 
structure, although the function is not well understood. RNAi loss of function 
studies earned out on the two TRP genes in C. elegans resulted in no observed 
phenotype (Eneqvist et al, 2003). The nematode-specific TTR-like proteins are 
distinguished from the TRPs, by their lack of a highly conserved four amino acid 
motif at the C-temiinal (Enequist et al, 2003). Little is known about the 
function or structure of the nematode TTR-like proteins.
Despite the function of the AcTTR remaining unknown, it has been suggested 
that it might scavenge host retinol (Hotez et al, 2003). Recombinant AcTTR has 
been evaluated in at least two protection trials, the first in the dog-A. caninum 
natural host system and the second in the hamster-A. ceylanicum model. In the 
former, antibody titre in response to vaccination was low. However, there was a 
significant inverse relationship between AcTTR specific IgE titre and worm 
burden (Hotez et al, 2003). The data from the hamster model trial is not yet
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available, however it has been reported that a similarly low antibody litre was 
elicited (Hotez et al, HHVÏ 3‘^  Annual Report).
There are several TTR-like genes in the H. contortus ESTs represented in 
libraries of all life stages. A proteomic analysis of the proteins excreted/secreted 
by adult H. contortus in culture identified several TTR-like proteins. Of interest, 
several of these TTR-like proteins were found to be amongst the most 
immunogenic proteins released by adult worms as judged by Western blot using 
sera from sheep naturally immune to H. contortus (Yatsuda et al, 2003).
On the basis of the reported immunogenicity of TTR-like proteins and the 
promise shown by the AcTTR as a vaccine candidate, a homologue of the 
AcTTR was sought in H. contortus and the biology and suitability as a potential 
vaccine candidate investigated. This chapter describes the identification of a 
homologous TTR in H. contortus, its expression and charactensation and studies 
carried out to identify the site of expression of the native protein.
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6.2 Results
6.2.1 Reactivity of H. contortus ES and extracts with anti-
recombinant A. caninum TTR serum
To attempt to seek a homologue of the A. caninum TTR-like protein in H. 
contortus, extracts and ES were probed with sera against the AcTTR, as 
described in Sections 3.2.3 and 2.2.4. Larval extracts and ES from H. contortus 
were screened by Western blot and probed with rabbit sera raised against a 
bacterial recombinant AcTTR (kindly provided by Professor P. Hotez). The 
AcTTR probe labelled a protein of approximately 16 kDa in larval soluble 
extract, but not in ES from any time point in culture (Figure 6.2.1). The 
predicted molecular weight of the AcTTR is 16 kDa thus the cross-labelling is 
likely to be of a similar protein, A second protein band at an estimated 60 kDa 
was also labelled, though the identity of this band remains unknown.
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Figure 6.2.1: Western blot of H. contortus L3 S1 extract probed with a 
primary anti-recombinant AcTTR sera (1:2000 dilution) and HRP labelled 
secondary anti-rabbit IgG (1:1000 dilution). 1 - H. contortus L3 SI 
extract. An arrow marks the putative HcTTR between 14 and 22 kDa in 
size.
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6.2.2 Identification of A. caninum TTR homologue in H. contortus 
EST dataset
Having confinned cross-reactivity of sera raised against the AcTTR with a band 
of the appropriate size in H, contortus extract, a bioinformatic approach was 
taken to investigate TTR-like proteins within the available 77. contortus dataset. 
The published 77. contortus EST dataset was searched (May 2003) with the A, 
caninum TTR amino acid sequence (kindly provided by Professor P. Hotez) as 
described in Section 2.4.1. Seventeen contiguous sequences (Table 6.2,1) 
produced significant alignments (similarity score over 150) with the AcTTR. The 
full length EST CA994587, clustered in HCC01741, proved the closest 
homologue. Full length cDNA containing the CA994587 was amplified by PCR 
and cloned (Section 2.4,2 to 2.4.3). The full length gene was designated HcTTR.
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Table 6.2.1: Closest homologues to the AcTTR protein in the H. contortus 
EST dataset. The % identity over the length of the sequence and the 
corresponding E-value are shown.
Cluster
containing
contig
Accession numbers in 
contig sequence
% identity 
to AcTTR
E-value Stage
Hcc01741 CA994587, CA994643 64 8e-48 Egg
Hcc01741 BF423360, CB020963 62 8e-48 Adult
Hcc00775 BF186796, BM173984, 
BM174173, CA994790
61 2e-47 L4
Hcc00775 CA994783 61 2e-47 L4
Hcc02240 BM138829, BM138889, 
BM138926, BM139052, 
BM139325, CB012730
57 3e-42 Adult
Hcc02240 CB013103, CB015232 57 3e-42 Adult
Hcc02240 CB012455 57 3e-42 Adult
Hcc02240 CB020655 57 3e-42 Adult
Hcc00756 BF186811,BM174148 54 7e-42 L4
Hcc02251 BM138844, CB018766, 
CA957008, CB020778
53 9e-42 Adult
Hcc00365 BM139192, BF059980 56 le-41 Adult
Hcc00365 CA957899,CB020811, 
BF060064, BF422778, 
BF423083
55 6e-41 Adult
Hcc02849 BM174112, BM174127 55 2e-40 L4
Hcc00365 BM138977 55 6e-40 Adult
Hcc00365 CB013024, AW670763 58 2e-39 Adult
Hcc00756 BF186771, 52 4e-39 L4
Hcc00365 CB021070, CA869898 57 2e-38 Adult
Closer examination of the HCC01741 cluster that contained the CA994587 
sequence showed it to comprise of 2 contiguous sequences (Contigs), the first 
containing sequences BF423360 and CB020963 from an adult cDNA library; the 
second, CA994587 and CA994643 from an egg cDNA library. A Clustal 
alignment of the predicted protein sequence from Contigs 1 and 2 is shown in 
Figure 6.2.2, As can be seen, a full ORF is not available for Contig 1 but, other 
than the first residue, the sequences are identical at the amino acid level thus 
likely represent the same gene.
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Figure 6.2.2: Clustal alignment of the protein sequences encoded by the 
2 Contigs in cluster HCC01741. Contig 1 contains sequences BF423360 
and CB020963; Contig 2 CA994587 and CA994643. Regions of identity 
are highlighted in dark grey; amino acids showing a high similarity score 
are highlighted in light grey.
The HcTTR shows a 64% identity and a 74% similarity across the whole 
sequence to the AcTTR and has an ORF of 152 amino acids compared with the 
AcTTR ORF of 144 amino acids. The predicted molecular weight of the HcTTR 
is 16.9 kDa. Like the AcTTR, the first 15 amino acids of HcTTR constitute a 
predicted signal peptide with a likely point of cleavage between Ais and Mi6; the 
predicted molecular weight of the protein without signal peptide is 15.3 kDa. An 
alignment highlighting regions of homology between the AcTTR and the HcTTR 
is shown in Figure 6.2.3.
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Figure 6.2.3: A Clustal alignment of the HcTTR and AcTTR protein 
sequences. Regions of identity are highlighted in dark grey; amino acids 
showing a high similarity score are highlighted in light grey. The amino 
acids in the predicted signal peptides are in red.
6.2.3 Expression of recombinant He TTR and production of
antibody probe
In order to investigate whether the HcTTR protein was secreted and to allow 
immunolocalisation studies to be carried out, the HcTTR was expressed as a 
bacterial protein and rabbit antisera produced. Following subcloning of the
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bacterial protein and rabbit antisera produced. Following subcloning o f the 
CA994587 HcTTR into pBluescript, adapted primers (as described in Section
2.4.3) were used to amplify a product, either with or without the predicted signal 
sequence, for expression in E. coli using the pET 22b or pGEX-6P-3 plasmids. 
The periplasmic leader sequence (peLB) in pET vectors is provided to direct an 
expressed protein to the cell periplasm. Inclusion o f the peLB leader has 
previously been reported to block expression o f certain H. contortus proteins (D. 
Redmond, personal communication), thus expression attempts were made 
following cloning into pET both with and without this peLB sequence. 
However, expression o f the full length protein in both pET 22b with or without 
the vector peLB leader sequence, and in an alternative E. coli expression plasmid 
pGEX-6P-3, failed. Following this failure, expression attempts were carried out 
having removed the signal peptide from HcTTR. Expression in pET 22b o f the 
recombinant HcTTR (rHcTTR) without the signal peptide and without the peLB 
leader sequence resulted in expression o f a His-tagged protein migrating with an 
estimated weight close to that o f the predicted molecular weight o f 16 kDa 
(Figure 6.2.4)
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Figure 6.2.4: 4-15% SOS PAGE gel of insoluble bacterial fraction
containing expressed recombinant HcTTR and the purified rHcTTR. 
1 -  Induced cell insoluble fraction; 2 -  non induced cell insoluble fraction;
3 -  Western blot of lane 2 probed with 1:500 rabbit anti-rHcTTR sera;
4 -  electroeluted and purified rHcTTR. The arrow points to the rHcTTR in 
lane 2 between 16 and 22 kDa.
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The rHcTTR was excised and subjected to a trypsin digest and MALDI-TOF 
analysis (Section 2.3.17); a comparison of the peptide mass fingerprint of the 
fragments with an in silico digest of the HcTTR amino acid sequence confirmed 
the expressed protein as the HcTTR (see Appendix 2). The rHcTTR was 
subsequently electroeluted and purified (Figure 6.2.4). An antibody probe was 
raised in rabbits using the purified rHcTTR (Section 2.7.1) and sera were 
confirmed to recognise a product of the appropriate size in an insoluble bacterial 
fraction (Figure 6.2.4). Pre-vaccinate rabbit sera did not react with a band at this 
size (not shown).
6.2.4 Temporal expression pattern of HcTTR
An investigation into the expression pattern of the HcTTR was made using PCR. 
RT-PCR using primers TTR-3 and TTR-2 (Section 2.4.3) was carried out on 
cDNA prepared from all life stages of H. contortus', a band of the appropriate 
size for the HcTTR appears to be expressed throughout all the life stages of the 
parasite (Figure 6.2.5). No firm conclusions regarding expression level can be 
drawn due to the non-quantitative nature of this PCR.
Figure 6.2.5: Expression of HcTTR in different life stages of H. contortus. 
Qualitative PCR on cDNA prepared from various stages of H. contortus 
using primers designed to the HcTTR.
1 -  DNA ladder (bp); 2 -  egg; 3 -  L3; 4 -  ExL3; 5 -  L4; 6 -  day 11 adults; 
7 -  day 28 adults; 8 -  negative (no template).
Using the rHcTTR probe, the expression pattern of the native protein was sought 
by probing Western blots of H. contortus L3 extracts and ES and adult extracts.
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The antibody probe reacted very faintly with a protein of the approximate 
predicted weight of HcTTR (-17 kDa) in soluble extract of both exsheathed L3 
(data not shown) and adult worms (Figure 6.2,6). Antibody labelling was 
stronger in the adult extract and intriguingly a band migrating at approximately 
60 kDa was also labelled, as detected by the AcTTR probe in L3 extract (Figure
6,2.1). There was no reactivity with pre-vaccinate rabbit sera in any of the 
extracts or ES.
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Figure 6.2.6: Western blot of adult H. contortus S1 extract probed with 
1:500 anti rHcTTR rabbit sera. 1 -  adult S1. The arrow marks the 
peptide at -17 kDa
6.2.5 [mmunolocaiisation of native He TTR
To localise the native HcTTR in the nematode, immunohistochemistiy was 
carried out using ExL3 and adult H. contortus sections as described in Section 
2.7. In ExL3 sections, there was not a clear cut difference between the level of 
staining observed when sections were probed with rabbit anti-TTR and pre­
vaccinate sera (Figure 6.2.7). However, the exposure time required to 
photograph the negative control sections was longer than that required to 
photograph the positive sections (45s versus 15s) leading to false positives. 
There was a tendency for more intense staining at focal points beneath the cuticle 
and foci of staining in the gut region in sections probed with the rHcTTR 
antibody compared to the control semm. (Figure 6.2.7a versus 6.2.7b). Binding
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in adult sections was to the subcuticular muscle, the wall of the uterus in female 
worms, and to the surface of eggs within the uterus (Figure 6,2.7). Adult 
sections that were probed with pre-vaccinate rabbit sera and those probed with 
the secondary FITC labelled anti-rabbit IgG alone showed only background 
fluorescence compared with the post-vaccinated sera antibody probe.
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Figure 6.2.7: Immunohistochemistry of ExL3 and adult H. contortus 
transverse sections probed with anti-rHcTTR rabbit sera. Larval sections 
were probed with 1:500 anti-rHcTTR rabbit sera (positive) or 1:500 pre- 
vaccinate control sera (negative): Adult sections were probed with 1:2000 
positive sera or 1:2000 negative sera a- ExL3 positive; b- ExL3 negative 
control; c- adult positive; d- adult negative control. Labels: g- gut; cu- 
cuticle; ut- uterus; eg- egg; mu- muscle.
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6.2.6 RNA interference of a C. elegans HcTTR homologue
To investigate a possible gene function of the HcTTR, its homologue in 
C  elegans was sought and RNAi experiments were carried out to search for a 
phenotype that might be associated with ablation of the TTR transcript. A 
BLASTp search of the C. elegans database (WoiTnbase) with the HcTTR amino 
acid sequence identified a large gene family of TTR-like proteins within the C 
elegans genome, the closest homologue of which was C  elegans TTR-like 
family protein, accession number CE09030 (CeTTR). CeTTR demonstrated a 
68% identity at the amino acid level to HcTTR and a 61% amino acid identity to 
the AcTTR. Interestingly, the AcTTR showed a closer homology to a different 
C. elegans TTR-like family protein, CE06389, with an amino acid identity of 
66%.
The entire CE09030 open reading frame (471 bp) was cloned from mixed stage 
C. elegans cDNA into the L4440 vector and sequenced to confinn its identity. 
To investigate the gene function of transthyretin-like proteins, RNAi was canied 
out on the CeTTR, as described in Section 2.9, Following three attempts at 
RNAi, no visible phenotype was observed; in all experiments a phenotype of 
reduced progeny was achieved using dsRNA to C. elegans rme-2 (yolk protein 
receptor, kindly provided by C. Britton) as a positive control, confirming success 
of the RNAi procedure. One-step PCR (Section 2.9,4) demonstrated success of 
the RNAi to reduce the CeTTR transcript (Figure 6.2.8). Amplification by PCR 
of CeTTR was not achieved on worms treated with RNAi of CeTTR inferring 
gene transcript knockdown; amplification of the CeTTR sequence was achieved 
from the control treated wornis and amplification of a control gene, F54D5.4 
(F54.2 primers were kindly supplied by P. Geldhof; Geldhof et ai, 2005) was 
successful, confirming the RNA quality. This lack of an RNAi phenotype for the 
CeTTR is in agreement with the published CE09030 RNAi phenotype of wild 
type (http://www.wormbase.orgl.
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Figure 6.2.8: One step RT-PCR on RNA prepared from CeTTR RNAi 
treated and control worms confirming knockdown of CeTTR in RNAi 
treated worms but not in control worms. 1- DNA ladder (bp); 2- F54.2 
PCR on control treated C. elegans RNA; 3- F54.2 PCR on CeTTR RNAi 
treated C. elegans', 4- TTR PCR on CeTTR RNAi treated worms; 5- TTR 
PCR on control treated worms; 6- negative TTR PCR control with no 
template. Arrow in lane 2 points to the 250 bp F54.2 product in lanes 2 
and 3; the upper band is genomic DNA. The arrow in lane 5 points to the 
471 bp CeTTR product.
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6.3 Discussion
Activated L3 A. caninum release, amongst other characterised proteins, a 
transthyretin-like protein, AcTTR (Hotez et al, 2003). At least one vaccine trial 
using a P. /?a.stom-expressed, recombinant AcTTR has confiimed its protective 
potential, however the antibody titres raised against AcTTR were comparatively 
weak (Hotez et al, 2003). A significant negative correlation between 
AcTTR-specific IgE titre and worm burden was found. Yet, as with other 
hookworm antigens tested, there was an inherent difficulty reported in eliciting 
high antibody titres using yeast expressed proteins (Hotez et ai, 2003). 
Consequently, it is difficult to establish the potential efficacy of antigens such as 
the AcTTR. Identification of an AcTTR homologue in H. contortus would allow 
studies of its suitability as a vaccine candidate and, ultimately, discovery of the 
native protein, thus opening the door to potential vaccine efficacy studies using 
native protein in a natural host.
Using sera raised against the recombinant AcTTR, Western blot analysis of /-/. 
contortus ES and extracts identified a protein of approximately 16 kDa in adult 
and L3 soluble extracts but not in L3 ES. A previous study (Yatsuda ei aL, 2003) 
had used proteomic analysis to show that TTRs were present in adult ES. The 
predicted molecular weight of the AcTTR is 16 kDa, thus the band labelled in H. 
contortus extract appeal's to be of the correct molecular weight to be attributed to 
a TTR-like protein. A second band at about 60 kDa was also labelled, however 
the possible identity of this is unknown. Mammalian transthyretin and the TRP 
proteins exist as homotetramers with a non-reduced molecular weight of about 
58 kDa (Eneqvist et al, 2003). It is interesting that the only other band in H. 
contortus extract recognised by AcTTR sera is of a molecular weight that would 
correspond to a homotetrameric version of the TTR. However, as the protein 
should have been completely reduced, this is deemed unlikely. This issue may be 
resolved by isolating the -60 kDa peptide and subjecting it to proteomic analysis.
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The AcTTR is excreted/secreted by L3 but no protein was recognised in L3 ES 
by antisera to AcTTR or the HcTTR described here despite the fact that the 
transcript is present.
To investigate the identity of the potential AcTTR homologue in //. contortus 
(HcTTR) a bioinformatic approach was taken. The option of creating a cDNA 
library and then screening the library with the AcTTR sera was decided too time 
consuming. Therefore, BLAST searches of the published H. contortus ESTs 
were caiiied out with the AcTTR sequence. Of the 17 contigs identified with a 
significant similarity score of over 150, the 2 contigs that were most homologous 
are likely to be the same gene identified from an adult and an egg cDNA library. 
Like the AcTTR, the HcTTR had a 15 amino acid signal sequence and the 2 
proteins shared an identity of 64%.
Following bacterial expression of HcTTR as an insoluble protein, antibody raised 
against the electroeluted protein was confirmed to cross-react with the 
bacterially-expressed protein. The HcTTR probe recognised a protein band 
corresponding to the predicted molecular weight of HcTTR in L3 and adult 
soluble extract. Despite the protein band labelled being of a similar molecular 
weight to that labelled by the AcTTR probe, no conclusion can be drawn from 
ID analysis as to whether the same protein is cross-reacting. Future studies 
immunoblotting 2D gels of H, contortus extract would likely be more conclusive. 
No HcTTR band was recognised in either L3 ES at any time point or EF 
suggesting that the HcTTR under investigation is perhaps not secreted, although 
a lack of recognition of a potentially processed and secreted form cannot be ruled 
out. A band at 60 kDa in L3 and adult soluble extract was recognised by the 
HcTTR probe in an analogous situation to the blots probed with the AcTTR 
probe. As discussed above, the identity of this protein remains unknown.
Fuither evidence of expression of HcTTR in both larval and adult life stages 
came from RT-PCR earned out on cDNA prepared from all life stages of ti. 
contortus. Despite the product of this PCR appearing more abundant in the ExL3 
to adult stages, conclusions regarding transcript abundance can not be drawn due 
to the non-quantitative nature of this assay.
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The site of immunolocalisation of HcTTR in L3 sections was not conclusive, 
however it appeared that the protein localised to subcuticular cells that are most 
probably muscle cells. Despite the negative control L3 sections appearing to 
show high background fluorescence, this was actually an artefact of the increased 
exposure time required to photograph these sections due to the lower levels of 
fluorescence. Immunolocalisation in adult sections appeared more decisive, with 
the HcTTR localising to the subcuticular muscle tissue and to the wall of the 
uterus in female worms. Bright staining was also observed on the surface of 
eggs in utero. These immunolocalisation studies corroborate the RT-PCR and 
bioinfoimatic data and confirm that the mRNA is translated into a protein 
product in the egg, L3 and adult stages. Despite the predicted signal sequence, 
the sites of protein expression do not imply an excreted/secreted role for the 
HcTTR, although as the protein lines the uterus and egg cuticle it may well be 
detectable in adult ES cultures. Yatsuda et al, (2003) found several TTR-like 
proteins in adult H. contortus ES, although it is worth pointing out that these 
proteins are distinct to the described HcTTR and therefore may have different 
functions and expression patterns. It is also possible that the HcTTR probe 
cross-reacts with other members of the TTR-like family and that the 
immunolocalisation observed is of several different, but related proteins.
As mentioned previously, there are 52 TTR-like genes in C. elegans. A brief 
loss of function study of the CeTTR most homologous to the HcTTR confirmed 
reports on Wormbase of a wildtype RNAi phenotype and as such, did not point 
to a possible function for the TTR-like proteins. It is interesting though that the 
CeTTR (CE09030) showed a 68% identity to the HcTTR, yet the AcTTR has a 
64% identity to HcTTR. This might suggest that the HcTTR is not the true 
homologue of the AcTTR as if this were the case they would likely show a closer 
homology to one another than to TTR-like proteins in the more distantly related 
C. elegans. As the ESTs available do not give a full coverage of the genome, the 
anticipated publishing of the annotated H. contortus genome will allow 
confirmation of this.
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The AcTTR and HcTTR proteins both share a 19% amino acid identity with 
human TTR, but their tertiary structure is not understood. Human TTR acts as a 
homotetramer that binds the small (21 kDa) retinol binding protein (bound itself 
to retinol) and prevents its loss during glomerular filtration (Monaco, 2000). The 
C. elegans TRP proteins share a similar structure to mammalian TTR, and 
although there is at least one TRP in O. ostertagi and two in T. circuincincta 
(Eneqvist et al., 2003) there were none found in the A. caninum or H. contortus 
datasets. Fatty acid and retinol binding proteins of nematodes (FARs) are small 
(20 kDa) proteins that have been shown to bind retinol (Garofalo et al, 2002; 
Basavaraju et al, 2003). Studies have pointed towards a requirement of retinol 
for nematode survival. For example, in rodents that were retinol depleted, the 
microfilaria of Litosomoides sigmodontis showed a retarded development 
(Bradley et al, 2001). Two FAR proteins were described from A. caninum that 
are secreted by the worm following transition to parasitism (Basavaraju et al, 
2003) and these were demonstrated to bind lipids and retinol. Thus it could be 
that the TTR-like proteins function by forming a homotetramer similar to the 
mammalian TTR that binds FAR proteins bound to retinol. This theory could be 
tested by both protein structure modelling and ligand binding studies. However, 
whilst this would fit with the TTR-like proteins in parasitic nematodes being 
secreted, it does not necessarily fit with the localisation data reported here, or 
with the free-living nematode C. elegans having such a large TTR-like gene 
family. If a soluble form of HcTTR were produced, it might be possible to 
investigate ligand binding studies in the future.
In summary, there is a TTR-like gene family in H. contortus, one of which shows 
a 64% identity to the AcTTR but, unlike the AcTTR, is not detectable in L3 ES. 
The HcTTR protein is localised to the musculature, the uterus wall and to the egg 
surface, however its function remains unknown. The sites of localisation and 
lack of detectable protein in L3 ES combined with the fact that there is a TTR in 
C. elegans that shows closer homology with HcTTR than AcTTR, suggests the 
HcTTR and the AcTTR may not necessarily be ortho logons proteins. The non- 
ES nature of HcTTR and its localisation within the woiTn make it an unlikely 
antibody target. Thus, although possibly unsuitable as a vaccine target, HcTTR 
may have potential as a drug target. The HcTTR antibody probe does bind to the
168
egg therefore it would be very interesting to investigate whether bound antibody 
might have deleterious effect on egg hatching. The potential as a vaccine 
candidate could be investigated by caiTying out sheep protection trials using the 
recombinant protein, or affinity purified native protein.
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Chapter 7
Larval Astacln-like Metailoprotease
7.1 Introduction
Astacin-like MTPs have been reported from several parasitic nematodes and 
comprise a 39 member gene-family in C. elegans (Mohiien et ai, 2003). Those 
discovered in parasitic nematodes are generally associated with the transition to 
parasitism and are developmental 1 y regulated (Zhan et al, 2002; Lun et ai, 
2003; De Maere et al, 2005; Gomez Gallego et al, 2005). The suggested roles 
for the parasitic MTPs include moulting, feeding, tissue penetration and 
immunomodulation, thus making them prime targets for intervention by 
vaccination to control infection.
MTP activity was described in A, caninum L3 ES and its release demonstrated to 
be coincident with activation (Hawdon et al, 1995). More recently, Zhan et al, 
(2002) isolated a full length cDNA encoding a member of the astacin-like MTP 
family from A. caninum (AcMTP). The gene was identified by screening cDNA 
libraries with sera from hookworm infected patients and was cloned and 
expressed in E, coli (Zhan et al, 2002). Importantly, recognition by sera from 
infected patients indicates that the protease is released in vivo. AcMTP anti serum 
was used to screen Western blots of activated L3 ES and recognised a protein of 
a similar moleculai’ weight to the MTP activity described in ES suggesting the 
Acmtp may code for this protease. There are homologues of AcMTP in the ESTs 
from N. americanus as well as at least another 3 similar genes in the A. caninum 
dataset (Zhan et al, 2002). Since then an almost identical MTP gene has been 
identified in A. ceylanicum (Hotez et al, 2003 HHVI 3rd annual report).
Like the AcMTP, the astacin-like MTPs identified in O. ostertagi are strongly 
recognised by serum from immune animals (De Maere et al, 2002). Four MTPs 
have been found in O. ostertagi and these are developmentally expressed, the 
majority of expression of all but one limited to the L3 or L4 parasitic stage (De 
Maere et al, 2005). Other parasitic nematode species from which astacin-like 
MTPs have been described include Trichinella spiralis (Lun et al, 2003), 
Strongyloides stercoralis (Gomez Gallego et al, 2005) and Trichostrongylus 
vitrinus (A. Nisbet, personal communication).
171
Vaccine trials have been earned out using recombinant AcMTP in dogs and, 
although the levels of protection varied, there was a significant inverse 
relationship between worm burden and specific anti-AcMTP IgG2 (Hotez et al, 
2003). Moreover, the dog with the highest specific antibody titre showed a 
decrease in woiTn burden of 50% compared to the controls (Hotez et al, 2003). 
In addition, sera from dogs vaccinated with AcMTP significantly reduced the 
number of activated larvae that could penetrate the skin (A. Loukas, personal 
communication).
MTP activity has been described in H. contortus L3 EF and in ExL3 ES (see 
Gamble et al, 1989a; Gamble et al, 1996 and Chapter 3). Although no MTP 
gene has been reported, it was recently demonstrated that NAS-37 (the NAS 
protein that mediates ecdysis in C. elegans) can specifically lead to refractile ring 
formations in the L3 sheath and mediate exsheathment of H. contortus (Davis et 
al, 2004). This evidence would suggest that there are likely to be astacin-like 
MTPs in H. contortus, MTP activity was also demonstrated in the unbound 
fraction used in the sheep vaccine trial described in Chapter 4, sera from which 
reduced larval abomasal penetration in vitro.
As with many of the hookwomi vaccine candidates, levels of protection using a 
bacterially-expressed AcMTP have been highly variable. Assessment of the 
native protein in a natural host/ parasite model might allow better indication as to 
the true protective efficacy of nematode astacin-like MTPs. It would therefore 
be of benefit to both the HHVI and to the development of a vaccine against H. 
contortus to identify homologue(s) of the AcMTP in H, contortus, thus opening 
the door for future vaccine trials. The work in this chapter describes the isolation 
and characterisation of a homologue of the AcMTP from H. contortus and 
presents data on its immunolocalisation.
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7.2 Results
7.2.1 Degenerate PCR Identification of a novel astacin-like
metailoprotease transcript in H. contortus
MTP activity has been identified in H. contortus EF and ES, however no astacin- 
like MTP sequences have been identified to date. A BLAST search (April 2004) 
of the H. contortus EST dataset with the AcMTP sequence revealed no 
homologues, though this could be due to the fact that the datasets are heavily 
biased towards adult stage ESTs. Therefore, a degenerate PCR approach was 
taken to attempt to identify astacin-like genes in H. contortus. Degenerate 
primers were designed as described in Section 2.5.1 and were a kind gift from A. 
Nisbet. PCR was carried out using primers MTP-deg-f and MTP-deg-r (Section
2.5.1) on H. contortus ExL3 cDNA and resulted in the amplification of a band at 
approximately 700 bp (Figure 7.2.1).
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Fiqure 7.2.1: Degenerate PCR on H. contortus ExL3 cDNA using primers 
designed to regions of homology with the published nematode astacin- 
like protein sequences. 1 - DNA ladder (bp); 2 - negative control (no 
template); 3 - ExLS cDNA. Arrow marks product at approximately 700 bp 
that was excised and cloned for sequencing.
Following PCR, the product of approximately 700 bp was excised and cloned 
into pGEM-T (Section 2.5.1) and sequenced. Six sequencing reactions of three 
individual clones resulted in near identical 680 bp sequences (sequencing 
reactions of other clones resulted in vector only sequence being identified). An 
amino acid translation of the contiguous nucleotide sequence from the 6 
sequencing reactions was used in a Clustal alignment with the AcMTP and the O.
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ostertagi MTP sequences (used in the design of the degenerate primers). The 
alignment confirmed the cloning of a novel astacin-like MTP fragment from H. 
contortus (HcMTP) and indicated that the full length MTP was likely to be in the 
region of 500-600 amino acids. Re-amplification of the HcMTP fragment from 
freshly synthesised 3’ or 5’ RACE ready ExL3 cDNA using gene-specific 
primers was not successful although a product of 640 bp (using primers MTP-f-1 
and MTP-r-1) was amplified from L4 3’ and 5’ RACE ready cDNA. This 
sequence of this product was identical to the original sequence derived from 
ExL3 cDNA.
To obtain full length sequence, 3’ and 5’ RACE PCR was earned out as 
described in Section 2,5,2. 3’ and 5’ RACE PCR resulted in the cloning of a full 
length gene sequence that included an ATG start codon and a TAG stop codon 
with a total length of 1509 bases (Figure 7,2,2).
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M M P H M g ^ B B a g g c t t t t t c a a a g g a g g c a a t c t g a t t g a t a g g a t c a a a
AACGCGACCCTCACTAGATTTGGAAAGATCTTTGTGAAGACTGGACTTTTTTCA
TTCGGCAGCAAGTTGAACCAGATCAGGAAAAAGACGATGAATAAACTGAAACTT
ACATGGCAGAAGAAGAAGGTGGAACTGGAAAGCAAGATGAAGGAAATCCTAGCG
AGAAGAGACAATACCATTGAGGACTTGAAAGACACGATAGTCGAGATCAACGCA
GCCAGTAACATCGGCAAACACCTCTTCCAGAGTGATATCCTCTTGACAAAGAAA
CAAGCAGATGAAGTCCTGGAAGCTGTCGACGGAACCAGTGGTAGGAAGAAGAGA
CAAGCGTTCAAAGATAAAAATTATCCCAATACCACATGGCTAGGAGCACAAGTC
TTTTACAAGTTTGACGACAGCGCAGACCACTTCACCAGAGAAATGTTCAAGAAG
GGAGCCAAACAATGGGAAGACGTGTCGTGCATCAAGTTCCACCATGATAAGGAG
AACAÀATCTGAACACAGTATCGTGTTAATCAAAGAGGAAGGCTGTTGGTCCTAT
GTGGGACGCCTTGGAGGCGAACAACCTCTTTCGCTCGGAGTTGGCTGTGAGGAG
Mtp-Nde ►
g t c g g a a c t g c g g c a c a c p a a c t c g g c ^ a c g S M B g g t c t t t t c c a t a c a a t g
TCTCGTTACGATCGAGATGACTTCATAACTATCGCTTTGGAGAATGTTCGAGAA
GATTTCGTGGACCAGTACATCAAGGAGACCACTGAAACTACTACCAACTATGAC
c t t a c c t a t g a c t a c g c c a g c a t c a t g c a t t a c B ^ M i I I I  "c t t c t c a I
^55vGAAACCTAcjACAAG AAC CS TGATAGCTAACGACGTAAACTTCCAAGAATCGATGGGC
TCGCACATCCTGACATTCATAGACAAATCCATGATCAACGACCATTATAACTGT
AAAGCCAAATGTCTGAATGCCAAGgCTCACCAGTGCAAGAATGGTGGATTCCC^
Mtp-r-2
EACCCaGAAAAATGCTCGGAATGTATTTGTCCAAGCGGCTATGGCGGTGCCTTC
TGCAATGAACGACCTTCTGGATGCGGTAGGAAGTTAGTGGCGAAACAGAGCAAG
CAGTTCCTCATTGACAAACTCGGCTTCGGTGGTCCTGTCAGGGATGAATTCACT
TTCTGCAACTACTGGATTGAAGCTCCTGAAGGGAAAACGATAGAAGTTAAGATC
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— ..............  — ^ —  Mtp-X/iog pGAAATOBAATCAAGATCAAACTCGAACCGGATACCGACTCTGCTCACCGAAT
GATCGTAATGTGAAGCTAGTCTCGGCCTCCAACCGGCTGCCTGTAATCACCTTC
AACAGGTTGGGTCAGCAGCAAGTTATCf^^ÂGTÂCAAAATTGCCGA^TAG
4 -  Mtp-R-X/io
Figure 7.2.2: Nucleotide sequence of novel astacin-like MTP amplified by 
degenerate PCR from H. contortus ExL3 cDNA and extended by RACE 
PCR from L4 cDNA. Primer sites for specific cloning, expression and 3’ 
and 5’ extension are shown above or below sequence (forward and 
reverse respectively) and shaded in grey. Boxed region was cloned into 
pET and expressed. (Accession number AM159505). Start (ATG) and 
stop (TAG) codons are in red.
The full length cDNA (submitted to EBI, Accession number AM 159505) codes a 
502 aa open reading frame (Figure 7,2,3). The first 16 aa represent a predicted 
signal sequence with a putative site of cleavage between Alai6 and Glyi?. The 
protein contains a 127 amino acid putative pro-peptide with a likely site of 
cleavage between Argu2 and Lysi43 (ProP 1.0). A search of the protein structure 
databases (Prosite) showed the catalytic region of the protein contains the 
characteristic metzincin domains including the zinc-binding region 
HELGHALGLFH (Prosite PDOC00129) and the Met-tum (SIMHY) (Figure
7,2,3). Furthermore, the extended astacin-family specific motif, 
HEXXHXXGFXHEXXRXDR is found in HcMTP and the HcMTP shares all but 
2 of the 18 residues with this motif (the HcMTP extended motif is 
HELGHALGLFHTMSRYDR). Homology modelling of the 3D protein 
structure was carried out using the SwissModel software 
(http://swissmodel.exDasv.0 rg//SWISS-MQDEL.html) and the Deepview Swiss- 
pdbViewer version 3.7. A comparison of the catalytic region (Tyri52 -  Sersos) of 
HcMTP with the crystal structure of crayfish astacin (pdb iQJl) predicts that the 
HcMTP will have a similar structure (Figure 7,2,4). The model demonstrates 
how the side chains of the three Histidine residues from the zinc binding domain 
and the glutamic acid side chain from the Met turn form the zinc-binding site. 
The catalytic region is followed by a 34 aa epidermal growth factor-like domain
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containing 6 conserved cysteine residues (EGF, Prosite PDOC00021) and a CUB 
(Clr/s complement-like, sea urchin protein, Uegf and BMP-1-like, (Bork and 
Beckman, 1993)) domain, both of which are characteristic of the nematode 
astacin-like MTPs identified to date (Figure 7.2.5). The full 502 aa ORF has a 
predicted molecular weight of 56.5 kDa and contains 3 putative /V-linked 
glycosylation sites (N-X-S/T-X) at Asu]?, Asn ,54 and Asnigg. Cleavage of the 
pro-peptide would result in a protein with a predicted molecular weight of 41 
kDa (not including the impact of possible glycosylation).
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N SISH G YAYDGCILGGVEIKSNQDQTRTGYRLCS PNDRNVKLVSASNRLPVITF 
NRLGQQQVILEYKIAE
I  I T . (VtJpeptide I
Figure 7.2.3: Amino acid sequence and schematic diagram of full length 
H. contortus MTP. Putative signal peptide (S) is shown in purple. 
Putative pro-peptide is shaded in yellow. Predicted A/-linked glycosylation 
sites are shown in pink. The catalytic domain is shaded in light grey and 
the astacin-like domains are shaded in dark grey. The zinc-binding site is 
highlighted in red and the Met-turn motif is boxed. The EGF domain is 
highlighted in pink and the CUB domain is highlighted in blue.
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Figure 7.2.4: Molecular model of the catalytic domain of HcMTP based 
on the crystal structure of Crayfish Astacin (PDB 1QJ1). Beta sheets are 
shown in yellow and alpha-helices shown in red. A shows the ribbon 
structure of amino acids Tyri52 to Seraos of HcMTP based on homology 
modelling to Astacin. The sidechains of the three His in the zinc binding 
domain and the Glu in the MET turn are highlighted; these make up the 
zinc ligation site. Amino acids in the MET turn are highlighted in blue. B 
shows the ribbon structure of Astacin (PDB 1QJ1). 0  shows an overlay 
of HcMTP (red) superimposed onto Astacin (yellow) and highlights the 
similar structure and folding.
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7.2.2 Homology of HcMTP with other nematode astacin-like
metalloproteases
Astacin-like MTPs have been reported in several parasitic nematode species, and 
constitute a 39 member (NAS proteins) family in C. elegans (Mohreln et al, 
2003) therefore the relationship of the HcMTP to MTPs from other species was 
investigated. A WuBlast search of the NCBI database with the determined 
HcMTP aa sequence revealed closest homology to MTPs I and III (61% and 46% 
identity, respectively) from the cattle stomach worm O. ostertagi and a ClustalW 
alignment highlighting the regions of identity to these and the AcMTP (46% 
identity) is shown in Figure 7,2.5. Of the NAS proteins from C. elegans, NAS- 
31 and NAS-32 show the closest homology to HcMTP with an amino acid 
identity of 42% and 34%, respectively. A phylogenetic tree was produced using 
the MEGA 3.1 programme and neighbour-joining method with the published 
astacin-like MTPs from other parasitic nematodes and NAS-31, -32 and -37 from 
C. elegans (Figure 7.2.6). The protein sequences for the T, vitrinus MTPs were 
kindly provided by Dr A. Nisbet. HcMTP is situated in a group with O, ostertagi 
MTP3 and NAS-31 but was in a distinct group from AcMTP. A distinctive 
feature of the tree is that the MTPs from O. ostertagi, for which the most 
sequences are available, do not cluster together suggesting that there may be 
distinct functions attributable to certain groups of the protease.
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Figure 7.2.5: ClustalW alignment of a protein translation of the hc-mtp 
nucleotide sequence amplified from H. contortus cDNA with the amino 
acid sequences of A. caninum MTP and the O. ostertagi MTPs 1 and 3. 
Regions of amino acid identity to the HcMTP are shaded in dark grey; 
regions of similarity are shaded in light grey. Regions to which the 
original degenerate primers were designed are highlighted with black 
arrows (see Chapter 2, Figure 2.5.1)
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Figure 7.2.6: Phylogenetic tree of the published parasitic nematode 
astacin-like metalloprotease sequences and three NAS family proteins 
from C, elegans. Crayfish astacin is included for comparative purposes. 
Tv- T. vitrinus; O.ost- O, ostertagi, He- H. contortus, Ac- A. caninum, 
A.cey- A. ceylanicum, T.spir- T. spiralis, S.sterc- S. stercoralis. Line 
length indicates divergence.
7.2.3 Expression of recombinant HcMTP
To provide an antibody probe to investigate expression of the native protein, the 
210 aa HcMTP fragment (boxed region in Figure 7.2.2) was cloned into pET 
using primers MTP-Nde and MTP-X/io and expressed in E. coli as an insoluble 
recombinant protein (rHcMTPf) with an estimated molecular weight of 24 kDa 
(Figure 7.2.7), The protein was expressed abundantly within the induced 
bacterial insoluble fraction and was also visible at a lower level in the insoluble 
fraction from non-induced bacteria. The vector pET 22b has been previously 
demonstrated a “leaky” vector (G. Ball, personal communication), thus this is 
likely to represent low level bacterial expression prior to induction. The 
rHcMTPf was excised and subjected to a trypsin digest and MALDI-TOF 
analysis (Section 2.3.17); a comparison of the peptide mass fingerprint of the
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fragments with an in silico digest o f  the HcMTP fragment aa sequence confirmed 
the expressed protein as rHcMTPf (see Appendix 2.2). The expressed fragment 
was purified by electroelution and used to raise antibody in rabbits. The 
vaccinated rabbit sera recognised the recombinant HcMTPf in E. coli insoluble 
extract, and cross-reacted with a band at 38 kDa (Figure 7.2.7). Pre-vaccinate 
sera also cross-reacted with a bacterial protein at 38 kDa in the extract, but 
showed only a very weak recognition o f  the recombinant HcMTPf, likely to be 
attributable to non-specific binding.
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Figure 7.2.7: SDS PAGE gel of recombinant HcMTPf expressed as an 
insoluble bacterial protein. An anti-His(6) antibody probe recognises the 
expressed rHcMTPf protein in a Western blot. The rHcMTPf protein was 
purified by electroelution and used to raise antisera in rabbits. Panel A:
1- Insoluble fraction from induced bacteria; 2 insoluble fraction from non­
induced bacteria; 3- Western blot of Lane 1 probed with anti-His antibody; 
4- Western blot of Lane 2 probed with anti-His antibody; 5- electroeluted 
rHcMTPf. An arrow marks the rHcMTPf protein Panel B: Western blot 
of insoluble protein fraction from E. coli expressing rHcMTPf. 1- probed 
with pre-vaccinate rabbit sera; 2 probed with rabbit anti-rHcMTPf sera. A 
protein of the appropriate size to be rHcMTPf is recognised by the sera 
(arrow).
The full length MTP without signal peptide was cloned into pET/ E. coli 
(rHcMTP). Upon induction, three proteins were expressed, the largest with a 
molecular weight o f approximately 55 kDa (corresponding to the predicted
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molecular weight of the expressed His-tagged HcMTP without signal sequence, 
of 55.7 kDa) and a protein doublet migrating with an estimated molecular weight 
of 49 and 45 kDa (data not shown). All three bands were cleanly excised and 
subjected to trypsin digest and MALDI-TOF analysis. Comparisons with an in 
silico digest of the full length amino acid sequence confirmed that all three 
represented the HcMTP. An insight into possible processing or truncation could 
not be gained. However, it is interesting that a peptide fragment matching 
position 43 in the expressed rHcMTP (without signal peptide) was identified in 
the 55 kDa band and not in either of the lower molecular weight bands perhaps 
indicating they may have been slightly truncated at the A-terminal (Appendix
2.3).
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Figure 7.2.8: Western blots of insoluble bacterial fractions expressing full 
length rHcMTP probed with either rabbit anti-rHcMTP antisera, diluted at 
1:1000 (A) or sera from H. contortus immune sheep, diluted at 1:500 (B). 
Panel A: 1- pre-vaccinate rabbit sera; 2 anti-rHcMTP rabbit sera. The 
arrow marks the 55 kDa rHcMTP. Panel B: 1- pre-immune sheep sera;
2- H. contortus immune sheep sera. Arrows mark the three expressed 
forms of rHcMTP
When an insoluble fraction from bacteria expressing the full length rHcMTP was 
probed with rHcMTPf antiserum, a band, likely to correspond to the 55 kDa 
rHcMTP, was recognised at 55 kDa (Figure 7.2.8). Pre-vaccinate rabbit serum
183
only recognised a band at 38 kDa, likely to be a result of non-specific binding. 
Sera from a sheep immune to H. contortus reacted strongly with the three bands
corresponding to the expressed forms of rHcMTP, sera from naïve sheep showed 
background reactivity likely to be the result of non-specific binding and did not
To investigate whether the hc-mtp was a member of a gene family, Southern 
blots were earned out on high molecular weight H, contortus genomic DNA 
digested completely using one of EcoRI, BamBl, Hindlll or Notl restriction 
enzymes. The blots and hybridisation conditions were as described in Section 
2.3.16. The probe used was the fragment that was cloned into pET for 
expression cut out by restriction enzyme digest and DIG-labelled. Despite 
several attempts, the blots remained very smeary and could not be interpreted.
7.2.5 Immunolocaiisation of HcMTP in worm extracts and
sections
The site of protein expression within the ExL3 was investigated by 
immunohistochemistry studies using the rHcMTPf antiserum. This analysis 
indicated that the protein localises to the lateral hypodermal cords, adjacent to 
the lateral alae or possibly to the excretory/secretory system (Figure 7.2,9). 
Neither pre-vaccinate rabbit serum (the negative control) nor the secondary FITC 
labelled anti-rabbit IgG serum (a background control) labelled any structure 
within the ExL3 sections. Background fluorescence was only detected following 
a prolonged exposure (45s) time compared to the test sections. This was 
necessary as control sections were not visible when photographed at the same 
exposure time (15s) as control sections due to the lack of fluorescence.
recognise the 55 kDa band.
'i
7.2.4 Southern blot using the hc-mtp gene fragment
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Figure 7.2.9: Immunohistochemical labelling of H. contortus ExL3 
transverse section probed with rabbit rHcMTPf antiserum. Sections were 
probed with 1:200 anti-rHcMTPf rabbit sera (positive) or 1:200 pre- 
vaccinate control sera (negative) or 1:50 FITC labelled anti-rabbit IgG 
(background control). A- rHcMTPf antiserum; B light microscopy of 
panel A; C- background control; D- negative control. Cu- cuticle; LA- 
lateral alae. Arrows mark the site of immunolocaiisation in Panel A 
labelling the lateral hypodermal cords.
To determine the expression and excreted/secreted nature of the HcMTP 
identified. Western blots were carried out on ExL3 and adult extracts and L3 EF 
and ES using sera raised against the rHcMTPf as a probe. The rHcMTPf 
antiserum recognised a band of an estimated 47 kDa in ExL3 soluble extract
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(Figure 7.2.10). The antiserum failed to recognise any bands in any other ExL3 
or adult extract, EF or ES (data not shown).
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Figure 7.2.10: Western blot of reduced H. contortus ExL3 soluble extract 
probed with rabbit sera raised against rHcMTPf. 1- anti-rHcMTPf sera; 2- 
pre-vaccinate rabbit sera. Arrow marks the protein band reacting with the 
sera in Lane 1.
An insoluble bacterial ûaction containing the full length recombinant rHcMTP 
was probed with sera from animals vaccinated with the unbound ES fraction 
(Chapter 4), to which MTP activity partitioned (Figure 7.2.11). Two bands of 
the appropriate size to be the expressed rHcMTP were differentially recognised 
by vaccinate sera compared with pre-vaeeinate sera. These bands were also 
absent from insoluble fraction made from cells containing an empty pET vector. 
However a general recognition of several E. coli proteins by both vaccinate and 
pre-vaccinate sera rendered the blot difficult to interpret.
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Figure 7.2.11: Western blot of reduced insoluble bacterial fraction 
expressing either empty pET vector (negative control) or full length 
recombinant HcMTP. Blots were probed with a 1:1000 dilution of sera 
from sheep vaccinated with the unbound ES fraction or pre-vaccinate 
(control) sera. 1- Empty pET; 2 rHcMTP; 3- Empty pET; 4- rHcMTP.
An investigation o f the stage specific expression o f HcMTP was carried out 
using cDNA prepared from all life stages o f H. contortus. Transcript was 
detected from L4, day 11 (immature) adult and day 22 (young but mature) adult 
cDNA. HcMTP was also detected in egg, ExL3 and day 28 adults but at far 
lower levels (Figure 7.2.12). Despite the non-quantitative nature o f the PCR, it 
is suggestive o f increased expression o f HcMTP in the L4 and early adult stages 
when compared with the HcTTR stage specific RT-PCR analysis o f identical 
template cDNA run under the same amplification conditions (Chapter 6, figure 
6.2.5).
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Figure 7.2.12: RT-PCR of HcMTP on cDNA prepared from all life stages 
of H. contortus. Primers (Mtp-f-2 and Mtp-r-2) produce a 200 bp product 
marker by lower arrow. Upper arrow marks probable genomic product. 
1- Molecular weight marker (bp); 2- egg cDNA; 3- L3 cDNA; 4- ExL3 
cDNA; 5- L4 cDNA; 6- day 11 cDNA; 7- day 22 cDNA; 8- day 28 cDNA; 9- 
negative control (no template); 10- positive control (full length HcMTP 
cloned into pET).
7.2.6 RNA Interference of nematode-astacin genes in C.
elegans
The possible function of the astacin-like MTP was investigated by conducting 
RNAi experiments astacin-like genes in C. elegans that showed closest 
homology to HcMTP, nas-31 and nas-32. RNAi was carried out using a soaking 
method. Successful knockdown of mRNA transcript was achieved by RNAi in 
experiments targeting nas-31 and nas-32 individually and in combination 
(Figure 7.2.13). The F54D5.3 gene (Geldhof et al., 2005) was used as a control 
gene to check the uniformity of RNA preparations using F54 primers, kindly 
provided by Dr P. Geldhof. Amplification of F54D5.3 was successful on all 
RNA prepared from treated and control worms, confirming success of the one- 
step PCR. It would suggest however, that the RNA prepared from worms that 
underwent combinatorial RNA was of a slightly lower concentration (Figure 
7.2.13 B). No visible phenotype was observed when either nas-3\ or nas-32 
was targeted individually or in combination.
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Figure 7.2.13: One-step RT-PCR on C. elegans that have undergone 
RNAi for nas-31 and/or nas-32. The gene targeted by RNAi (A) and the 
PCR positive control gene (B) were amplified by RT-PCR to ascertain 
that both RNAi and RT-PCR had been successful. Panel A: 1- DNA 
ladder; 2- nas-31 RNAi, nas-31 PCR; 3 nas-32 RNAi, nas-32 PCR; 4- 
Control, nas-31 PCR; 5- nas-31 and nas-32 combinatorial RNAi, nas-32 
PCR; 6- nas-31 and nas-32 combinatorial RNAi, nas-31 PCR; 7- Control, 
nas-32 PCR. Panel B, control PCR using F54 primers: 1- DNA ladder; 2 
Control cDNA; 3- nas-31 RNAi; 4- nas-32 RNAi; 5- nas-31 and nas-32 
combinatorial RNAi; 6- negative control (no template).
In Panel A, upper arrow marks the genomic DNA product for nas-32; 
lower arrow marks the cDNA product for both nas-31 and nas-32 visible 
only in the control worm cDNA.
7.2.7 Direct chaiienge assay
AcMTP antiserum has been demonstrated to inhibit larval penetration of the skin 
by A. caninum, suggesting the AcMTP may play a role in invasion of host tissue 
(A. Loukas, personal communication). The ability of rHcMTPf anti serum to 
prevent in vitro establishment of H. contortus ExL3 in abomasal tissue was 
examined as described previously (Sections 2.10 and 4.2.3). Pre-incubation with 
rHcMTPf anti serum actually increased the percentage of tissue associated L3 
(83% +/- 4.4) compared to those pre-incubated with pre-vaccinate rabbit control 
serum (64% +/- 7.5).
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7,3 D iscussion
On transition to parasitism, A. caninum infective larvae secrete an astacin-like 
MTP enzyme (Hawdon et al, 1995; Zhan et al, 2002) and specific antiserum 
can inhibit tissue penetration by infective larvae in vitro implying a role in skin 
penetration. The recombinant AcMTP has shown potential as a vaccine 
candidate (Hotez et al, 2003). Since then, astacin-like MTPs have been isolated 
from the infective larval stages of several parasitic nematodes (Lun et al, 2003;
De Maere et al, 2005; Gomez Gal lego et al, 2005). H. contortus larvae release |
a MTP that mediates exsheathment and a likely distinct MTP into ES after 72 
hours in vitro culture (Gamble et al, 1989a; Gamble et al, 1996; see Chapter 
3). Despite characterisation of the protease activity, no sequence data has been 
forthcoming, and astacin-like genes are notably absent from the H. contortus 
EST dataset. Considering the potential of MTPs as vaccine targets, it would be 
of benefit to identity homologues of the AcMTP in H. contortus. Here, the 
isolation and characterisation of a novel H. contortus MTP belonging to the 
astacin family is described.
An initial BLAST search (April 2004) of the H. contortus available ESTs with 
the AcMTP sequence resulted in no significant hits, however the EST dataset is 
incomplete and is heavily biased towards adult stage sequences (15,000 adult 
compared to 1100 larval ESTs). Therefore transcripts expressed predominantly 
by larvae may not be represented. Degenerate PCR followed by RACE 
extension of the 3’ and 5’ ends resulted in the amplification and cloning of a 
novel gene, HcMTP.
The astacin family of MTPs were recognized during the 1990s following the 
characterisation of the eponymous crayfish (Astacus astacus) protease, astacin 
(Titani et al, 1987). Members of this diverse family include a sea urchin 
developmental protein (SpAN; Reynolds et al, 1992), the human bone 
morphogenetic protein (BMP-1; Wozney et al, 1988), the mammalian and 
Drosophila tolloids (HuTLD; Takahara et al, 1994 and DrTLD; Shimmel et al,
1991), the mammalian meprins (Bond and Beynon, 1995), a 39 strong gene 
family in C. elegans (Mohrlen et al, 2003) and several MTPs identified in
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parasitic nematodes. On account of the uniformity of the zinc-binding site 
amongst the astacin-like MTPs, a group of snake venom metalloproteases, the 
serralysins and the matrix MTPs, Bode et a l (1993) suggested they be grouped 
into a common family called the metzincins. The astacin-family belongs to the 
M12A subfamily of the metzincin supeifamily (www.merops.sanger.ac.uk/). 
Metzincins are characterised by a catalytic domain including the
HEXXHXXGXXH motif (which includes the zinc-binding site) and Met turn
(SXMHY) 50 or so residues downstream (Bond and Beynon, 1995). Members of 
the astacin-like family have a conserved extended motif of
HEXXHXXGFXHEXXRXDR (Stocker et al, 1995). HcMTP shares 15 of the
18 residues with this conserved astacin-specific extended motif, however does 
not have the Glutamic acid residue following the third Histidine that is a feature 
of astacins (Hooper et al, 1994). HcMTP exhibits a conserved Met turn a 
further 38 amino acids downstream (Figures 7,2,3).
The structure of astacin has been solved by X-ray crystallography and shown to 
consist of an V-terminal and C-terminal domain with a deep cleft in between the 
two domains (Gomis-Ruth et al, 1993) as seen in Figure 7.2.4B. The zinc ion, 
which is essential for activity, is located at the bottom of this cleft and is thought 
to be penta-coordinated through the three histidine residues and glutamic acid 
residue of the zinc binding motif and the tyrosine residue from the Met turn; the 
Met turn directing the residue towards the binding site (Stocker et al, 1993). 
Despite crayfish astacin itself only consisting of a signal peptide, pro-peptide and 
the catalytic domain, most other members of the astacin-family show several C- 
terminal domains following the catalytic region, normally containing one or 
more EGF and CUB domains (Bond and Beynon, 1995).
A molecular model of the catalytic region of HcMTP, based on the structure of 
astacin (Gomis-Ruth et al, 1993), highlights the similar structure and folding of 
the two enzymes (Figure 7.2.4A and C). Based on this model, it is likely that 
HcMTP also binds the zinc atom with the imidazole sidechains of the three 
histidine residues (Hjs24o, His244 and His2so) and a water molecule from the 
glutamic acid (Glu 243) of the zinc binding site, with the Met turn positioning an 
oxygen from a tyrosine (Tyr29p) to complete the 5 ligands (Bond and Beynon,
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1995). HcMTP shares all the characteristics, with the exception of the glutamic 
acid following the third histidine, to be classified as a member of the astacin- 
family of MTPs.
The C-terminal region of HcMTP contains an EGF domain followed by a CUB 
domain. Both of theses domains aie common in the C-terminal of astacin family 
proteins though are both notably absent from astacin itself (Bond and Beynon, 
1995), These C-terminal domains are shared by the astacins described to date 
from other parasitic nematodes (Zhan et al., 2002; Lun et al, 2003; De Maere et 
al, 2005; Gomez Gallego et al, 2005) and from the C. elegans astacin-like 
proteases from subgroup III, IV and V (Mohrlen et al, 2003). It has been 
suggested that these are non catalytic domains that play a role in protein- 
8 ub strate (or protein-protein) interactions (Bond and Beynon, 1995). EGF 
domains are present in single copies in the parasitic nematode sequences 
determined to date (Zhan et a l, 2002; Lun et al, 2003; De Maere et al, 2005; 
Gomez Gallego et al, 2005) and exist as single or multiple copies in several 
astacin family proteases and other secreted proteases more generally (Bond and 
Beynon, 1995). CUB domains have been suggested to form anti-parallel p- 
baiTels similar to those in immunoglobulins and are features of diverse members 
of the astacin-family MTP including the tolloid proteins, BMP-1 and subgroup 
III, IV and V NAS proteins from C. elegans (Mohrlen et al, 2003) as well as 
non-MTP proteins such as the complement subcomponents Cls/Clr (Bork and 
Beckmann, 1993).
The closest homologue of HcMTP was O. ostertagi MTP III (OoMTP III) which 
showed a 61% amino acid identity and was of a similar length. Both OoMTP I 
and AcMTP shared a 46% homology with HcMTP and had extended C- termini, 
the significance of which is unknown (Figure 7.2.5), Like the OoMTPs I and III 
and AcMTP, but unlike other astacin-family members, the residue immediately 
following the third histidine in the zinc-binding site is a threonine not a glutamic 
acid; this has lead some authors to suggest a reclassification of astacin-family 
into two distinct families (De Maere et al, 2005). The closest homologues of 
HcMTP in C. elegans were NAS-31 and -32 (42% and 34% amino acid identity 
respectively). Phylogenetic analysis confiimed OoMTP III and the C. elegans
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NAS-31 as the closest relatives of HcMTP (Figure 7.2.6). An interesting feature 
of the phylogenetic analysis was that MTPs from the same species do not 
necessarily group together suggesting that they may have evolved distinct 
functions. Further evidence for different functions comes from the temporally 
regulated nature of the O. ostertagi MTP family; OoMTP I being expressed in 
the adult stage, OoMTPs II and IV in the L3 and lA  and OoMTP III expressed 
by the L3 and the adult (De Maere et al, 2005), Of note, the T. spiralis MTP 
clusters with NAS-37 perhaps suggestive of a role in moulting rather than in 
digestion as implied by Lun et al (2003).
The catalytic domain of HcMTP was expressed as an insoluble bacterial 
recombinant protein and the reduced protein was used to raise a specific 
antiserum (Figure 7.2.7). Expression of the full length HcMTP (without the 
signal peptide), also as an insoluble bacterial recombinant, resulted in expression 
of three proteins with molecular weights of 55 kDa, 49 kDa and 45 kDa. 
MALDI-TOF analysis confirmed that all three proteins represented HcMTP but 
this analysis did not allow an insight into possible truncation to be gained. Like 
the full length expression of HcMTP described here, bacterial expression of 
AcMTP also resulted in a triplet of proteins being expressed, one of which 
coiTesponded to the predicted size of the pro-enzyme; the authors suggested the 
other bands were likely to be processed or partially processed forms (Zhan et al., 
2002; Hotez et al, 2003). Following vaccination with recombinant AcMTP, sera 
from dogs recognised a triplet of closely migrating bands in activated A. caninum 
L3 ES corresponding to the pro-enzyme, the processed from of enzyme and a 
band migrating with a weight of between the two (Hotez et al, 2003). This 
might con'espond to a partially processed form, or to a related MTP.
Immunolocaiisation studies focusing on the larval stage identified foci of 
antibody recognition within a strip subcuticular to the lateral alae that extend 
from within 14 pm of the anterior end of the worm to the end of the tail 
(Lichtenfels et al, 1990) (Figure 7.2.9). The identity of the labelled region is 
difficult to categorise for certain, however it may be the secretory/excretory 
system or the hypodermal chords (I. Miskelly, personal communication). 
Interestingly, this focus of localisation is somewhat similar to that of the A.
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caninum MTP (Williamson et al, 2006). These authors describe the AcMTP as 
localising to secretory channels to the L3 cuticle; however, this work was earned 
out by electron microscopy so a direct comparison is difficult to make. 
Considering the immunoreactivity of the recombinant HcMTP, it is likely that 
HcMTP is at least accessible to antibody or secreted, despite the lack of detection 
of the native protein in ES. It may be stored in the foci immunolabelled prior to 
secretion/excretion. An alternative theory is that the protein is stored prior to its 
involvement in the moult from the L3 to L4. Nematode astacins have been 
implicated in ecdysis, (Hishida et al, 1996; Davis et al, 2004); AcMTP, OoMTP 
III and IV and strongylastin are associated with transition to parasitism therefore 
have been attributed roles such as larval penetration. However they may also be 
involved in the L3 to L4 moult which occurs soon after the parasitic transition 
(Zhan et al, 2002; De Mare et al, 2005; Gomez Gallego et al, 2005).
RT-PCR analysis in strand cDNA prepared from all the life stages of H. 
contortus resulted in HcMTP transcript detection in the L4 and immature adult 
(day 11) and young adult (day 22) stages (Figure 7,2.12). Transcript was also 
detected in egg and in ExL3 cDNA. A low level of transcript in ExL3 might 
explain why, despite original identification of the HcMTP by degenerate PCR in 
ExL3 cDNA, RACE PCR and extension was only achieved from RACE-ready 
L4 cDNA, not the RACE-ready ExL3 cDNA. Moreover, a protein of the conect 
size was detected in ExL3 SI extracts, but not in adult extracts (Figure 7.2.10), 
Like AcMTP, despite mRNA transcript being detectable in the adult stage, the 
protein product was only detected in the larvae (Zhan et al, 2002). Detection of 
HcMTP transcript in egg cDNA is interesting, as astacin-like proteins in C. 
elegans have been implicated in embryonic development and hatching (Hishida 
e ta l, 1996),
Sera from sheep immune to H. contortus infection reacted strongly with the 
rHcMTP implying that in natural infection HcMTP is recognised by the immune 
system (Figure 7.2.8B). Both the A. caninum and the O. ostertagi MTPs were 
demonstrated antigenic proteins providing a basis for identification as lead 
vaccine candidates (Zhan et al, 2002; De Maere et al, 2002). The AcMTP is 
secreted by activated L3 although it is not known whether the OoMTPs are
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secreted. Clearly to be a viable vaccine candidate a protein must be accessible to 
antibody (or cellular) attack; immune recognition of the MTPs in these species 
and of rHcMTP confirms this. The rHcMTPf antiserum recognised a single 
protein band only in the soluble extract of ExL3 H, contortus. The band had an 
estimated molecular weight similar to that of the MTP activity previously 
reported in H. contortus ES (Chapter 3 and Gamble et al., 1996) and to the 
predicted molecular weight of the processed form of HcMTP (47 kDa versus 41 
kDa, the disparity likely due to the two V-linked glycosylation sites in the 
processed enzyme). It is surprising that the rHcMTPf anti serum does not 
recognise the MTP confirmed in L3 ES (Chapter 3). It is possible that this is 
due to a distinct and as yet unidentified MTP being responsible for the observed 
protease activity, a possibility that could be investigated by 2D gel analysis and 
mass spectrometry analysis. Two bands of an appropriate size to be 
recombinantly expressed full length foims of HcMTP were recognised when an 
insoluble bacterial fraction expressing rHcMTP was probed with sera from sheep 
that were vaccinated with the unbound ES fraction (to which MTP activity 
partitioned, Chapter 4) (Figure 7.2.11). Bands at this size were not recognised 
by pre-vaccinate sera, nor was there recognition by vaccinate sera of bands in an 
empty vector control fraction. This might suggest that the MTP in the unbound 
ES is encoded for by the HcMTP or a homologous protein, however recognition 
by both vaccinate and pre-vaccinate sera of E. coli proteins makes interpretation 
difficult.
The role played by astacin-like MTPs has only been well studied in C. elegans. 
However, the function of NAS-31 is unknown. In fact of the 39 NAS genes in C. 
elegans the functions of only a few are understood (Mohrlen et al., 2003). NAS- 
34 (also known as HCH-1) is involved in embryonic hatching and ecdysis 
(Hishida et at, 1996) and NAS-37, as discussed in Section 7.1, is involved in 
moulting and ecdysis (Davis et al, 2004). The Genome wide RNAi analysis 
(results of which are published on www.wormbase.org) that has targeted the nas 
genes, describes an obvious visible phenotype for only 3 of the 39 genes: nas-9, - 
11 and -37 (Mohrlen et al, 2003). However, mutants for NAS-34 (HCH-1) and 
NAS-35 show a defective embryonic hatching and a dumpy phenotype 
respectively, but RNAi results in no phenotype. Reasons for this could be
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incomplete gene-silencing by RNAi (transcript knockdown was not investigated) 
or that the NAS proteins exhibit a high degree of functional redundancy 
(Mohrlen et al, 2003). Recent work has shown that combinatorial RNAi can be 
used to silence the products of two or more related genes thereby circumventing 
to a degree the problem posed by functional redundancy (Geldhof et al, 2006). 
Here, RNAi of nas-3\ and nas-32 resulted in a knockdown of transcript as 
measured by RT-PCR. RNAi of neither gene alone gave a phenotype (in 
agreement with the published RNAi phenotype on Wormbase) and combinatorial 
RNAi resulted in no detectable phenotype; feeding and reproduction appeared as 
in the control worms. NAS-31 and NAS-32 are the only two members of 
subgroup IV (groups based on structural similarity, Mohrlen et al, 2003) thus it 
might be that this sub-type of astacin-like MTP is not essential for survival and 
development or that another subtype of NAS protein can provide a degree of 
compensation. Recent work in our lab has demonstrated that effective RNAi of 
an entire class of proven H, contortus vaccine candidates in C. elegans had no 
phenotypic effect on woims (Geldhof et al, 2006 and unpublished results). 
Thus, care is needed in the interpretation of such RNAi experiments.
The closest C. elegans homologues to HcMTP are NAS-31 and NAS-32 
therefore, it seems unlikely that HcMTP plays a role in exsheathing as NAS-37 
has been determined to be an exsheathing protease orthologue (Davis et al, 
2004), although there may be more than one metalloprotease involved in 
exsheathing. This observation, coupled with the number of astacin-like MTPs in 
C. elegans and those identified so far in parasitic nematodes (for example, the 
three in T. vitrinus and 4 in O. ostertagi) suggest that HcMTP is likely to be a 
member of a protein family. Confirmation of a gene family was attempted by 
Southern blot analysis however the probe failed to hybridize clearly to the 
digested genomic DNA on several attempts. The failure of Southern blots using 
H. contortus genomic DNA is something that has been reported by several other 
co-workers (D. Redmond, personal communication). Although not complete, the
H. contortus genome is searchable but has not been annotated. A BLAST of the 
cuiTent genome with the HcMTP sequence indicated there is at least one other 
similar gene, although the number of potential MTPs is difficult to conclude.
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Vaccination experiments using the recombinantly expressed OoMTP I in cattle 
did not result in protection. However, the antigen was expressed in a highly 
truncated form and anti serum from vaccinated animals did not recognise native 
proteins in O. ostertagi ES or extract suggesting the recombinant protein was 
abeiTantly folded compared to the native antigen (De Maere et al, 2005). The 
AcMTP however, has shown considerable promise as a vaccine candidate; 
protection was coiTelated with AcMTP-specific IgG2 (Hotez et al, 2003). 
Moreover when the A. ceylanicum MTP was used as an immunogen in 
combination with the lead larval hookworm vaccine candidate (ASP-2) in the 
hamster-A. ceylanicum challenge model, it increased the levels of protection 
compared with either immunogen alone confirming the MTP’s status as a 
hookwoim vaccine candidate (Mendez et al, 2005). That pre-incubation of 
infective hookworm larvae with sera against AcMTP reduced larval skin 
penetration in vitro added further evidence to the MTP as a vaccine candidate 
(Williamson et al, 2006). Pre-incubation of H. contortus ExL3 with HcMTP 
rabbit anti serum did not reduce abomasal establishment in vitro compared with 
those larvae exposed to pre-vaccinate serum. However, incubation with sera 
from sheep vaccinated with the Unbound ES fraction (see Chapter 4, Table 
4.2.4) did result in a reduction in tissue associated larvae; metalloprotease 
activity partitioned with this ES fraction.
The H. contortus MTP described here is a homologue of the A. caninum MTP 
therefore represents a potential larval vaccine candidate against homologous 
challenge. The full length recombinant HcMTP is recognised by sera from 
naturally immune sheep thus the native protein is likely to be available for 
targeting by immune cells. Full length recombinant HcMTP is awaiting trial in a 
sheep protection experiment. It may be possible to use antibody affinity 
chromatography to purify enough of the native protein to allow a trial using the 
native antigen in the natural host, thus assessing the efficacy of the HcMTP 
specifically and the nematode MTPs, including the hookworm MTPs more 
generally.
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Chapter 8
General Discussion
" ' '" I;
The recognition of hookwoim infection as a leading cause of global morbidity 
has led to the establishment of a major initiative to develop a vaccine against 
human hookworms (Hotez et al, 2003). Despite an apparent absence in humans 
of the acquirement of natural immunity to hookworms, several lines of evidence 
point towards the feasibility of vaccination (Loukas et al, 2005). Vaccination 
with iiTadiated A. caninum larvae could induce high levels of protection (albeit 
not sterile) and this protection could be transferred passively in serum (Miller,
1965; Miller, 1967). In regions of endemic hookworm infection, levels of IgE
#specific for a larval ES antigen (ASP-2) are significantly associated with lower 
hookworm infection (Bethony et al, 2006). An alternative line of evidence 
comes from the veterinary field. Like hookworms, L4 and adult H. contortus are 
voracious blood feeders and research towards vaccine development against this 
parasite has identified several highly protective protein complexes from the 
worm gut proving vaccination against H. contortus is a feasible strategy (Knox 
and Smith, 2001). Efficacious protective antigens have also been identified in H. 
contortus ES (Schallig et al, 1997). Of these already well established vaccine 
candidates, several have homologues in the hookworms. Lead candidate i
hookworm antigens have thus been selected on account of either their association 
with the attenuated larval vaccine, or because they are homologues of the major 
H, contortus vaccine candidates (Hotez et al, 2003).
Using these selection criteria, several hookworm antigens, from both larval and 
adult stages have been identified as potential vaccine candidates and expressed as 
recombinant proteins for vaccine testing (Hotez et al, 2003). Some of these 
antigens have been established as modestly protective in recombinant form, but 
due to the difficulties involved in obtaining sufficient quantity of native protein, 
have not been tested as native antigens. In comparison, higher levels of 
protection against homologous challenge have been achieved using the 
corresponding native H. contortus antigen in sheep trials. The inference here is 
that the native hookworm antigens may be highly protective but that this level of 
protection cannot be obtained with recombinants tested to date due to, perhaps, 
inappropriate post-translational processing. It is quite feasible to obtain 
sufficient biomass of the different H, contortus life cycle stages to purify the 
homologues of putative hookworm vaccine targets and to evaluate their efficacy
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in vaccine trials in sheep using infection regimes mimicking natural exposure. 
This fact and the convergence of vaccine targets in hookworms and H. contortus 
render the latter a very useful model to aid vaccine development against the 
former.
Upon activation by incubation with host serum, A. caninum L3 begin to secrete 
proteins that are thought to be essential for the transition to parasitism, host entry 
and adaptation to the new host environment. Notably, activated A. caninum L3 
release several well characterised proteins including AcASP-1, Ac ASP-2 and 
AcMTP, therefore it is likely that homologues of some or all of these are 
represented within H. contortus 13 ES. In an analogous situation, H. contortus 
L3s can be exsheathed by re-creating in vitro the likely stimuli that larvae are 
exposed to upon host infection. Exposure to 37°C and to CO2 results in the 
release of a number of proteins including a MTP that mediates exsheathment 
(Chapter 3; Gamble et al, 1989). In vitro culture of L3 following exsheathment 
resulted in the secretion of a range of ES proteins, the concentration and 
complexity of which increased with time in culture (Chapter 3). These included 
a MTP with a molecular weight of 40 kDa, as estimated by non-reducing gelatin- 
substrate SDS-PAGE, similar to that described by Gamble et at. (1996) and 
likely distinct from the EF MTP. A single domain homologue of ASP-1 has been 
previously identified in H. contortus 13 ES (Sharp and Wagland, 1998), the full 
coding sequence of which is described in Chapter 5 (HeASP-1), and shows a 
26% identity at the amino acid level to the ^terminal domain of AcASP-1. In 
this study, production of a recombinant He ASP-1 proved impossible, however 
the elucidation of the full length sequence confiimed the He ASP-1 as a single 
domain type ASP demonstrating a higher homology to the A-terminal domain of 
the double domain ASP-1 than to ASP2, similar to those described from O. 
ostertagi (Geldhof et ah, 2003).
H. contortus L3 ES can be fractionated by lentil lectin affinity chromatography 
with the binding fraction purportedly enriched for the larval He ASP-1 (Shai*p and 
Wagland, 1998). These authors infer that this enriched fraction contained little 
other contaminating protein, however in this study it was clear from Western 
blots, and SDS PAGE examination of the bound and subsequently eluted protein
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fraction, that L3 ES contained lentil lectin binding proteins other than the 40 kDa 
protein previously identified as the ASP-1 homologue (Chapter 3), The presence 
of contaminating proteins within a crude fractionate complicates the 
interpretation of vaccine trials, particularly as in a previous study the authors 
implied the He ASP-1 protein to be the protective component of lectin bound ES 
in vaccine trials using a guinea pig model (Shaip and Wagland, 1998).
A sheep protection trial aimed at evaluating the protective potential of H. 
contortus larval ES proteins was earned out. ES was fractionated into a lentil 
lectin binding fraction and a non-binding fraction, the former purportedly 
enriched for the larval He ASP-1 (Shaip and Wagland, 1998). The trend towards 
lower EEC, statistically significant reduction in worm numbers and reduction in 
the length of female adult worms suggest that the lectin-binding fraction can 
confer a modest degree of protection in systemically immunised sheep. 
Assuming the bound L3 ES fraction described in this study did contain the larval 
HcASP-1, the modest protection reported here provides further evidence for the 
protective potential of ASPs confiiming their status as lead hookworm 
specifically, and nematode generally, vaccine candidates.
The levels of protection reported here fall short of the 85% reduction in worm 
burden reported in the guinea pig trials (Shaip and Wagland, 1998) and of those 
reported using ASP enriched adult H. contortus ES fractions (Hc24, Schallig and 
Van Leeuwen, 1997; Schallig et al, 1997; Kooyman et al, 2000) and O. 
ostertagi fractions (Geldhof et al, 2003). However it is possible that only trace 
amounts of protective protein were actually injected here; future work could 
focus on the identification and further purification of the protein(s) responsible 
for the protection reported here. Clearly a first step would be confirmation of the 
presence of the larval He ASP-1 either by an antibody probe, by using sera from 
vaccinated sheep to screen H. contortus cDNA libraries or through a proteomic 
approach. Both the latter two approaches would also likely yield information on 
other potentially protective proteins within the bound L3 ES fraction. Expression 
of the He ASP-1 in an alternative expression system would also allow exploration 
of its protective potential in a vaccine trial.
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Hookworm studies have revealed that IgE specific for N. americanus ASP-2 
reduces the intensity of infection in man (Bethony et al., 2005) and 
anti-NaASP-1 IgE also coiTclates with a reduction in woi*m burden in dog 
protection studies (Hotez et a l, 2003). It may also be relevant that protection in 
lambs vaccinated with an adult H. contortus ES fraction enriched for an ASP-2 
homologue conelated with IgE levels (Kooyman et al, 2000). In this study, IgE 
titres were not significantly increased in the group that received the bound L3 ES 
fraction in comparison with the adjuvant control group. It might be that an 
increase in the specific IgE titre could improve protection levels, although a 
recent vaccine study, trialing microparticles as a delivery system for hookworm 
calreticulin as a potential vaccine against N. americanus, questioned the 
protective effect of specific IgE (Winter et al, 2005).
Vaccination with a lentil lectin non-binding fraction of L3 ES resulted in a trend 
towards lower EEC and reduced w o i t h  burdens in vaccinated lambs compared to 
controls. Notably, MTP activity partitioned in this fraction (Chapter 3) and sera 
from sheep vaccinated with the unbound ES fraction inhibited the percentage of 
larval establishment in an in vitro abomasa! penetration assay (Chapter 3). Pre­
incubation of A. caninum L3 with AcMTP specific sera can inhibit in vitro tissue 
penetration suggesting that the AcMTP may play a role in larval migration 
(Williamson et al, 2006). Sera against the MTP in the H contortus unbound 
fraction may have had an effect on the establishment of L3, analogous to the 
situation in hookworm. MTPs have also been implicated in establishment of O. 
ostertagi larvae; L3s are non-feeding yet L3 metalloprotease activity could digest 
mucin, perhaps suggesting a role in penetration of the abomasal glands (Geldhof 
et al, 2000). The preliminary work described here requires further investigation; 
confirmation that a MTP might play a role in establishment could be sought by 
pre-incubating exsheathed L3 in a range of specific protease inhibitors prior to 
application to explanted abomasal tissue.
Another consideration is the nature of the vaccine-induced immune response 
desired to give maximum efficacy. Adult H. contortus imbibe host blood and, 
therefore, circulating antibody. Hence, antigens expressed on the surface of the 
worm intestine can be readily targeted. The L3s penetrate the abomasal glands,
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and are thus in intimate contact with potential local immune effectors (antibody 
and cells) but not necessarily exposed to systemic immune effectors. In the trial 
described in Chapter 4, the vaccine was administered systemically using Qui! A 
as adjuvant, thus favouring high systemic antibody titres. Perhaps, protection 
would be enhanced by delivering antigen directly to the GI lymphoid system. 
Adult H. contortus ES induces a strong IgE response during natural infection, 
levels of which conelate negatively with worm burden, and this may be required 
for the full expression of protective immunity (Kooyman et ai, 1997). In the 
trial described here, systemic IgE levels in sheep vaccinated with the 
lectin-bound L3 ES fraction were not significantly higher in vaccinates compared 
to control animals, although those animals vaccinated with the non-binding 
fraction did have a significant specific IgE response.
Despite only eliciting a modest degree of protection, the vaccination trials 
reported here do confirm the usefulness of targeting the larval stage worms as a 
vaccination strategy. The reduction in female worm size following vaccination 
with the lectin bound fraction indicates that an immune response against the 
larval worm may result in a detrimental effect earned through to adulthood. 
Hookworm trials in the hamster model also indicated that vaccination with larval 
antigens (ASP-2) could lead to a measurable reduction in adult worm size [10% 
compared with worms from control animals (Goud et al, 2004)]. Recently, 
Bethony et a l (2005) reported that vaccination of dogs with ASP-2 resulted in a 
69% reduction in EEC yet only a 26% reduction in adult worm burden. Given 
this large reduction in fecundity of woims, an immune response directed towards 
an antigen of the L3 must have an attenuating effect on adult woims, These 
findings are of significance as a successful hookwoim vaccine is likely to 
comprise of a cocktail of larval and adult antigens (Hotez et al, 2003). Should 
the immune response against larval antigens not only prevent some worms 
developing to adult but also have a deleterious effect on those worms that do 
reach maturity, targeting an adult antigen may result in a higher efficacy against 
these “weakened” adults. This principal would also apply to H. contortus 
vaccination. It would be interesting to investigate whether combining larval 
antigens with the recombinant cysteine proteases, [the best recombinant 
immunogens described in H. contortus to date, vaccination with which achieved
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a 38% reduction in adult worm burden (Redmond and Knox, 2005)], could 
increase the levels of protection.
A. caninum L3 secrete a transthyretin-like protein, specific IgE titre against 
which showed a slight negative conelation with worm burden in a dog vaccine 
trial (Hotez et ai, 2003). However, only low antibody titres were elicited to the 
recombinant AcTTR, thus a more appropriate indication of its prospect as a 
vaccine candidate might come from a trial using native protein, potentially by 
identifying its homologue in H. contortus, A bioinformatics approach allowed 
the identification of the H. contortus TTR that showed highest homology to the 
AcTTR (Chapter 6). The HcTTR was expressed throughout all life stages, but 
unlike the AcTTR did not appear to be secreted. Western blots identified the 
protein in soluble extract from L3 and adult worms, but not in ES. This result 
strongly suggests that the HcTTR was not in either of the previously discussed 
ES fractions evaluated in the protection trial. Immunolocalisation studies 
showed the native HcTTR to be strongly expressed in the lining of the uterus and 
on the eggs in utero as well as in the sub cuticular muscle tissue.
The function of the nematode TTR-like family of proteins is not well understood 
and a brief loss of function study in C. elegans demonstrated RNAi of a 
homologous TTR-like protein to have effect on worm phenotype. Some authors 
have suggested that they might play a retinol scavenging role (Hotez et al, 
2003). As discussed at length in Chapter 5, several nematodes, including 
hookworm, have been shown to secrete retinol binding proteins. It might be 
suggested that the TTR like proteins act much like mammalian transthyretin to 
stabilise retinol bound to the retinol-binding proteins. The site of localisation of 
the HcTTR neither confirms nor dismisses this theory. Parasitic nematodes are 
likely to require retinol for a variety of demands; indeed model systems have 
demonstrated retarded development of nematodes in retinol depleted hosts (see 
review by Bradley et al, 2001). Retinol is required for vertebrate and 
invertebrate embryo development (Maden, 2001) and as such may be required 
for nematode embryogenesis, hence the localisation of HcTTR to the egg and 
uterus. In filarial nematodes, lipid-binding proteins have been localised to the 
egg and developing embryo (Michalski et al, 2002). Of course this does not
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explain how retinol is initially scavenged from the host. Future work should 
concentrate on expression of TTR-like proteins in a soluble form to investigate 
ligand binding and to assess whether, like mammalian transthyretin, they form 
homotetramers that can interact with retinol binding proteins.
The potential of the HcTTR as a vaccine candidate would at first seem limited, as 
the site of expression is unlikely to be available to antibody. However, related 
TTR-like proteins have been detected in adult H, contortus ES (Yatsuda et al, 
2003) and have been shown to be immunoreactive. These proteins may play a 
different role and be expressed at other sites accordingly, or they may have been 
detected in culture because of release with eggs. Because of the intense 
expression of HcTTR on the egg, any immune interference (such as antibody 
binding) to the egg might inhibit or prevent successful hatching. It would, 
therefore, be of interest to investigate the effect of antibody on the development 
of eggs in vitro. The HcTTR may also represent a novel drug target. Although 
the HcTTR may be of value to intervention research in H. contortus, its lack of 
secretion suggests it plays a different role to that of the AcTTR identified as a 
potential vaccine candidate, thus the findings here may be of limited usefulness 
in its evaluation as a hookwoiTn immunogen.
The identification of a novel astacin-like MTP from H. contortus cDNA 
(HcMTP, Chapter 7) provides further evidence of the ubiquitous nature of these 
proteins in parasitic nematodes. A. caninum L3 secrete an astacin-like MTP that 
is likely to play a role in skin penetration and degradation of skin 
macromolecules (Williamson et al, 2006). The AcMTP has shown promise as a 
vaccine candidate (Hotez et a l,2003) and vaccination with the homologue in A. 
ceylanicum increased levels of protection against homologous challenge in 
combination with ASP-2 when compared with vaccination using ASP-2 alone 
(Mendez et al, 2005). MTP activity has been deseribed in H, contortus larval 
ES (Gamble et ai, 1996), the presence of which is confiimed in this study. 
Interestingly the foimer study associated protease release with the L3 to L4 
moult in vitro, ascribing it a potential role within this moult; in this study most 
L3 did not moult to L4, even after 120 hours in culture, similar to findings 
described by other groups (C. Britton, personal communication). The MTP may
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be involved in moulting and be released by the few worms that did develop to 
L4. Or it may play a role in moulting but other proteins essential for the 
completion of the L3 to L4 moult may not have been appropriately expressed, 
thus moulting could not be completed. An alternative explanation is that the 
metalloprotease activity is not involved in moulting but, like the AcMTP, 
functions in larval establishment within the host.
Sera raised against a fragment of the HcMTP localised the native protein to 
exsheathed L3 soluble extract, but interestingly did not react with any proteins 
within the larval ES. This may suggest that the HcMTP cloned and characterised 
in this study is not responsible for the MTP activity described in L3 ES, 
something proteomic analysis could substantiate. An alternative explanation 
might be that the native protein within the ES was at a far lower and more dilute 
concentration, thus antibody binding was not detected by Western blot. The full 
length recombinant HcMTP was recognised by sera from naturally immune 
sheep, suggesting secretion of the native protein, and was weakly recognised by 
sera from sheep vaccinated with the unbound L3 ES fraction. In other related 
parasitic nematodes (O. ostertagi for example. De Maere et ai, 2005) and in C. 
elegans (Mohrlen et al, 2003) astacin-like MTPs form a gene family and this 
may be the case in H, contortus. A search of the unannotated available H. 
contortus genome suggests there is at least one, and potentially more, other 
related but distinct astacin-like MTPs in H. contortus. Should this gene(s) prove 
to be coding, the protein product(s) may account for the activity in either EF 
(Gamble et al, 1989) or ES.
The HcMTP described in this study was immunoiocalised within exsheathed L3 
sections. Foci of localisation labelled either the lateral hypodermal chords, or 
possibly the excretory/secretory system. Very recent studies have localised 
AcMTP to secretory granules in the oesophagus and to channels that connect the 
oesophagus to the cuticle (Williamson et al, 2006). These studies were 
conducted using electron microscopy, therefore it is difficult to compare them 
directly with the results described here. However, the focus of localisation of 
HcMTP within the subcuticular region might suggest a similar site of 
localisation. Williamson et a l (2006) postulate that secreted proteins involved in
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the invasion and larval establishment processes in hookworm are packaged in 
eosphageal granules prior to secretion across the cuticle via secretory channels. 
This may also prove the case in H, contortus. Like the hookworm MTP, the 
HcMTP represents a potential larval vaccine candidate. Recombinant HcMTP is 
recognised by sera from naturally immune sheep and the full length recombinant 
HcMTP is awaiting vaccine trial. To gain a real insight into the protective 
potential of the HcMTP, it may be possible to purify enough native protein, using 
a high avidity antibody, to carry out a protection trial using the native antigen.
In summai'y, this body of work has demonstrated that vaccination of sheep with a 
non lentil lectin-binding fraction of H. contortus L3 ES resulted in a reduced 
EEC and final worm burden that, whilst not statistically significant, was lower 
than the adjuvant control group. Pre-incubation of L3 with vaccinate sera 
significantly reduced larval establishment in an in vitro assay. MTP activity 
partitioned with this fraction and by analogy to studies in hookworm, sera 
directed against the MTP may be responsible for the reduction in in vitro 
abomasal establishment. Vaccination with the lectin-binding fraction 
(purportedly containing the larval HcASP-1) had a modest protective affect 
against H. contortus challenge. Homologues of the hookwoiTn larval TTR and 
MTP vaccine candidates were identified and characterised in H. contortus and 
represent novel potential vaccine and/or drug targets.
Future work should concentrate on identification of homologues of other 
hookwoiTn vaccine candidates in H. contortus. For example several 
anticoagulant serine protease inhibitors are secreted by adult A. caninum (see 
Stanssens et al., 1996), in vitro neutralization of which can be achieved by 
specific antibody (Hamson et al., 2001). At least two homologous proteins have 
recently been identified in H. contortus (Clark and Knox, unpublished results). 
Identification of the native proteins would allow examination of protective 
potential in sheep vaccine trials.
A proteomic approach using ID SDS-PAGE (thus requiring less protein than 
needed for 2D analysis) followed by analysis through tryptic digest and Tandem 
MS/MS was successful in identifying proteins in T. circumcincta L4 and adult
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ES (Craig et al, 2006). This approach could be applied to both the unbound and 
bound fraction of L3 ES described here. Future work should focus on the 
identification of the proteins within the lectin binding and non-binding fractions; 
further purification of the proteins responsible for protection may lead to an 
increase in vaccine efficacy.
As a model for hookworm vaccine development, verification of the He ASP-1 in 
the lectin bound ES fraction as a target for protective immune responses would 
confirm the ASPs as lead larval vaccine candidates. The ability of sera from 
sheep vaccinated with the unbound ES, containing a MTP, to reduce H. contortus 
larval establishment in abomasal tissue may indicate that this, in part, contributes 
to vaccine-induced protective immunity and supports the exploration of the 
hookwoim MTPs as lead vaccine candidates. Purification of the natural HcMTP 
would also allow native protein vaccine trials. In terms of the usefulness of H. 
contortus as a model for hookworm larval vaccine development, the limited 
concentration of protein available from ES culture will hamper progress in 
canying out native protein vaccination trials. This paradigm has however led to 
the discovery of novel potential larval vaccine candidates against H. contortus 
and may lead to discovery of novel adult vaccine candidates, allowing their trial 
as native antigens and providing evidence of their potential in hookwoim vaccine 
design.
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Appendices
Appendix 1 Common Buffers and Reagents
Reagent Recipe
Acetate pH buffer 
(pH range 4-7)
0.1 M Sodium Acetate; adjusted to 
required pH by addition of glacial 
acetic acid
Acrylamide Gels: 10% Resolving Gel 3.3 ml 30% Acrylamide; 2.5 ml 4X 
Separating buffer; 4.2 ml dHzO; 0.01% 
w/v Sodium Dodecyl Sulphate (SDS); 
50 pi 10 % w/v ammonium 
persulphate; 10 pi TEMED.
Acrylamide Gels: 3% Stacking Gel 1 ml 30% Acrylamide; 5 ml 2X 
stacking buffer; 4 ml dHiO; 0.01% w/v 
SDS; 100 pi 10 % w/v ammonium 
persulphate; 10 pi TEMED
Anode buffer 1 0.3 M Tris in dHsO
Anode buffer 2 25 mM Tris in dHgO
Anode buffer 3 25 mM Tris-Glycine pH 9.4 in dHgO
Bicarbonate Buffer pH 9.6 0.25 mM NazCOs adjusted to pH 9.6 
with 0.25 mM NaHCOs
Coomassie Blue Stain 0.5% v/v Coomassie blue in 10% v/v 
methanol; 30% v/v acetic acid in dHzO
DNA Loading buffer 30% v/v glycerol, 0.25% v/v 
Bromophenol blue, 0.05% v/v xylene 
cyanol in dH20
Earles Balanced Salt Solution (EBSS) 25 mM NaHCOs; 5 mM KCl; 0.1 M 
NaCl; 1 mM NaHzP04 ; 0.1% w/v 
glucose pH 7.2
Laemmli electrophoresis buffer 0.25 M Tris; 2 M Glycine; 1% w/v 
SDS in dHzO and pH to 8.3 with HCl. 
Diluted 1 : 10 to give IX Laemmli
Lectin Wash Buffer (LWB) 0.5 M NaCl; 0.01 M Tris; 0.05% w/v
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NaNs in dH20 . Adjust pH 7.4 with 1 M 
HCl
Luria-Beitani Agar (LB agar) 1% w/v Bacto-tryptone; 0.5% w/v 
Bacto yeast extract; 1% w/v NaCl; 
1.5% w/v agar
Luria-Beitani Broth (LB broth) 1% w/v Bacto-tryptone; 0.5% w/v 
Bacto yeast extract; 1% w/v NaCl;
NZY top agar 85 mM NaCl; 10 mM MgS04 ; 0.5% 
w/v Bacto-yeast extract; 1% w/v casein 
hydrolysate; 0.7% w/v agarose pPI 7.5 
in dH20
Phosphate buffer (Sorenson’s) 
(pH range 7-9)
0.1 M K2HPO3 adjusted to required pH 
with 0.1 M KH2PO4 in dH20
Phosphate buffered saline (PBS) 0.1 M Phosphate buffer pH 7.5 with 
0.9% w/v NaCl in dH20
Protein Sample Buffer (Reducing) 0.125 M Tris-HCl pH6 .8; 20% v/v 
glycerol; 0.01% w/v SDS; 0.02% v/v 
bromophenol blue; 0.4 ml 2-j3- 
mercaptoethanol
Protein Sample Buffer (Non-reducing) 0.125 M Tris-HCl pH6 .8; 20% v/v 
glycerol; 0.01% w/v SDS; 0.02% v/v 
bromophenol blue
Separating buffer (4 X) 1.5 M Tris-HCl pH 8.8
SM buffer 0.1 M NaCl; 0.01 MgS04 ; 0.05 M Tris- 
HCl pH 7.5; 0.01 % w/v Gelatin
SOC Medium 2% w/v Bacto-tryptone, 0.5% w/v 
Bacto-yeast extract, 10 mM NaCl, 2.5 
mM KCl, 10 mM MgCL, 10 mM 
MgS04 , 20 mM glucose
Stacking buffer (2 X) 0.5 M Tris-HCl pH 6.8
TAB Agarose gel electrophoresis 
buffer
40 mM Tri8-acetate, pH 8.0; 1 mM 
EDTA in dHgO
Tris-EDTA buffer 10 mM Tris-HCl (pH 7.4); 1 mM
î
.3 ,, '
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EDTA (pHS.O)
Tris Buffered Saline (TBS) 0,5 M Tris-HCl pH 8.8; 1.5 M NaCl 
adjusted to pH 7 with HCl in dHgO. 
Dilute 1: 10 to give IX TBS
Tris Buffered Saline plus Tween 20 
(TEST)
IX TBS + 0.05% Tween 20
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Appendix 2.1 MASCOT Output for HcTTR (Section 6.2.3)
Match to: HcTTR Score: 71 Expect: 1.6e-07 
HcTTR
Nominal mass (Mr) : 16892; Calculated pi value: 4.87 
NCBI BLAST search of HcTTR against nrUnformatted sequence string for pasting into other applications
Variable modifications : Carbamidomethyl (C),Oxidation 
(M),Propionamide (C)Cleavage by Trypsin : cuts C-term side of KR unless next residue 
is PNumber of mass values searched: 28 Number of mass values matched: 7 
Sequence Coverage : 41%
Matched peptides shown in Bold Red
1 MKAVILLLFF GVAVAMRDQS lAVKGKLLCG SKPAANVRVK LWEEDGGPDP
51 DDELDAGYTD GSGMFQLSGG TAELTPIDPV FKVYHDCDDG IKPGSRKVKF101 YLPKSYITEG RVPKKTFDIG VLNLETIFPG EERELWSRA RRYYFLDDDY
151 DD
Appendix 2.2 MASCOT Output for rHcMTP fragm ent 
(Section 7.2.3)
Match to: MTP Score : 76 Expect : 5.5e-08 
MTP
Nominal mass (Mr): 22402 ; Calculated pi value : 6.30 NCBI BLAST search of MTP against nrUnformatted sequence string for pasting into other applications
Variable modifications : Carbamidomethyl (C),Oxidation 
(M),Propionamide (C)Cleavage by Trypsin : cuts C-term side of KR unless next residue 
is PNumber of mass values searched: 26 
Number of mass values matched: 9 Sequence Coverage: 68%
Matched peptides shown in Bold Red
1 MEIGHAIiGLF HTMSRYDRDD FITIALENVR EDFVDQYIKE TTETTTNYDL
51 TYDYASIMHY GATGASHNKK PTMIANDVNF QESMGSHILT FIDKSMINDH
101 YNCKAKCLNA KSHQCKNGGF PHPEKCSECI CPSGYGGAFC NERPSGCGRK
151 LVAKQSKQFL IDKLGFGGPV RDEFTFCNYW lEAPEGKTIE RKINSISHG
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Appendix 2.3 MASCOT Output for rHcMTP (Section 7.2.3)
55 kDa rHcMTP
Match to: hcMTP Score: 155 Expect: 9.5e-16 hcMTP
Nominal mass (M^ ) : 55874; Calculated pi value: 8.64 
NCBI BLAST search of hcMTP against nrUnformatted sequence string for pasting into other applications
Variable modifications : Carbamidomethyl (C),Oxidation 
(M),Propionamide (C)Cleavage by Trypsin : cuts C-term side of KR unless next residue 
is PNumber of mass values searched: 41 
Number of mass values matched : 20 
Sequence Coverage : 44%
Matched peptides shown in Bold Red
1 MGLFEKAKGF FKGGNLIDRI KNATLTRFGK IFVKTGLFSF GSKLNQIRKK
51 TMNKLKLTWQ KKKVELESKM KEILARRDNT lEDLKDTIVE INAASNIGKH101 LFQSDILLTK KQADEVLEAV DGTSGRKKRQ AFKDKNYPNT TWLGAQVFYK
151 FDDSADHFTR EMFKKGAKQW EDVSCIKFHH DKENKSEHSI VLIKEEGCWS
201 YVGRLGGEQP LSLGVGCEEV GTAAHELGHA LGLFHTMSRY DRDDFITIAL251 ENVREDFVDQ YIKETTETTT NYDLTYDYAS IMHYGATGAS HNKKPTMIAN
301 DVNFQESMGS HILTFIDKSM INDHYNCKAK CLNAKSHQCK NGGFPHPEKC
351 SECICPSGYG GAFCNERPSG CGRKLVAKQS KQFLIDKLGF GGPVRDEFTF401 CNYWIEAPEG KTIEVKINSI SHGYAYDGCI LGGVEIKSNQ DQTRTGYRLC451 SPNDRNVKLV SASNRLPVIT FNRLGQQQVI LEYKIAELEH HTHH
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49 kDa rHcMTP
Match to: hcMTP Score: 213 Expect: 1.5e-21 
hcMTP
Nominal mass (Mr) : 55874; Calculated pi value: 8.64 
NCBI BLAST search of hcMTP against nr
Unformatted sequence string for pasting into other applications
Variable modifications: Carbamidomethyl (C),Oxidation 
(M),Propionamide (C)Cleavage by Trypsin : cuts C-term side of KR unless next residue 
is PNumber of mass values searched: 30 Number of mass values matched: 20 
Sequence Coverage : 49%
Matched peptides shown in Bold Red
1 MGLFEKAKGF FKGGNLIDRI KNATLTRFGK IFVKTGLFSF GSKLNQIRKK
51 TMNKLKLTWQ KKKVELESKM KEILARRDNT lEDLKDTIVE INAASNIGKH101 LFQSDILLTK KQADEVLEAV DGTSGRKKRQ AFKDKNYPNT TWLGAQVFYK151 FDDSADHFTR EMFKKGAKQW EDVSCIKFHH DKENKSEHSI VLIKEEGCWS
201 YVGRLGGEQP LSLGVGCEEV GTAAHELGHA LGLFHTMSRY DRDDFITIAL251 ENVREDFVDQ YIKETTETTT NYDLTYDYAS IMHYGATGAS HNKKPTMIAN
301 DVNFQESMGS HILTFIDKSM INDHYNCKAK CLNAKSHQCK NGGFPHPEKC
351 SECICPSGYG GAFCNERPSG CGRKLVAKQS KQFLIDKLGF GGPVRDEFTF
401 CNYWIEAPEG KTIEVKINSI SHGYAYDGCI LGGVEIKSNQ DQTRTGYRLC451 SPNDRNVKLV SASNRLPVIT FNRLGQQQVI LEYKIAELEH HTHH
45 kDa rHcMTP
Match to: hcMTP Score : 167 Expect : 8e-17 
hcMTP
Nominal mass (Mr): 55874 ; Calculated pi value : 8.64 
NCBI BLAST search of hcMTP against nrUnformatted sequence string for pasting into other applications
Variable modifications : Carbamidomethyl (C),Oxidation (M),Propionamide (C)Cleavage by Trypsin : cuts C-term side of KR unless next residue 
is PNumber of mass values searched: 28 Number of mass values matched: 17 
Sequence Coverage : 39%
Matched peptides shown in Bold Red
1 MGLFEKAKGF FKGGNLIDRI KNATLTRFGK IFVKTGLFSF GSKLNQIRKK51 TMNKLKLTWQ KKKVELESKM KEILARRDNT lEDLKDTIVE INAASNIGKH101 LFQSDILLTK KQADEVLEAV DGTSGRKKRQ AFKDKNYPNT TWLGAQVFYK151 FDDSADHFTR EMFKKGAKQW EDVSCIKFHH DKENKSEHSI VLIKEEGCWS
201 YVGRLGGEQP LSLGVGCEEV GTAAHELGHA LGLFHTMSRY DRDDFITIAL251 ENVREDFVDQ YIKETTETTT NYDLTYDYAS IMHYGATGAS HNKKPTMIAN
301 DVNFQESMGS HILTFIDKSM INDHYNCKAK CLNAKSHQCK NGGFPHPEKC
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351 SECICPSGYG GAFCNERPSG CGRKLVAKQS KQFLIDKLGF GGPVRDEFTF401 CNYWIEAPEG KTIEVKINSI SHGYAYDGCI LGGVEIKSNQ DQTRTGYRLC
451 SPNDRNVKLV SASNRLPVIT FNRLGQQQVI LEYKIAELEH HTHH
[caSGOW2 4 3  j !  \  R R S I T Y  I L I B R A R Y  1
